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ABSTRACT 
Microbubble-mediated focused ultrasound therapies such as blood-brain barrier 
opening, sonothrombolysis, and sonoporation can non-invasively deliver drugs to a targeted 
region. Despite the potential impact this technology could have in the clinic, there are 
currently concerns regarding its efficacy, uniformity and safety. These challenges ultimately 
stem from a limited ability to control the microbubble dynamics during ultrasound exposure. 
In the current thesis, we sought to design ultrasound exposure sequences and develop 
monitoring techniques that promote the desired acoustic cavitation activity and suppress 
unwanted stimuli that do not produce a safe therapeutic bioeffect. For example, violent 
cavitation activity could cause irreversible damage within the treatment area. The behaviour 
of microbubble populations exposed to low-power therapeutic ultrasound was first 
qualitatively studied using high-speed microscopy. Microbubbles were found to form large 
clusters within milliseconds of exposure and collectively coalesce into larger bubbles. Based 
on these observations and findings in the literature, new therapeutic sequences were designed 
and tested. Rapid short-pulse sonication consisted of μs-long pulses separated by short off-
times. When compared to conventional ultrasound sequences, this pulse sequence enhanced 
the lifetime and mobility of cavitation nuclei and resulted in more uniform acoustic activity 
distributions. To better monitor ultrasound treatment as it evolves, we developed a method 
that passively measures microbubble velocities via the Doppler effect emerging in the 
microbubble acoustic emissions. Using standard passive cavitation detection techniques in 
one and two dimensions, we estimated microbubble velocities on the order of m s-1 during 
ultrasound exposure. Finally, we tested our new therapeutic design in a mouse model in order 
to improve the safety of blood-brain barrier opening. We achieved drug delivery with a 
similar magnitude but with a better uniformity compared to conventional sequences, thus 
demonstrating evidence of favourable microbubble dynamics within the targeted region. 
Taken together, our contribution in ultrasonic stimulation using new sequences and 
monitoring using passive acoustic detection techniques improves our control of microbubble 
dynamics in ultrasound therapy and has the potential to promote treatment efficacy and 
suppress unwanted damage.   
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PREFACE 
 
I hereby confirm that the present Ph.D. thesis is a product of my own work unless 
otherwise stated. The copyright of this thesis rests with the author and is made available 
under a Creative Commons Attribution Non-Commercial No Derivatives licence. 
Researchers are free to copy, distribute or transmit the thesis on the condition that they 
attribute it, that they do not use it for commercial purposes and that they do not alter, 
transform or build upon it. For any reuse or redistribution, researchers must make clear to 
others the licence terms of this work. 
The present thesis is divided into four parts. The first part describes the underlying 
physics governing the dynamics of microbubbles within a therapeutic ultrasound field. An 
outline of the basic theory of isolated and interacting microbubbles is given and is later 
confronted against qualitative and quantitative high-speed microscopy data. The second part 
consists of the therapy designing and the different methods used to assess its success, i.e. 
passive cavitation detection and passive acoustic mapping. The third part focuses on the 
techniques we developed to monitor ultrasound therapy as it evolves. Finally, the last part is 
devoted to the application of the developed methods to achieve targeted drug delivery in vivo. 
The overall aim was to increase our control over the microbubble dynamics emerging in 
ultrasound therapy.  
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INTRODUCTION 
Recent advances in molecular engineering and our understanding of diseases have led 
to the development of highly potent pharmaceutical compounds such as chemotherapeutic 
agents (Kamal et al 2010), viral vectors (Kay et al 2001), siRNA molecules (Castanotto and 
Rossi 2009), and nanoparticles (Peer et al 2007). However, many of these drugs are poorly 
delivered to the targeted site. Only a minute percentage of the injected drug dose finally 
reaches its target due to a series of biological barriers. In order to achieve the desired 
therapeutic effect, an increased systemic dose is introduced into patients. High doses often 
result in deleterious systemic side-effects, with healthy tissues receiving unnecessary 
exposure. Thus, different methods aim to widen the therapeutic window by decreasing the 
dose needed to achieve the desired effect. This can be accomplished by designing targeted 
drug delivery systems that can increase the drug concentration in the diseased site by locally 
overcoming the biological barriers found in the body.  
i.  Biological barriers limiting drug delivery 
Drugs introduced into the patient via the intravenous route circulate throughout the 
entire body within the vasculature. The cardiovascular system is composed of a complex 
network of vessels of different diameters, forming a closed loop in the human body. Starting 
from the heart’s left ventricle, oxygenated blood is pumped through the aorta into the main 
systemic arteries which are in turn branched into arterioles and capillaries. Capillaries consist 
of a lining of endothelial cells connected by junctions, forming a vessel of 5-10 μm in 
diameter which allows an average blood velocity of approximately 1 mm s-1 (Ivanov et al 
1981). Due to their small size, capillaries are responsible for the molecular transport (e.g. 
oxygen, water, nutrients, drugs) between the vasculature and the tissues (Goddard and Iruela-
Arispe 2013). Blood gives off most of its vital payload and takes away waste from the 
surrounding tissues while passing through capillary beds, which are denser in areas with 
increased metabolic demands. Following molecular exchange, deoxygenated blood is 
transferred back to the heart through capillaries merging into venules and veins. The 
pharmacokinetics of a particular drug are thus heavily influenced by capillary permeability.  
The rate in which drugs are transferred from the intravascular system into the 
extravascular space is particularly affected by the capillary type and structure in a given 
tissue (Firth 2002, Clough 1991). There are continuous, fenestrated  and sinusoidal 
capillaries, found for instance in the central nervous system (Paaske and Sejrsen 1989), the 
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kidney (Levick and Smaje 1987), and the liver (Yokomori et al 2012), respectively. The 
ultrastructure of each capillary type has been developed according to the function of the 
relative tissue. A characteristic example of a continuous vessel is the blood-brain barrier, i.e. 
the system that separates the vessel lumen from brain interstitial space. The blood-brain 
barrier is composed of several components that include a tight endothelial cell lining 
surrounded by astrocytes, pericytes, and microglia, and its function is to strictly regulate the 
molecular interchange between the brain and the circulatory system (Zlokovic 2008). Factors 
affecting the vascular permeability rates of a particular drug are the size, charge, 
hydrophilicity, and lipophilicity of the permeating molecule, receptor-mediated uptake, etc. 
(Michel and Curry 1999). Following extravasation, therapeutic molecules need to pass 
through the interstitial space to interact with their therapeutic target. For Alzheimer’s disease, 
many therapeutic targets, such as amyloid plaques, reside within the brain parenchyma. For 
gene therapies, drugs must traverse both the cell membrane and the nuclear membrane to 
interact with the DNA.  
Chemical and physical approaches have been proposed to overcome these biological 
barriers and locally increase the drug concentration in a targeted area without exposing 
healthy tissues to unnecessary doses (Lopes et al 2013). One of the proposed methods is to 
physically alter the vascular permeability within a targeted tissue region. Capillary 
permeability can be non-invasively increased by delivering focused ultrasonic pulses under 
the presence of circulating microbubbles. The current thesis is devoted to improving this drug 
delivery tool, with the aim of increasing its ability to produce uniform drug delivery in a safe 
and controllable manner. 
ii. Focused ultrasound and microbubbles as a drug delivery tool 
Focused ultrasound and microbubbles can locally increase the vascular permeability by 
mechanically agitating the vascular walls (Konofagou et al 2012). Ultrasound is a mechanical 
longitudinal wave with frequencies above the audible range (> 20 kHz). Ultrasound is being 
widely used as an imaging as well as a non-invasive therapeutic tool (Bailey et al 2003, 
Dalecki 2004). An ultrasound beam can be spatially focused to target a specific region deep 
inside the body (i.e., the focal volume) during treatment. Ultrasound alone is being used in 
applications such as thermal ablation of tumours via high intensity focused ultrasound 
(HIFU) exposure (Jensen et al 2013, Hu et al 2007, Huang et al 2012). However, localised 
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mechanical agitation of the microvasculature requires the presence of ultrasound-activated 
microparticles, such as microbubbles. 
The introduction of microbubbles into the bloodstream not only served as an 
improvement of contrast in ultrasound imaging, but also broadened the therapeutic 
applications of focused ultrasound (Stride and Coussios 2010). Microbubbles are typically 
composed of a stabilised gas core and a lipid or polymer shell with a diameter of less than 10 
μm. Due to their compressible gas core, microbubbles interact with the ultrasound field in a 
behaviour known as acoustic cavitation (Apfel 1997). Due to the changes of the applied 
acoustic pressure, microbubbles are driven into radial oscillations following the 
compressional and rarefactional phase of the acoustic wave (Apfel 1997). Additionally, 
acoustic radiation forces can cause the microbubbles to move along the direction of wave 
propagation and towards or away from each other during ultrasound exposure (Dayton et al 
1997, 2002). Consequently, microbubbles can produce a therapeutic or harmful effect due to 
one or more of these phenomena, i.e. mainly due to their vibration and movement. 
These interactions exert mechanical forces onto biological interfaces, such as the 
vascular wall or the cell membrane. Microbubble-mediated mechanical agitation of the 
vascular wall can increase capillary permeability by widening the junctions between adjacent 
cells (Sheikov et al 2008), enhancing trans-cellular transport via endocytosis and 
upregulation of carrier proteins (Meijering et al 2009), forming short-lived pores in the cell 
membrane (van Wamel et al 2006), and potentially other yet undiscovered mechanisms. 
Finally, oscillating microbubbles can disturb cell homeostasis. For example, unstable levels 
of reactive oxygen species and intracellular calcium have been correlated with an increase in 
intra- and inter-cellular permeability of endothelial cells (Juffermans et al 2009, Kooiman 
and Steen 2013). Thus, microbubble-mediated ultrasound therapy increases the concentration 
of drugs in a selected target tissue, allowing the reduction of administered doses and 
minimisation of side-effects.  
iii. Current status and challenges 
Despite successful drug delivery in both in vitro and in vivo applications using focused 
ultrasound, several challenges remain to be addressed. First, drugs should be delivered 
without compromising safety in both the targeted and surrounding tissues. Second, the 
distribution of the drug delivery increase should be uniform within the targeted tissue in order 
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to avoid over- and under-treated regions. Finally, ultrasound therapies have to be adequately 
monitored in order to account for variability that may be produced in different treatment 
sessions and to estimate the therapeutic effects in real-time. These challenges are associated 
with the microbubble dynamics produced during ultrasound therapy and are the focus of this 
dissertation.  
Drug delivery using focused ultrasound has been demonstrated in animal models for 
several organs such as brain (Hen et al 2001), kidney (Li et al 2013, Fischer et al 2009),  liver 
(Wang et al 2013), and prostate (Liu et al 2013). Due to the limited drug permeability 
through the blood-brain barrier, many studies have focused on its disruption (Wang et al 
2014, Nhan et al 2013, Vlachos et al 2011, Choi et al 2011a, Tung et al 2010), showing the 
potential impact of this technology in the treatment for neurodegenerative pathologies such as 
Alzheimer’s disease, Parkinson’s syndrome, and multiple sclerosis. Promising in vivo results 
have led to the initiation of clinical studies for the ultrasonic microbubble-mediated treatment 
of pancreatic cancer (Kotopoulis et al 2013) and glioblastoma multiforme (Carpentier et al 
2016). Apart from neurodegenerative diseases and cancer, microbubble therapies may find 
use in cardiovascular diseases such as atherosclerosis, in liver fibrosis, and others.  
Despite the demonstrations of ultrasound-mediated delivery of a range of drugs to a 
range of targets, this targeted drug delivery system has been also associated with undesired 
side-effects. Examples of erythrocyte extravasation, inflammation, cellular or tissue damage, 
and haemorrhage have been reported in the literature. Increasing acoustic pressures improves 
the delivery of therapeutic agents but also compromises the integrity and homeostasis of the 
surrounding cells and tissues. As a consequence, there is currently a trade-off between 
efficacy and safety in ultrasound therapies (Choi et al 2011b, Baseri et al 2010). 
An additional challenge is that, although the magnitude of permeability increase can be 
adjusted, its spatiotemporal distribution is poorly controlled. The induced bioeffects are 
correlated with the acoustic cavitation dynamics which are in turn dictated by the sonication 
conditions within the focal volume. The magnitude of this effect mainly depends on the 
emitted ultrasound parameters, i.e. the pulse shape and sequence. For example, increasing 
acoustic pressures consistently result in increased permeability rates and higher delivered 
doses. However, conventional ultrasound pulses have not been successful so far in producing 
a uniform distribution of the yielded bioeffect, presenting either a spot-like drug distribution 
(Stieger et al 2007) or an inhomogeneous and asymmetric pattern (Choi et al 2007b, Nhan et 
 Controlling microbubble dynamics in ultrasound therapy 
 
 
20 
 
al 2013, Choi et al 2011b). Due to the lack of control of the in vivo acoustic cavitation 
dynamics, microbubble-vessel interactions are produced in a stochastic and random manner, 
resulting in over-treated and under-treated areas of the surrounding tissue.  
Currently, capillary permeability increase is typically assessed either with T1-weighted 
MRI using Gd-based contrast agents (Tung et al 2010, Choi et al 2007a, 2007b) or with 
microscopy using fluorescently tagged drugs such as dextran (Choi et al 2011b, Nhan et al 
2013). MRI or microscopy testing of the resulting bioeffect is typically performed post-
sonication. While this is sufficient for research purposes, clinical applications require fast, 
real-time, non-invasive, localised and safe monitoring of the therapeutic outcomes. Clinical 
therapies may be unpredictable in terms of their safety and efficacy, due to the differences 
between patients, treatments, targeted regions, drugs etc. This unpredictability stems from the 
produced acoustic cavitation dynamics within the target. A series of technologies have been 
developed for the real-time monitoring and control of microbubble-mediated therapies using 
the microbubble acoustic emissions (O’Reilly and Hynynen 2012, Arvanitis et al 2012) and 
for spatially localising the type and magnitude of microbubble activity in vivo (Gyöngy and 
Coussios 2010), and will be implemented in our work. 
The aim of this doctoral dissertation is to address these challenges and enhance our 
control over microbubble-mediated ultrasound therapies, by promoting the desired 
microbubble dynamics while suppressing the unwanted effects. The first aim was to 
qualitatively and empirically describe the response of microbubbles exposed to a low-power 
therapeutic ultrasound field. Based on our observations and the literature, we designed new 
therapeutic sequences that would achieve better control on the magnitude and distribution of 
the acoustic cavitation dynamics within a physiological environment. In parallel, we sought 
to develop new methods to acoustically monitor the evolution of microbubble movement 
during ultrasound therapy. Finally, we applied our new therapeutic design to achieve targeted 
opening of the blood-brain barrier in a mouse model. Consequently, this thesis is divided into 
four parts: understanding, designing, monitoring, and producing microbubble-mediated 
ultrasound therapy (figure 1). The general aim was to increase the control of microbubble 
dynamics in ultrasound therapy. In doing so, this thesis is expected to advance one step 
further towards clinical implementation of this non-invasive and targeted therapeutic system. 
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Figure 1: Microbubble-mediated ultrasound therapy control loop. Understanding the microbubble 
dynamics arising in a therapeutic field allows for better therapy designs. Monitoring therapy as it evolves aids in 
adjusting the therapeutic design in order to produce better therapies. 
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UNDERSTANDING ULTRASOUND THERAPY 
 
 
 
 
“PHYSICS IS THE ART OF APPROXIMATION” 
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CHAPTER 1 
MICROBUBBLE DYNAMICS IN A THERAPEUTIC ULTRASOUND FIELD 
 
1. Introduction   
Bubbles and sound are routinely used in biomedical and industrial applications. As gas 
pockets embedded within the liquid phase, bubbles are compressible and hence “feel” 
pressure variations on their surface. When exposed to the alternating phases of an acoustic 
field, they respond by expanding and contracting during the rarefactional and compressional 
phases, respectively. This oscillatory behaviour is known as acoustic cavitation (Apfel 1997, 
Leighton 1994). Micrometre-sized bubbles are used as intravascular seeds of acoustic 
cavitation in the biomedical field, both for imaging and therapeutic purposes (Coussios and 
Roy 2008, Stride and Coussios 2010).  
Microbubbles are pre-formed, stabilized, shelled gas nuclei of 0.5-3 μm in radius 
(Lindner 2004). Their minute size allows them to freely flow throughout the vasculature, 
from arteries to arterioles and into the smallest capillaries. Due to their compressibility and 
gas/liquid interface which introduces a large acoustic impedance mismatch surface, they are 
excellent scatterers of ultrasound. These characteristics explain why microbubbles are 
routinely used in the clinic as intravascular ultrasound contrast agents (Cosgrove 2006, 
Cosgrove and Harvey 2009). Microbubbles flowing through the vasculature enhance the 
ultrasound signal received from within the vessels and allow for blood flow visualisation. A 
large body of work has focused on understanding the microbubble behaviour in the 
ultrasound imaging regime, both experimentally and clinically.  
Our understanding of microbubble response to therapeutic sonication in vivo is still not 
complete. The behaviour of microbubbles exposed to a therapeutic field differs from the 
behaviour in an imaging field due to the difference in the acoustic pressure, pulse length and 
insonation centre frequency. These factors greatly influence the way that microbubbles 
volumetrically oscillate, move, and interact with each other. The interaction between the 
circulating microbubbles and therapeutic ultrasound determines the induced bioeffect in vivo. 
To control the treatment outcome, we need to understand the microbubble interaction with 
the ultrasound field. In this chapter, we studied the collective motion of microbubbles 
exposed to a low-pressure therapeutic ultrasound field. Our aim was to quantify specific traits 
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of microbubble movement and determine when multiple microbubble interactions become 
important in a therapeutic field. We also aimed to qualitatively describe microbubble 
behaviours that may emerge in ultrasound therapy. These observations gave us some insight 
about how the ultrasound exposure parameters affected the translational dynamics of the 
sonicated microbubble population. This provided information that allowed us to design pulse 
shapes and sequences that either promoted or suppressed certain microbubble dynamics, in an 
effort to improve therapeutic outcomes.   
i. Cavitation dynamics of a single microbubble  
A single, isolated bubble suspended within an infinite liquid and exposed to alternating 
phases of a pressure wave is a well-studied system. Sonicated microbubbles radially oscillate 
in response to the pressure changes on their surface. Their radius over time can be 
approximated by the Rayleigh-Plesset (RP) equation (Rayleigh 1917, Plesset 1949). The RP 
equation is derived from the Navier-Stokes equation under the assumptions of spherical 
symmetry, infinite body of surrounding liquid and spatially uniform pressure field within the 
bubble (Lin et al 2002). In effect, the RP equation balances the different pressures acting on a 
bubble surface. Many variations of the RP equation have been developed in an effort to 
accurately describe the highly non-linear pulsations of bubbles undergoing acoustic 
cavitation. One of the widely accepted forms of the RP equation in the context of ultrasound 
contrast agents is the Marmottant model (Marmottant et al 2005). This model is based on 
previous models of large-amplitude bubble oscillations (Keller and Miksis 1980) and takes 
into account the different regimes for the surface tension of a non-linearly oscillating lipid-
shelled microbubble. The radius over time is given by:   
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 (1.1) 
where on the left-hand side (LHS) , ,R R R  are the microbubble radius, wall velocity, and wall 
acceleration respectively, and l  is the density of the surrounding liquid. The LHS describes 
the bubble response to the pressure changes expressed on the right-hand side (RHS). These 
are determined by the radius-dependent surface tension  R , the surrounding liquid 
viscosity  , the dilatational viscosity of the lipid shell surface s  and the externally applied 
pressure field   sin(2 )ext pk neg cP t P f t , with cf  being the ultrasound centre frequency and 
pk negP   the peak-negative pressure. The ambient pressure 0P , the initial microbubble radius 
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0R , the polytropic gas exponent  , and the speed of sound c   are constants in equation (1.1). 
  was equal to /P VC C , i.e. the ratio between the specific heats PC  and VC  of the gas core 
under constant pressure and volume, respectively. Also, the speed of sound is considered 
constant in the ultrasound regime, i.e. centre frequency above 20 kHz. 
Marmottant et al. argued that the surface tension changes for the different regimes 
during volumetric oscillations. In the elastic region, surface tension increases linearly with 
radius, up until the rupture point. Rupture occurs when the lipid molecules constituting the 
shell are so far apart, so that the gas phase is in direct contact with the liquid and the surface 
tension of the bubble is effectively equal to the tension of the gas/liquid interface w  . For 
radii smaller than a critical value, the microbubble shell is buckled due to the extensive 
packing of the lipid molecules which decreases the surface tension close to zero (Marmottant 
et al 2005). The transition points were initially considered as sharp edges, but were 
subsequently approximated with second-order polynomials to allow for smooth derivation 
(Sijl et al 2010).  
Equation (1.1) predicts recurrent sinusoidal oscillations in the elastic regime only if the 
driving pressure is sinusoidal and extremely low. The recurrent harmonic oscillation implies 
that the major contributor in the RHS of equation (1.1) is the externally applied sinusoidal 
wave  extP t . This oscillation regime is typically described as stable and non-inertial 
cavitation (Leighton 1994). Increasing the applied pressure increases the radial oscillation 
amplitude, up until the inertial cavitation threshold. Above this threshold, the inertia of the 
surrounding fluid dominates the bubble wall acceleration during the compression phase. 
According to Flynn, a pulsating bubble undergoes inertial cavitation if the value of the 
inertial function is lower (i.e., more negative) than the value of the pressure function, when 
the latter reaches its minimum (Flynn 1975). The inertial collapse of an oscillating bubble can 
be a repetitive process. When inertial cavitation is sustained over a number of acoustic cycles 
we refer to stable inertial cavitation (Church and Carstensen 2001). When microbubbles are 
ruptured or disintegrated into smaller bubbles (Chomas et al 2001), we refer to transient 
inertial cavitation events. Cavitation can also cease due to extensive gas dissolution through 
the lipid shell during the expansion phase over many acoustic cycles (Borden and Longo 
2002, O’Brien et al 2013).   
Sonicated bubbles have a natural frequency or eigenfrequency and a resonance 
frequency. The resonance frequency is lower than the eigenfrequency when a damping factor 
A.N. Pouliopoulos  Doctoral dissertation 
 
 
29 
 
is present. When sonicated at a centre frequency close to resonance, the energy transfer from 
the acoustic wave into the microbubble oscillation is optimal and thus the oscillation 
amplitude acquires its maximum value. For lipid-shelled microbubbles, the eigenfrequency in 
the elastic oscillation regime is given by (van der Meer et al 2007): 
 
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 ,               (1.2) 
which sums the contributions of the Minnaert frequency, i.e. the resonance frequency of 
a free, uncoated bubble (Minnaert 1933), and a shell contribution which increases the 
eigenfrequency. The shell contribution is on the order of 
3
04 / / 2l R   , where   is the 
shell elasticity. Microbubbles with stiffer shells require higher frequencies to reach 
resonance. The resting microbubble radius 0R  is a defining factor in eq. (1.2). Larger 
microbubbles resonate at lower centre frequencies (figure 1.1, for Definity® microbubbles).  
 
Figure 1. 1: Resonance frequency curve for Definity® microbubbles. Red and green areas correspond to 
the size ranges in which microbubbles are resonant in ultrasound imaging and therapy, respectively.  
Microbubbles were first used clinically as ultrasound contrast agents and their sizes 
were engineered in order to ensure safety, by allowing them to freely flow through the entire 
vasculature. Typical ultrasound imaging frequencies lie in the range 2.5 - 10 MHz. Definity® 
microbubbles with a radius between 1.4 and 3.6 μm (figure 1.1) are resonant in this frequency 
range (van der Meer et al 2007). The microbubble size range that resonates within imaging 
frequencies overlaps with the microbubble size range used in the clinic, thus most 
microbubbles are sonicated close to their resonance in ultrasound imaging. 
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In contrast to imaging applications, many therapeutic ultrasound methods require lower 
centre frequencies to allow for deeper penetration and larger focal volumes. Furthermore, the 
cavitation pressure threshold decreases at lower insonation frequencies (Apfel and Holland 
1991). This facilitates the production of the desired bioeffect at low pressures. In applications 
such as sonothrombolysis (de Saint Victor et al 2014) or blood-brain barrier opening 
(Konofagou 2012), centre frequencies are typically between 0.2 and 2 MHz. Only large 
microbubbles with radii between 4 and 15 μm resonate in this frequency range (figure 1.1). 
Clinically-available contrast agents have an average radius of ~ 1 - 1.5 μm (Sennoga et al 
2010). Consequently, an isolated, average-sized and coated microbubble oscillates below its 
resonance state during therapeutic sonication. This conclusion is valid only for single 
microbubbles embedded within an infinite fluid. However, in realistic environments one has 
to deal with microbubble populations embedded within defined structures. 
      
ii. Cavitation dynamics of a microbubble population 
Although the dynamics of a single microbubble are well-described in the literature, the 
time-resolved behaviour of a population of interacting microbubbles within physiological 
environments is not fully understood. Each oscillating bubble is effectively a distinct source 
of ultrasound, producing a secondary pressure field in its surrounding environment. Acoustic 
emissions reradiated by individual microbubbles stem from their volumetric oscillations and, 
neglecting higher order terms, are proportional to (Leighton 1994, Vokurka 1990): 
 2 22lemP R R RR
r

  .                             (1.3) 
These pressure fields are slowly decaying with 1/ r , where r  is the distance from the 
microbubble centre. Although small in amplitude, scattered fields can affect the oscillations 
of neighbouring microbubbles. Multiple scattering can significantly influence microbubble 
dynamics even at moderate concentrations of 106 microbubbles ml-1 (Stride and Saffari 
2005). This concentration limit is valid provided that a sufficient proportion of relatively 
large microbubbles is present within the population, and depends on the insonation frequency 
and acoustic pressure. To account for multiple scattering events, the RP equation (1.1) can be 
extended (Doinikov 2004, Bremond et al 2006b) by adding the interaction term given in 
(1.3): 
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 (1.4) 
where the summation is conducted over the population of the spatially-fixed microbubbles 
within a given distance range from the studied i-th microbubble. 
ijr  is the inter-bubble 
distance, i.e. the distance between the centres of the i-th and j-th bubbles.  
Equation (1.4) describes a system of N coupled differential equations and can be solved 
by assuming low-pressure sonication and linearising the system (Zeravcic et al 2011). The 
solution of this set of damped, coupled, linear oscillators results in the collective oscillations 
of the microbubble population. For high-pressure and close-to-resonance sonication, eq. (1.4) 
can no longer be solved in the linear regime, thus the solutions are no longer harmonic 
functions of defined amplitudes. Instead, chaotic oscillatory dynamics emerge even for 
systems of few interacting microbubbles (Chong et al 2010, Dzaharudin et al 2013). Chaotic 
oscillations are more likely to occur at sonication frequencies close to the microbubble 
natural frequency or eigenfrequency. However, the effective microbubble resonance 
frequency may decrease for high coupling strength between the microbubbles (Yasui et al 
2009). Coupling strength increases with concentration. Above a specific concentration 
threshold, the resonance frequency of the microbubbles decreases with concentration. A 
highly concentrated population can lead to an up to 100 times decrease of the natural 
frequencies, due to the close proximity and large influence of the neighbouring microbubbles  
(Yasui et al 2009). Pressure fields produced by the ultrasonic transducer and the 
neighbouring microbubbles produce a pressure gradient on the surface of each microbubble. 
This pressure gradient gives rise to radiation forces, which may influence the movement of 
microbubbles during sonication. 
 
iii. Microbubble translational dynamics  
Many microbubble-mediated therapies such as sonothrombolysis or sonoporation 
require microbubble movement from within the lumen of a large vessel towards the treatment 
site, i.e. a blood clot or a cell monolayer. Thus, understanding the way that microbubbles 
move in the presence of an acoustic pressure field is important when designing ultrasound 
therapies.  
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Knowing the pressure acting on the surface of a body allows direct estimation of the 
force experienced by this body. This is feasible by calculating the surface integral of the 
pressure P  by the outward normal nˆ  across the surface S . For a small body embedded in an 
ideal fluid and assuming that the wavelength is much larger than the object, i.e. that the 
pressure gradient is constant across its surface, the force can be approximated as (Landau and 
Lifshitz 1959): 
ˆ
S V
F PndS PdV V P         .                           (1.5) 
In the case of a spherical pulsating microbubble, both the volume and the pressure field 
are time-dependent, thus the time-averaged acoustic radiation force reads as (Doinikov 2005): 
   rad
t t
F V t P t   .                  (1.6) 
The experienced pressure is a combination of the primary and secondary pressure fields 
generated by the ultrasonic transducer and the neighbouring microbubbles, respectively. We 
will hereby refer to primary and secondary acoustic radiation, or Bjerknes, forces, depending 
on the origin of the pressure field (Bjerknes 1906). Long ultrasonic pulses used in ultrasound 
therapy promote acoustic radiation forces and trigger microbubble movement. However, the 
extent to which this motion affects ultrasound therapies is not yet clear.  
Primary acoustic radiation forces are experienced by each microbubble and force it to 
migrate through the acoustic field, in the direction of propagation in the case of a free 
travelling wave (Dayton et al 1997, 1999a). When a standing wave is considered, primary 
Bjerknes forces gather microbubbles at the pressure nodes (Crum 1975, Eller 1968, Doinikov 
2005). On the other hand, secondary Bjerknes forces are due to inter-bubble interactions and 
can be either repulsive or attractive. The direction of the secondary force depends on the 
phase difference in the volumetric oscillations of the interacting microbubbles (Lanoy et al 
2015, Doinikov 2005). When driven in phase, microbubbles experience attractive forces and 
form clusters (Chen et al 2016, Fan et al 2014), while when driven in antiphase they repel 
each other (Doinikov 2005). Interestingly, time-averaged secondary Bjerknes forces are 
inversely proportional to 2r , having a striking resemblance to gravitational and electrostatic 
forces. According to Apfel, this analogy highlights the similarities in the nature of the 
acoustic, gravitational and electrostatic fields (Apfel 1988).  
Bjerknes forces have been used to drive microbubble-mediated applications, both in 
vitro and in vivo. Primary forces have been used to promote the binding of targeted 
microbubbles in vivo (Dayton et al 1999b, Zhao et al 2004), dissolve blood clots (Bader et al 
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2015) or push against soft interfaces in order to measure their elasticity (Koruk et al 2015). 
Secondary forces were shown to deform and detach targeted microbubbles attached to a 
surface (Kokhuis et al 2013, Garbin et al 2011), even in low-intensity ultrasound exposure 
(Schmidt et al 2008).  
Collective microbubble behaviour under long-pulse ultrasound excitation has been 
qualitatively studied in the literature. Low-pressure and long-pulse sonication of a dense 
microbubble population moving in a capillary led to extensive cluster formation (Kotopoulis 
and Postema 2010). Clusters behaved as one entity and translated through the capillary in the 
direction of propagation due to primary radiation forces. Qualitatively, the cluster number, 
size, and position depended on the microbubble concentration and applied acoustic pressure 
(Chen et al 2016). However, there is currently a lack of quantified characterization of the 
translational dynamics of individual microbubbles in therapeutically-relevant conditions. It 
has been also observed that microbubbles can undergo coalescence during ultrasound 
exposure (Postema et al 2004). This fusion may lead to the creation of big bubbles that move 
faster than the surrounding smaller microbubbles (Fan et al 2014).  
The role of these dynamics in therapeutic may be important, because they are likely to 
affect the treatment outcome. Here, we study the translational dynamics of microbubble 
populations in the ultrasound therapy regime using high-speed microscopy. Our aim was to 
quantify the clustering process and describe microbubble behaviours emerging in ultrasound 
therapy.  
 
2. Materials and methods 
 
We investigated the movement of a polydisperse microbubble population sonicated at 
therapeutically-relevant ultrasound conditions. These dynamics were empirically studied in 
an in vitro setup. High-speed microscopy videos were analysed and compared against 
theoretical predictions. Trackable microbubble dynamics were quantified using image 
processing techniques. A preliminary qualitative evaluation was performed for dynamics that 
were not quantifiable using our setup. 
 
i. Experimental setup 
Lipid-shelled microbubbles were prepared in-house using previously described 
protocols (Pouliopoulos et al 2014, Shamout et al 2015). The lipid shell consisted of three 
phospholipids (Avanti Polar Lipids Inc., AL, USA), namely dipalmitoylphosphatidylcholine 
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(DPPC-82%), dipalmitoylphosphatidic acid (DPPA-8%), and 
dipalmitolyphosphatidylethanolamine-PEG5000 (DPPE-PEG5000-10%). The lipid solution 
was activated prior to every experiment by introducing perfluorobutane gas (FluoroMed L.P., 
Texas, USA) and mechanically agitating the solution. Lipids spontaneously assembled 
around gas cores and formed spherical micrometre-sized bubbles. We characterized the 
microbubble population using optical microscopy (figure 1.2(a)) and image processing 
algorithms (Sennoga et al 2010). The microbubble size distribution was measured once 
before the experiments. The average microbubble radius was 0.66 ± 0.38 μm, with a range of 
0.25 to 3.96 μm (figure 1.2(b)). These values are potentially skewed towards smaller radii, 
due to many microbubbles being out of focus thus appearing smaller. Also, the size 
distribution may change over time due to gas dissolution (Borden and Longo 2002) or 
rectified diffusion (Crum and Hansen 1982). The concentration of the activated microbubble 
solution was 3.25 × 109 microbubbles ml-1 and the gas concentration was 9.98 μl ml-1.  
 
Figure 1. 2: Characteristics of the microbubble population. (a) Characteristic microbubble population in a 
bright-field microscopy image. Magnification: 20x, bar: 5 μm. (b) Size distribution histogram, fitted with a 
spline function. The mean microbubble radius was 0.66 ± 0.38 μm. 
To ensure clinical relevance, we diluted the activated microbubble solution in 
phosphate buffer saline (PBS) to a concentration of 107 microbubbles ml-1. In comparison, 
the recommended dose of Definity microbubbles for ultrasound cardiac imaging applications 
is 20 μl kg-1 (Unger et al 2004). For an average adult of 70 kg weight and 5 L of blood 
volume, this translates into a concentration of 2 × 106 microbubbles ml-1 of blood. The 
diluted microbubble solution was continuously mixed with a magnetic stirrer (Jencons-VWR, 
East Grinstead, UK). However, the number of microbubbles within the field of view was not 
consistent across the repeats. A round borosilicate glass capillary (inner diameter: 0.6 mm; 
outer diameter: 0.84 mm; CM scientific, West Yorkshire, UK) submerged in a water tank 
(figure 1.3) was used as vessel-mimicking material. We chose glass over plastic due to the 
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superior optical transparency, at the expense of having a stiffer boundary layer. A stiff 
boundary layer was expected to change the oscillation dynamics of each individual 
microbubble (Garbin et al 2007, Helfield et al 2014). As a consequence, microbubble 
movement next to this stiff boundary may differ from movement in physiologically-relevant 
environments. 
 
Figure 1. 3: In vitro experimental setup for investigating microbubble dynamics in ultrasound therapy. A 
0.6 mm in diameter round borosilicate glass capillary was submerged in a deionized water tank and was infused 
with microbubbles. Long-pulse therapeutic ultrasound was emitted from either a 0.5 MHz or 1 MHz focused 
ultrasound transducer. Top view high-speed videos were recorded through a 40x water-immersive lens. 
Microbubbles were infused into the capillary using a syringe pump (Harvard Apparatus, 
Cambridge, UK) and were left to rise into the field of view before sonication. Unless 
otherwise stated, microbubbles were sonicated with ms-long continuous pulses produced by a 
function generator (33500B Series, Agilent technologies, Santa Clara, CA, USA). We have 
also tested pulsed sonication schemes (see chapters 2 and 3), with short μs-long pulses at 
pulse repetition frequencies on the order of kHz. The therapeutic pulses were first amplified 
using a 50 dB power amplifier (325LA, 25W, E&I; Precision Acoustics Ltd, Dorchester, UK) 
and then applied to either a 0.5 MHz focused ultrasound transducer (element diameter: 19 
mm, focal length: 23.6 mm, full width at half maximum (FWHM): 10.2 mm,  part number: 
Q4200001; Olympus Industrial, Essex, UK) or a 1 MHz focused ultrasound transducer 
(element diameter: 25.4 mm, focal length: 50.8 mm, FWHM: 4.7 mm, part number: 
U8517412; Olympus Industrial, Essex, UK). The generated focal pressures were measured 
before the experiments using a 0.2 mm polyvinylidene fluoride (PVDF) needle hydrophone 
(Precision Acoustics Ltd, Dorchester, UK). We tested a pressure range of 25 – 600 kPapk-neg 
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(table 1.I), to trigger the whole spectrum of acoustic cavitation dynamics. A pulser-receiver 
(DPR300; Insidix, Seyssins, France) was used to position the capillary in the acoustic focus 
of the ultrasonic transducers.  
A high-speed camera (Fastcam SA5; Photron Europe Ltd., West Wycombe, UK) was 
connected to an upright bright-field microscope (Olympus, Surrey, UK). A 40x water-
immersive objective (working distance: 3.3 mm, N.A.: 0.8, F.N.: 26.5, part number: 
N2667700; Olympus Industrial, Essex, UK) was mounted onto the microscope and 
submerged into the water tank, so that its focal plane coincided with the plane where large 
bubbles accumulated, i.e. in close proximity with the capillary upper wall. We positioned an 
LED light source (KL2500; Schott AG, Mainz, Germany) below the capillary, to provide 
ample background illumination for high-speed video recording. Video acquisition was 
externally triggered by the function generator sync port and included frames before and after 
sonication. We chose a frame rate of 40,000 frames per second (fps), first to capture 
translational dynamics in the sub-ms time scale, and second to allow for a large field view 
containing an adequate number of microbubbles. Unless otherwise stated, this was the frame 
rate for the captured high-speed videos. The field of view varied between 54 × 78 μm2 and 
287 × 287 μm2, depending on the chosen frame rate and on the spatial range of the observed 
phenomenon. A capillary of known dimensions was imaged before the experiments to 
calibrate our system, which had a resolution of 0.28 μm pixel-1.  
ii. Video processing 
Based on the observed phenomena, we processed the high-speed videos using different 
image processing techniques. Wherever these techniques were not applicable, we 
qualitatively described our optical observations. 
 
a. Motion analysis for individual microbubbles 
We developed an in-house code in Matlab (The Mathworks, Natick, MA, USA) to 
quantify individual microbubble motion. First, high-speed videos were interpolated by 4 
times and then binarized using arbitrary thresholds. Interpolation (figure 1.4(a)) and 
binarization (figure 1.4(b)) allowed clearer delineation between the microbubbles and the 
background. A circular Hough transform (Duda and Hart 1972) was used to detect the 
microbubble centres  ,i ix y  and radii iR  in each binary frame (figure 1.4(b)). Individual 
microbubbles were tagged and their position was monitored in a frame-to-frame manner. For 
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any given couple of successive frames , 1N N  , we calculated the displacement, velocity and 
momentum of each microbubble (figure 1.5) as: 
 1 1,N N N Ni i i i id x x y y    ,  /i i frv d t , and 3,0 ,0
4
3
i i i PFB i i PFB i ip m v V v R v       (1.7) 
where 
frt  was the time between frames and PFB  was the ambient density of 
perfluorobutane (considered as an ideal gas). 
frt  was generally equal to 25 μs for a frame rate 
of 40 kfps.   
 
 
Figure 1. 4: Image processing routine to determine microbubbles centres and radii. (a) Raw videos were 
interpolated by 4x to clearly resolve the boundaries of each microbubble. (b) Interpolated videos were binarized 
using arbitrary thresholds in order to allow for an easier implementation of the circular Hough transform. The 
centroids (green dots) and the perimeter (red circles) of each microbubble were monitored over time. Colour 
bars represent pixel intensity. Bar: 5 μm. 
 
Figure 1. 5: Microbubble displacement vectors. Vectors id   represent the spatial microbubble movement 
between two successive frames , 1N N  . The colour bar represents pixel intensity. Bar: 5 μm. 
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b. Motion analysis for fluid microstreaming  
To quantify less discernible motion at a pixel level, we implemented an optical flow 
analysis. Optical flow algorithms calculate the apparent velocities of objects in a sequence of 
images (Barron et al 1992), by estimating the intensity differences in neighbouring pixels. 
Optical flow implementation assumes limited movement between frames. This analysis 
provided information about the fluid motion or microstreaming induced by bubble radial 
oscillations. Also, we applied this method to estimate the movement in a highly-concentrated 
microbubble population, where individual microbubble tracking was not feasible. The latter 
application will be shown in chapter 4.  
iii. Time-average model 
To compare the experimental results with the existing theoretical models of 
translational dynamics, we applied a simplified time-averaged model of collective 
microbubble movement in the stable and non-inertial cavitation regime. There is a large body 
of work on time-resolved modelling of coupled oscillation and translation dynamics 
(Doinikov 1999, 2005, Oguz and Prosperetti 2006, Reddy and Szeri 2002, Garbin et al 2009, 
Zhang et al 2011). These models have shown remarkable agreement with experimentally 
measured trajectories of isolated microbubble pairs (Garbin et al 2009). However, they can 
be very complex when implemented in many-bubble systems. For example, it has been 
demonstrated that ninth-order terms need to be taken into account to reproduce the movement 
of interactive microbubble pairs at arbitrary distances (Doinikov and Bouakaz 2015). As a 
result, most studies investigating the collective oscillation dynamics of a microbubble 
population have been hitherto limited to spatially-fixed bubbles (Zeravcic et al 2011, 
Bremond et al 2006b, 2006a).  
Here, we implemented a time-average approximation, where the secondary radiation 
forces are time-independent and proportional only to the volume and the distance between the 
interacting microbubbles (Zheng and Apfel 1995, Dayton et al 1997). Our main assumption 
was that the microbubble oscillations were purely sinusoidal and small in amplitude, i.e. that 
microbubbles were undergoing stable and non-inertial cavitation. Microbubbles were 
assumed to maintain their resting radius and volume during low-pressure sonication, i.e. 
  ,0i iR t R  and   ,0i iV t V . This assumption was justified in a two-fold manner. First, the 
clustering timescale during low-pressure (< 200 kPapk-neg) and long-pulse (> 10 ms) 
sonication is on the order of ms (Kotopoulis and Postema 2010, Chen et al 2016). For centre 
frequencies on the order of MHz volumetric oscillations occur in the μs scale or 1,000 times 
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faster than the investigated timescale. Accurate calculation of the microbubble radius over 
time was not necessary in this context. Second, at sonication frequencies of 0.5 or 1 MHz, the 
microbubbles used in our experiments (figure 1.2) are expected to oscillate well below 
resonance, i.e. 0cf f   (eq. (1.2) and figure 1.1). Consequently, the volumetric oscillations 
were expected to be small, recurrent and in phase with the driving field.  
Mild sinusoidal oscillations lead to negligible primary radiation forces (eq. (1.6)), hence 
in our model we ignored the contribution from the primary Bjerknes force. Since all 
microbubbles oscillated in phase with the primary field, they were assumed to experience 
only attractive forces (Doinikov 2005). The total attractive force felt by each bubble i  was 
calculated as the vector sum of all the pairwise interactions with the neighbouring bubbles j , 
i.e int,i j i
j i
F F 

 . Applying Newton’s second law, we formulated a system of N  coupled 
time-averaged equations for a population of N  interacting microbubbles. Taking into account 
the secondary Bjerknes force 
int,iF , the quasi-static drag force ,drag iF , and an added mass force 
,add iF , the time-averaged equation of motion read: 
 
3 3
2 ,0 ,02 3
int, , , ,0 ,02
2 2
ˆ 6 0
9 3
i jl
i drag i add i pk neg ij i i i i
i j ij
R R
F F F P r R v R v
r

   

           (1.9) 
  where 2 cf   was the angular frequency of the driving field, 
21/ lc   was the 
compressibility of bubbles suspended in water (Dayton et al 1997), and   was the water 
dynamic viscosity (table 1.I). iv  and iv  were the microbubble velocity and acceleration, 
respectively. 
ijr  and iˆjr  were the norm and unit vector along the path connecting two 
interacting bubbles, respectively. This time-averaged expression was derived under the 
assumption of 
,0iR   and ijr  , where   is the ultrasound wavelength (Zheng and 
Apfel 1995). This assumption is generally valid in ultrasound therapy due to the relatively 
long wavelengths (1 - 3 mm for centre frequencies of 0.5 - 1.5 MHz). We did not include 
history forces (Garbin et al 2009) or friction from the capillary walls (Dayton et al 2002) in 
our model. Accurate history force estimation requires time-resolved modelling (Garbin et al 
2009) and friction estimation requires knowledge of the friction coefficient (Dayton et al 
2002). Neither was applicable in our approach. Eq. (1.9) was solved numerically in Matlab 
using the ode45 solver and a time step of 0.1 μs. We used the experimental frames before the 
sonication onset as initial condition in our simulations. Once clusters formed, they were 
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immobilised in their formation position and each clustered microbubble was forced to 
reorganise upon contact around the biggest bubble of the cluster (Vaz et al 2010, Cox and 
Graner 2004). 
 
Table 1. I: Experimental and simulation parameters for studying microbubble dynamics in ultrasound 
therapy. 
Symbol Parameter Values / Units 
cf  Centre frequency 0.5, 1 MHz 
pk negP   Peak-negative pressure 25, 50, 75, 100, 600 kPa 
PL Pulse length 0.005, 0.05, 10, 20, 100 ms 
l  Water density 10
3 kg m-3 
PFB  Perfluorobutane density (ideal gas) 9.7 kg m
-3 
  Water dynamic viscosity 10-3 Pa s 
  Microbubble compressibility in water 5 ×10-7 m2 N-1 
c Speed of sound 1.5 × 103 m s-1 
dt ode45 solver time step 0.1 μs 
 
 
iv. Secondary acoustic radiation potential and force field map derivation 
At low acoustic pressures, microbubble movement is mainly due to secondary acoustic 
radiation forces which follow the inverse square law. Acoustic radiation forces depend only 
on position, hence are conservative and can be expressed as the gradient of a secondary 
acoustic potential field. Analytical expressions for the acoustic radiation force potentials were 
proposed during the early 1960’s (Gor’kov 1962). Drawing inspiration from gravitational and 
electrostatic fields (Apfel 1988), we assumed that the secondary Bjerknes forces are produced 
by a potential field diminishing with 1/ r  which is proportional to the volume of each 
microbubble iV . The potential produced at a distance r  from a single microbubble is thus 
proportional to /iV r . At this location, the total potential energy would be the sum of the 
contribution of all the microbubbles surrounding this point. Consequently, using binary 
experimental images of microbubble populations, we approximated an effective secondary 
radiation force potential (figure 1.6(b)), as: 
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where volume iV   was represented in our 2D space as the total intensity decrease iI   
of the binary image due to the presence of each microbubble. Note that microbubbles had an 
intensity of 0 in the binary images (figure 1.4(b)). Summation was conducted over a defined 
circle C (figure 1.6(a)), whose radius represented the interaction range of secondary Bjerknes 
forces. The secondary acoustic radiation force field was acquired by simply calculating the 
gradient of the normalized potential field, secF U  . These first-order approximations were 
expected to give a rough estimate of the secondary force field magnitude and directionality in 
our high-speed observations, providing a comparative measure of secondary interactions 
around individual microbubbles and microbubble clusters. 
 
Figure 1. 6: Derivation of the secondary acoustic radiation potential field. (a) A region of secondary 
Bjerknes interactions was selected around every location in the binary image. (b) Normalized potential map. The 
colour bar represents normalised potential field values. Bar: 20 μm. 
 
3. Results 
 
We sought to characterise the movement of a microbubble population exposed to long-
pulse and low-pressure therapeutic ultrasound pulses. Using high-speed microscopy, we 
qualitatively and quantitatively studied the phenomena related to collective microbubble 
cavitation and translation. We will initially discuss the clustering dynamics during the first μs 
of sonication, both in small and in large microbubble systems. We will then investigate 
clustering dynamics of large microbubble systems in the ms time scale. Finally, we will 
qualitatively discuss the dynamics of coalescence events and chaotic behaviours arising in 
ultrasound therapy. 
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i. Clustering 
Secondary radiation forces dominated during long-pulse sonication. Microbubbles 
formed clusters within a few ms after the initiation of sonication (figure 1.7). Due to their 
strong acoustic emissions, large bubbles exerted large attractive forces to their surrounding 
microbubbles, serving as seeds for the clustering process.. These large clusters moved as one 
entity in the direction of ultrasound propagation (bottom up), due to primary acoustic 
radiation forces.  
 
 
Figure 1. 7: Clustering during long-pulse ultrasound therapy. Clusters formed in the first few ms after 
sonication started, and translated towards the ultrasound propagation direction (bottom up). fc: 0.5 MHz, Ppk-neg: 
100 kPa. 
 
a. Clustering initiation in a small microbubble system 
First, we studied an “isolated” system of clustering microbubbles (figures 1.4 and 1.5). 
Focusing on the first few frames after the pulse began (0 – 200 μs), the trajectories of each 
bubble were accurately monitored over time until all bubbles aggregated (figure 1.8). 
Applying equations (1.7), we calculated the vectors of displacement, velocity and momentum 
of each individual microbubble. When studying vector fields, polar plots are useful to gather 
and quantify both the magnitude and direction of the vector set. Velocity and momentum 
polar plots revealed the angular distribution of the clustering process for different time points 
(figure 1.9). This 2D distribution was a projection of the 3D microbubble movement. This 
movement occurred next to the capillary wall, thus the 2D approximations were not likely to 
differ significantly from the 3D values. The vectors showed in figure 1.9 are plotted on the 
N -th frame, to illustrate the movement observed on the ( 1N  )-th frame in figure 1.8. 
Microbubbles started moving at a relatively slow speed of up to 0.005 m s-1, and then 
accelerated up to 0.1 m s-1 right before the formation of the cluster at the centre of the field of 
view (figure 1.8-right). The velocity distribution changed over time, with the average 
microbubble velocity being ~ 15 mm s-1 (figures 1.9(b) and 1.9(c)). Polar plots indicated that 
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although the initial angular distribution is random (figures 1.9(c) and 1.9(d)-left), a 
preferential direction arises as time progresses.  
 
Figure 1. 8: Initial clustering of an isolated microbubble system. A large bubble served as a clustering seed, 
attracting the smaller neighbouring bubbles. fc: 0.5 MHz, Ppk-neg: 100 kPa. Bar: 5 μm. 
 
Figure 1. 9: Quantification of initial clustering dynamics in an isolated microbubble system. (a) 
Displacement vectors applied on the centroids of the recreated microbubbles. (b) Velocity histogram, showing 
the incidence of each measured microbubble velocity. The number of velocity bins was 10 and the width of each 
bin was calculated based on the maximum velocity detected. (c) Velocity polar plot. Each of the two concentric 
circles represents the microbubble velocity magnitude (in m s-1). The polar coordinate of each red vector (in 
degrees) represents the direction of the bubble movement. (d) Momentum polar plot. Each of the two concentric 
circles represents the microbubble momentum magnitude (in kg m s-1). The polar coordinate of each blue circle 
(in degrees) represents the direction of the bubble movement. fc: 0.5 MHz, Ppk-neg: 100 kPa. 
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b. Clustering initiation in a large microbubble system 
Similar analysis can be conducted for larger microbubble populations during the first 
microseconds of therapeutic sonication (figures 1.10 and 1.11). Large populations may be 
present in large vessels, where the blood flow is fast and the boundary conditions present in 
our setup are lacking. Large bubbles within the population served as “nucleation points” for 
the clustering process, which progressed rapidly within 200 μs (figure 1.10). Given the 
number of microbubbles which were not in the vicinity of a large bubble, many of the 
measured velocities were close to zero (figures 1.11(a) and 1.11(b)). Secondary radiation 
forces acted only within a specific range, letting a small subset of the population into motion 
(figure 1.11(b)). The peak of the motion for the beginning of the sonication was observed 
between 50 and 100 μs. During the first 200 μs of sonication, the maximum velocity observed 
had a range between 0.005 and 0.1 m s-1 (figures 1.11(b) and 1.11(c)). Polar plots showed the 
directionality “dispersion” of the microbubble velocities and momentums (figures 1.11(c) and 
1.11(d)), which is more extensive than in the isolated system (figures 1.9(c) and 1.9(d)).  
 
 
Figure 1. 10: Initial clustering of a large microbubble system. Large bubble served as clustering seeds, 
attracting the smaller neighbouring bubbles. fc: 0.5 MHz, Ppk-neg: 100 kPa. Bar: 5 μm. 
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Figure 1. 11: Quantification of initial clustering dynamics in a large microbubble system. (a) Displacement 
vectors applied on microbubbles. (b) Velocity histogram, showing the incidence of each measured microbubble 
velocity. The number of velocity bins was 10 and the width of each bin was calculated based on the maximum 
velocity detected. (c) Velocity polar plot. Each of the two concentric circles represents the microbubble velocity 
magnitude (in m s-1). The polar coordinate of each red vector (in degrees) represents the direction of the bubble 
movement. (d) Momentum polar plot. Each of the two concentric circles represents the microbubble momentum 
magnitude (in kg m s-1). The polar coordinate of each blue circle (in degrees) represents the direction of the 
bubble movement. fc: 0.5 MHz, Ppk-neg: 100 kPa. 
 
c. Clustering evolution in a large microbubble system 
The above analysis focused on the beginning of the clustering process (0 - 200 μs). 
Therapeutic sonication is typically performed using ms-long pulses, thus the clustering 
process progresses until the end of the ultrasound pulse. For long sonication periods, we were 
able to apply our time-averaged model (eq. (1.9)) and compare it against the experimental 
data (figure 1.12). Microbubbles formed clusters rapidly during the first few milliseconds of 
sonication. Clusters of 3 - 6 bubbles were formed in regions of high local concentration. 
Despite the number of assumptions in our time-average model, there was reasonable 
agreement between the experimental and predicted clusters’ number, size, and location. 
Clusters were immobilised upon formation in our simulations, thus cluster localisation 
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accuracy worsened with time. After 6 ms of sonication, there was 100% overlap between 
experimental and theoretical cluster localisations (7 out of 7), while after 13 ms of sonication 
the overlap was reduced to 71% (5 out of 7). In this example video, the average cluster size 
was 4 microbubbles, however this varied with concentration and pressure. 
 
Figure 1. 12: Clustering of a large microbubble system in the ms scale. Experimental (left column) and 
theoretical (middle column) configurations at the beginning of the therapeutic pulse (top), 6 ms (centre) and 13 
ms later (bottom). Theoretical cluster positions (red circles) showed good agreement with the observed positions 
(right column). fc: 1MHz, Ppk-neg: 50 kPa. 
To quantify the clustering process on the ms timescale, we counted the number of 
aggregated microbubbles as a function of time for three different acoustic pressures (figure 
1.13). Microbubbles clustered exponentially over time, both in the experimental and in 
theoretical conditions. A rapid clustering phase (0 - 5 ms), was followed by a reduction of the 
clustering incidences (5 - 15 ms), until a plateuau was reached and no more bubbles 
aggregated (> 15 ms). Higher pressures led to an earlier equilibrium state. Generally, our 
time-averaged model overestimated the number of aggregated microbubbles.  
To quantitatively describe the clustering dynamics on the ms scale, we fit the number of 
aggregated microbubbles over time to an exponential function  1  BtA e . A  was the 
number of clustered microbubbles by the end of the pulse in each experiment, while B   was 
the reciprocal time constant of the exponential fit. We normalised these values to the mean 
distance between microbubbles r , in order to acquire a comparable measure of the extent 
and rate of the clustering process across the acoustic pressures. r  was inversely 
proportional to the concentration. Division with this measure was conducted in order to 
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incorporate the effect of microbubble concentration to the measured clustering dynamics, and 
to provide values of clustering magnitude and rate per unit length. Our experiments imaged 
microbubbles on a 2D plane, thus the average inter-bubble distance was calculated as 
/occr S M , where occS  was the surface area occupied by the M  microbubbles in the 
first frame. On average, the normalised clustering magnitude increased linearly with pressure, 
both for experiments and simulations (figure 1.14). Experimental and theoretical clustering 
magnitudes were on the order of 1 - 3 and 1.5 - 4 microbubbles μm-1, respectively. On the 
other hand, the normalised clustering rate appeared constant for sonication at 50 and 75 
kPapk-neg, before increasing for 100-kPapk-neg sonication. Instead, the theoretical clustering rate 
increased monotonously with pressure. Experimental and theoretical clustering rates were on 
the order of 0.01 - 0.02  and 0.01 - 0.05 microbubbles ms-1 μm-1, respectively (figure 1.14). 
 
Figure 1. 13: Temporal evolution of microbubble clustering dynamics. Predicted (blue line) and observed 
(red circles) number of clustered microbubbles as a function of time. Exponential functions were fit to derive 
simulated (light blue dashed line) and experimental (light red dotted line) clustering functions. fc: 1 MHz. 
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Figure 1. 14: Normalised clustering magnitude and rate. Experimental (red filled symbols) and simulated 
(blue empty symbols) clustering magnitude and rate across the acoustic pressures (n=3). Clustering magnitude (
-1
A r , boxes connected with solid lines) increased linearly with pressure, while clustering rates (
-1
B r , 
circles connected with dotted lines) increased monotonously in the simulations but only after 75 kPapk-neg in the 
experiments. MB: microbubbles. 
Similar dynamics were observed in the low-pressure regime both for 0.5 and 1 MHz 
sonication. In acoustic pressures above the inertial cavitation threshold (> 150 kPapk-neg), 
microbubble dynamics became increasingly chaotic and quantification was not possible. 
Increasing the acoustic pressure above a certain threshold led to an increased incidence of 
another fascinating phenomenon: microbubble coalescence. 
ii. Observations of coalescence 
In contrast to free air bubbles, micrometre-sized ultrasound contrast agents are 
engineered so that they circulate freely throughout the entire vasculature. To improve 
stability and avoid fusion into larger bubbles, microbubbles are typically coated with a lipid 
shell. In our in-house prepared microbubbles, we incorporated DPPA which is a negatively-
charged lipid chosen to repel neighbouring bubbles. DPPA effectively introduces a repulsive 
electrostatic field that reduces the probability of coalescence driven by attractive radiation 
forces. As soon as the ultrasound field was turned off, we observed microbubble clusters 
slowly disintegrating due to the action of the repulsive electrostatic field. However, we 
observed multiple instances of microbubble clusters fusing into large bubbles due to 
secondary attractive forces. 
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a. Collective microbubble coalescence 
Coalescence occurred in the microsecond scale and typically originated from the fusion 
of multiple contrast agents which were originally aggregated in large clusters (figure 1.15). 
The resulting bubbles were on the order of 8 - 12 μm in diameter. Microbubbles of this size 
were resonant at 0.5 - 1 MHz sonication (figure 1.1) and underwent violent volumetric 
oscillations. Upon formation, the boundaries of the large bubble were not well defined.  This 
blurred depiction of the bubble boundaries may be due to the stroboscopic effect created by 
the oscillations of the large bubble, which were not adequately sampled due to the limited 
frame rate of our system. Intense primary Bjerknes forces violently accelerated the resonant 
bubbles at m s-1 velocities in the direction of ultrasound propagation.  
 
 
Figure 1. 15: Collective microbubble coalescence event. Large microbubble clusters collapsed under the 
influence of secondary radiation forces and fused to form large bubbles of resonant sizes. The produced bubbles 
were accelerated in the direction of ultrasound propagation at m s-1 velocities due to primary Bjerknes forces. fc: 
0.5 MHz, Ppk-neg: 100 kPa. Bar: 5 μm. 
 
b. Resonant microbubble behaviour 
Bubbles resulting from multiple coalescence events traversed the field of view within a 
few hundreds of microseconds, exerting large attractive forces to neighbouring bubbles up to 
~ 30 - 40 μm away (figure 1.16). Smaller microbubbles accelerated towards the big bubble at 
velocities on the order of m s-1. These microbubbles generally followed a spiral trajectory and 
eventually fused with the big bubble.  
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Figure 1. 16: Resonant microbubble movement. Big microbubble oscillating close to resonance and 
traversing the field of view at a speed of 0.6 m s-1. Smaller microbubbles were accelerated towards the bigger 
bubble and were eventually absorbed following a spiral motion. fc: 0.5 MHz, Ppk-neg: 100 kPa. Bar: 5 μm. 
High-speed observations of the collective microbubble coalescence provided insight 
into the mechanism behind this spiral motion. Optical flow analysis showed that the fluid 
around the big bubble is moving upon formation, indicating that the spiral trajectories of the 
attracted microbubbles are possibly due to acoustic microstreaming or the spinning motion of 
the resonant bubble. Axial fluid velocities computed with the optical flow method revealed 
microstreaming and fluid movement around both the bubble cluster (figure 1.17 - top) and the 
coalesced bubble (figure 1.17 - bottom). Interestingly, axial velocities towards the transducer 
were generally higher (up to 6 m s-1, in blue) than away from the transducer (up to 3 m s-1, in 
red).  
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Figure 1. 17: Optical flow analysis of collective microbubble coalescence. Axial velocity magnitudes away 
(in red) and towards (in blue) the transducer are plotted at each location. fc: 0.5 MHz, Ppk-neg: 100 kPa. Bar: 5 
μm. 
c. Coalescence of microbubble pairs 
Microbubble coalescence was also observed in pairs located within clusters of large 
bubbles (> 5 μm in diameter), at higher pressures than in systems of smaller microbubbles 
(figure 1.18). In this particular example the coalesced bubble did not accelerate due to 
primary Bjerknes forces as before (figures 1.15 and 1.17). This behaviour was observed once 
in our experiments and was possibly due to the short pulse length used in this example (5 
cycles at a PRF of 1.25 kHz) or due to strong attractive forces exerted from the neighbouring 
bubbles. An interesting observation is that the original large bubble cluster was organised in a 
2D hexagonal “lattice” structure. Dense packing was also observed in clusters of smaller 
microbubbles of approximately equal sizes.  
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Figure 1. 18: Pair coalescence in a system of 6 large microbubbles. fc: 0.5 MHz, Ppk-neg: 600 kPa. Bar: 5 μm. 
 
iii. Observations of chaotic behaviour 
During sonication at high acoustic pressures we observed instances of chaotic 
behaviours within microbubble clusters. Microbubble aggregates were continuously 
reorganising due to strong inner attractive forces (data not shown). Interestingly, we observed 
a phenomenon inverse to microbubble fusion. Instead of microbubble coalescence due to 
attractive forces, we captured an incidence of microbubble expulsion out of the cluster (figure 
1.19). This may be due to strong repulsive forces generated within the cluster. We speculate 
that these repulsive forces stem from the chaotic oscillations within the cluster. We 
hypothesise that due to the non-periodic nature of chaotic oscillations, a single microbubble 
may momentarily oscillate in antiphase with the rest of the aggregated microbubbles, thus 
experiencing strong repulsive forces. However, this explanation remains speculative and 
needs to be evaluated in future experimental and theoretical studies. 
 
Figure 1. 19: Microbubble repulsion out of a cluster. fc: 1 MHz, Ppk-neg: 600 kPa. Bar: 5μm. 
iv. Secondary acoustic radiation potential and force fields 
Microbubble clustering and coalescence in a therapeutic ultrasound field are driven by 
the secondary radiation forces. Secondary Bjerknes forces are long-range interactions and 
their potential falls with 1/ r . To visualise the interaction range and quantify secondary 
radiation forces for therapeutic sonication, we plotted the normalised secondary potential 
field as approximated in eq. (1.8). Below a specific potential threshold, microbubbles started 
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experiencing their neighbours’ attraction and the clustering process was initiated. By 
repeating the potential field calculation over different interaction ranges (figure 1.20), we 
qualitatively estimated that the interaction range was between 25 - 30 μm at 0.5 MHz and 10 
- 15 μm at 1 MHz sonication. This was determined by assuming that microbubbles that are 
about to cluster are embedded within a potential of the same intensity (i.e., colour). 
   
 
Figure 1. 20: Estimation of interaction range using potential maps. The colour bar represents normalised 
potential field values. . fc: 0.5 MHz, Ppk-neg: 25 kPa. Bar: 20 μm. 
The dynamic change of the secondary potential web connecting the interacting 
microbubbles confirmed the interaction ranges (figure 1.21). The potential threshold for the 
initiation of attraction was approximately 0.85, for an interaction range of 30 μm. As 
secondary forces stem from the action of the conservative secondary potential, we determined 
the attractive forces by simply calculating the gradient of the potential field (figure 1.22). 
Secondary Bjerknes forces were more intense in the areas of steep potential changes, and 
acquired the maximum values in the areas surrounding the microbubble clusters. Such force 
fields quantify the likelihood of microbubble movement towards a preferential direction.  
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Figure 1. 21: Normalised secondary potential field over time. Microbubbles connected with a web of similar 
potential values eventually formed clusters. The colorbar represents the normalised secondary radiation potential 
field (a.u.). Interaction range: 30 μm. fc: 0.5 MHz, Ppk-neg: 25 kPa. Bar: 20μm. 
 
Figure 1. 22: Secondary Bjerknes force field derived by the gradient of the normalised potential field over 
time. Microbubbles preferentially moved towards the direction of the larger secondary force. Microbubble 
clusters produced a strong attractive field in their surrounding areas. The colorbar represents the normalised 
secondary radiation potential field (a.u.). Interaction range: 30 μm. fc: 0.5 MHz, Ppk-neg: 25 kPa. Bar: 20μm. 
 
A.N. Pouliopoulos  Doctoral dissertation 
 
 
55 
 
4. Discussion 
 
i. Microbubble movement during ultrasound therapy 
Here, we quantified specific traits of the microbubble clustering process in a therapeutic 
ultrasound field. Furthermore, we reported some interesting observations that may be 
important in understanding the bioeffects produced in ultrasound therapy. Our motivation 
was to provide some empirical insight into the mechanisms that produce the bioeffects in 
vivo. Although it is often underestimated, or even ignored, microbubble movement has a key 
role in ultrasound therapies such as sonothrombolysis, sonoporation, targeted drug release, 
and blood-brain barrier disruption. Thus, studying the collective translational dynamics of 
microbubbles exposed to ultrasound therapy may aid in understanding of treatment outcomes 
and designing new therapeutic schemes. 
In contrast to ultrasound imaging, therapeutic pulses are usually long (> 1ms) and at a 
relatively low centre frequency (0.2 - 2 MHz). Such pulses promote the action of primary and 
secondary acoustic radiation forces (Dayton et al 2002, 1997). We have shown here that 
radiation forces in therapeutic ultrasound set microbubbles into continuous motion at m s-1 
velocities, i.e. several μm μs-1. Primary forces acting on resonant microbubbles accelerated 
them at 0.5-1 m s-1 at an acoustic pressure of 100 kPapk-neg (figures 1.15, 1.16, 1.17). These 
values are in agreement with instantaneous velocities reported in ultrasound imaging 
sequences at pressures below 200 kPapk-neg (Vos et al 2007, Tortoli et al 2009). Imaging 
pulses are usually comprised of 2 - 3 acoustic cycles, hence microbubbles experience 
radiation forces for a few μs. At long-pulse sonication, m s-1 velocities are maintained during 
the entire pulse duration. Microbubble displacement is proportional to the employed pulse 
length (Palanchon et al 2005) and this was confirmed here. Large primary Bjerknes forces 
were experienced only by large bubbles (> 10 μm in diameter) in our experiments. Smaller 
bubbles were driven below their resonant frequency (figure 1.1) and did not experience 
observable primary forces. 
In the low-pressure sonication regime, we showed that secondary Bjerknes forces 
dictate the microbubble movement (figure 1.12). Microbubbles accelerated during the first 
tens of microseconds reaching terminal velocities of a few cm s-1 shortly after the ultrasound 
exposure initiation (figures 1.8, 1.9, 1.10, 1.11). Due to the large deviation between the 
sonication and the resonance frequencies (figure 1.1), microbubbles oscillated in phase with 
the primary field and the secondary Bjerknes forces were only attractive (Doinikov 2005). 
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Driven by ms-long ultrasound pulses, microbubbles eventually aggregated into clusters 
(figures 1.7, 1.8, 1.12) as shown before (Dayton et al 1997, Kotopoulis and Postema 2010, 
Fan et al 2014, Chen et al 2016). Although the phenomenon of bubble clustering has been 
well studied in the literature, quantification of the clustering dynamics in a therapeutic 
ultrasound field was still lacking. 
ii. Microbubble clustering 
Here, we confirmed that microbubble clustering readily occurs at low-pressure 
therapeutic sonication at a centre frequency of both 0.5 MHz (figure 1.7) and 1 MHz (figure 
1.12). The number of clustered microbubbles increased exponentially over time and in a step-
wise manner (figure 1.13). Higher pressures led to larger number of aggregated bubbles and 
faster aggregation rates. We fit the evolution of the clustering process with an exponential 
function to quantify these dynamics across the acoustic pressures. Normalizing the number of 
aggregated microbubbles in the end of the therapeutic pulse with the average inter-bubble 
distance gave the normalized clustering magnitude (figure 1.14). We observed a linear 
increase of the clustering magnitude with acoustic pressure, ranging from 1 to 3 microbubbles 
μm-1. This suggested that the “potential” or likelihood of clustering increases linearly with the 
amplitude of the primary acoustic field.  
The use of the inter-distance parameter r  allowed us to decorrelate the clustering 
magnitude from the variations in the local concentration for each experimental repeat. 
Therefore, the trends found here depend only on the cavitation dynamics and not on the 
number of the bubbles involved in the clustering process. The experimental clustering rate 
appeared to increase from 0.01 to 0.02 microbubbles ms-1 μm-1 only after 75 kPa (figure 
1.14). This transition may be due the inertial cavitation threshold being surpassed 
(Radhakrishnan et al 2015, 2013, Chen et al 2003). Volumetric oscillations within the inertial 
cavitation transition were expected to lead to faster clustering rates (Chen et al 2016), and 
this was confirmed here. 
iii. Theory vs. experiment 
Interestingly, our time-average model which incorporated secondary acoustic radiation, 
drag and added mass forces (eq. (1.9)), showed reasonable agreement with the observed 
clustering dynamics at very low acoustic pressures (figure 1.12). The clusters’ size, shape, 
and location were reasonably reproduced at different time-points during sonication. Time-
averaging over an acoustic cycle (Mettin et al 1997, Dayton et al 1997) was assumed to be 
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valid within the stable cavitation regime where radial oscillations are sinusoidal and periodic. 
Our model generally produced faster clustering dynamics than experimentally observed 
(figures 1.13 and 1.14). The mismatch between the simulated and experimental values 
increased with acoustic pressure (figure 1.14), indicating that the more microbubble 
oscillations deviate from their sinusoidal shape the less valid our assumptions are. Faster 
movement was produced either due to overestimated attractive forces or underestimated 
viscous and inertial forces. Previous studies on microbubble secondary attractions favoured 
the latter hypothesis, demonstrating that drag forces may be underestimated by not 
accounting for the history force (Garbin et al 2009). History forces arise from the 
instantaneous radial oscillations of microbubbles and increase the drag felt by a translating 
microbubble. A time-average history force (Takemura and Magnaudet 2004, Mei 2006) is 
likely to slow down the resulting dynamics. Furthermore, the friction with the capillary wall 
(Dayton et al 2002, Garbin et al 2007) and the interaction with the image bubble (Marmottant 
et al 2006) are likely to decelerate the motion of the interacting microbubbles. Finally, the 
typical inter-bubble distances were around 20 μm, corresponding to microbubble 
concentrations of approximately 107 microbubbles ml-1. This calculation was performed 
assuming that the concentration is inversely proportional to 
3
r .  In these concentrations 
multiple scattering effects are expected to be significant (Stride and Saffari 2005), thus the 
time-resolved bubble cloud collective behaviour needs to be taken into account (Zeravcic et 
al 2011, Bremond et al 2006b, 2006a).   
iv. Microbubble coalescence 
For highly-concentrated microbubble populations and relatively high-pressure 
sonication, we observed instances of collective microbubble coalescence (figure 1.15). An 
illustrative empirical diagram of the different potentials felt by neighbouring microbubbles 
during sonication in our experiments is given in figure 1.23. We speculate that secondary 
forces may instantaneously surpass the repulsive electrostatic force within a cluster and cause 
microbubble fusion, either collectively or in a sequential manner.  
 Controlling microbubble dynamics in ultrasound therapy 
 
 
58 
 
 
Figure 1. 23: Illustration of potentials felt by interacting microbubbles. Schematic contribution of the 
attractive secondary force field (blue line) and the repulsive electrostatic repulsion field (red line). The potential 
energy sum (black line) becomes positive, i.e. repulsive, close to the microbubble surface, in order to avert 
fusion. 
 
Surprisingly, this phenomenon was observed only at a centre frequency of 0.5 MHz in 
our experiments. Drainage times for microbubble interfaces are on the order of 1 μs (Postema 
et al 2004), thus we hypothesize that at 1 MHz the expansion phase does not last long enough 
to allow for film drainage and coalescence. However, the experimental conditions required 
for coalescence to occur, i.e. high enough concentration and pressure, may have not been met 
in our 1 MHz experiments. Additional studies are required to investigate the frequency 
dependence of microbubble coalescence in the therapeutic ultrasound regime. 
  Due to the limited frame rate of 40 kfps, our system was not expected to capture 
single coalescence events that have been shown to occur under ultrasound exposure (Postema 
et al 2004). As an exception, we observed a coalescence event in a small system of large 
bubbles (figure 1.18). The inter-frame time on the order of tens of μs did not allow 
discrimination between collective or sequential pair-wise coalescence in many-bubble 
systems (figure 1.17). Nevertheless, the resonant bubbles produced by coalescence of large 
clusters were violently accelerated in the direction of propagation in m s-1 velocities (figures 
1.15 and 1.16). The secondary acoustic field produced by these large bubbles was felt by 
smaller microbubbles up to ~ 30 μm away. This distance matched the interaction range 
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estimated using the normalised potential map method at 0.5 MHz sonication (figures 1.20 and 
1.21), corroborating the validity of the potential field visualisation. Small microbubbles were 
accelerated towards the resonant bubbles and fused with them following a spiral path (figure 
1.16).  
v. Microstreaming  
 We hypothesise that spiral trajectories may rise due to acoustic microstreaming or due 
to the spinning motion of the translating resonant microbubble. Acoustic microstreaming 
around a single (Doinikov and Bouakaz 2010) or a pair of interacting microbubbles 
(Doinikov and Bouakaz 2016) generates fluid velocities on the order of cm s-1. Here, we 
measured fluid velocities on the order of m s-1 (figure 1.17). The presence of a boundary in 
the proximity of an oscillating bubble significantly increases the induced microstreaming 
effects (Doinikov and Bouakaz 2014), which may explain the measured velocities, given that 
the observed bubbles were very close to the upper wall of the capillary. It is also likely that 
the large microbubble is spinning, thus creating streamlines which are followed by the 
attracted smaller bubbles. This hypothesis is supported by the fact that big bubbles are in 
direct contact with the capillary wall. Despite the zero-tangential-stress condition for a free 
bubble, lipid-coated bubbles can sustain tangential stresses on their surface hence allowing a 
“rolling” motion. In other words, the relevant boundary condition for a shelled bubble is the 
“no-slip” condition. The driving torque may arise from the friction exerted by the capillary 
wall onto the bubble shell.   
 
vi. Secondary potential and force fields 
Radial stresses due to volumetric oscillations create a secondary acoustic radiation 
potential field which is present during sonication (figure 1.6). Our visualisation of the 
acoustic field is comparable with conservative electrostatic and gravitational fields, where the 
attractive forces depend on the object’s charge or mass (here, bubble volume) and the inverse 
squared distance (Apfel 1988). Following qualitative analysis, we estimated that the 
interaction range for 0.5 and 1 MHz sonication at an acoustic pressure of 25 kPapk-neg is 25 - 
30 and 10 - 15 μm, respectively (figure 1.20). The reason is unclear, but it may be due to the 
larger wavelength at 0.5 MHz. Furthermore, the attenuation coefficient is lower at low 
frequencies, thus the generated fields are quenched later at 0.5 MHz than at 1 MHz 
sonication. Also, the optical field of view may have not coincided with the maximum 
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pressure point within the focus, since the focal volume of the 1 MHz transducer was smaller 
than the 0.5 MHz transducer. Regardless, microbubbles attracted each other due to 
continuous secondary Bjerknes forces (figure 1.22), calculated here as the spatial gradient of 
the normalised secondary radiation field (figure 1.21). Microbubble movement was dictated 
by the magnitude and direction of the secondary acoustic radiation forces. Attractive forces 
were the greatest around microbubble clusters, where the potential variation acquired its 
largest value. Cluster-generated forces direction was generally towards the cluster’s centre of 
mass (figure 1.22).  
vii. Chaotic behaviour 
Although the data shown here correspond to the subset of the lowest tested acoustic 
pressures (i.e., 25 - 100 kPapk-neg), similar dynamics were observed at higher pressures. For 
pressures above the inertial cavitation threshold, i.e. > 150 kPapk-neg for the contrast agents 
used here (Pouliopoulos et al 2014), microbubble clustering, coalescence and/or destruction 
occurred at a faster time scale (< 50 - 100 μs). Due to the limited frame rate, we have not 
quantified these dynamics. We hypothesise that bubble clusters developed chaotic behaviours 
during high-pressure sonication (Sinden et al 2012, Chong et al 2010, Dzaharudin et al 
2013), showing continuous internal reorganisation and instances of bubble ejection out of the 
cluster (figure 1.19). However, this explanation must be verified by direct measurement of 
the instability and lack of periodicity, which indicate chaotic oscillations. 
viii. Clinical relevance 
Based on the data shown here, new pulse shapes and sequences can be designed 
(Pouliopoulos et al 2014) to induce more controllable bioeffects in vivo. The creation of 
bubble clusters can be promoted or suppressed by adjusting the acoustic pressure, centre 
frequency, pulse length and microbubble concentration (figures 1.13 and 1.14). Controlling 
the presence and size of microbubble clusters may influence the efficacy of clot dissolution 
(Holland et al 2002, Bader et al 2015), vascular permeability enhancement (Hynynen et al 
2001, Choi et al 2011) or acoustic particle palpation to derive elasticity values at a finer 
resolution (Koruk et al 2015). Microbubble clustering and coalescence can also affect 
sonoporation dynamics (van Wamel et al 2006, Fan et al 2014). The variation observed in the 
intracellular drug delivery across a cell monolayer exposed to low-power ultrasound may be 
due to the action of clusters and/or resonant bubbles (Shamout et al 2015). Also, clustering 
within large vessels may trigger non-uniform and spot-like bioeffects in capillary opening 
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applications such as cancer therapy (Carlisle et al 2013) or blood-brain barrier opening (Choi 
et al 2007). Although the results presented here provide some insight into when clustering 
and coalescence effects become important, the presence of flow and the different boundary 
conditions within physiological environments are expected to change the microbubble 
movement in vivo. 
5.    Conclusions 
In conclusion, we have quantitatively and qualitatively described microbubble 
dynamics arising in a low-power therapeutic ultrasound field. We quantified microbubble 
clustering magnitudes and rates during ultrasound therapy and provided some empirical 
insight into when and how clustering and coalescence become important in the therapeutic 
regime. We found that microbubbles exposed to therapeutic ultrasound form clusters of 1 - 3 
microbubbles μm-1 at clustering rates of 0.01 - 0.02 microbubbles μm-1 ms-1. We observed 
collective microbubble coalescence that produced resonant bubbles moving at m s-1 
velocities. We have also quantified the effects of secondary radiation force fields and showed 
that time-average models can adequately reproduce the observed dynamics at the low-
pressure regime. In subsequent chapters, we will use these observations in order to design, 
monitor, and produce microbubble-mediated therapies. 
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“EVERYTHING IS DESIGNED. FEW THINGS ARE DESIGNED WELL.” 
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CHAPTER 2 
RAPID SHORT-PULSE SEQUENCES – INDIRECT EVALUATION 
 
1. Introduction 
Microbubble-mediated ultrasound therapies such as targeted drug delivery (Ferrara et al 
2007), sonothrombolysis (de Saint Victor et al 2014, Bader et al 2015), sonoporation (Zhou 
et al 2008), renal ultrafiltration (Deelman et al 2010), blood-brain barrier opening (Hynynen 
et al 2001) and cancer therapies (Graham et al 2014) rely on the interaction between focused 
ultrasound and intravascular cavitation nuclei, i.e. microbubbles. Focused ultrasound can 
penetrate deep into the body and localise its interaction with microbubbles within the focal 
volume, which is a well-defined target region. When sonicated, microbubbles are driven into 
radial oscillations (eq. (1.1)) following the rarefactional and compressional phases of the 
acoustic wave (Apfel 1997). This acoustically-driven behaviour, known as acoustic 
cavitation, is capable of producing either therapeutic or unwanted bioeffects in vivo. 
Understanding how microbubble dynamics are dictated by ultrasound parameters (see chapter 
1) and designing new pulse shapes and sequences to produce controllable bioeffects could 
improve therapeutic and safety outcomes. In this chapter, we describe our approach in 
designing treatment and assessing its outcome using passive cavitation detection. Our 
purpose was to promote the microbubble dynamics producing safe drug delivery and suppress 
the dynamics that may cause damage.  
i.   Effect of pulse shape and sequence on cavitation dynamics 
Ultrasound excitation in a therapeutic application can be characterised by the 
ultrasound pulse shape and sequence. The pulse shape is defined by its centre frequency, 
pulse length (PL), and peak-negative pressure (PNP). The pulse sequence is defined by the 
pulse repetition frequency (PRF) and the total number of acoustic pulses during treatment. 
Taken together, the pulse shape and sequence trigger specific types and magnitudes of 
cavitation and produce the final therapeutic effect. The centre frequency matches the 
frequency at which microbubbles radially oscillate. Radial oscillations acquire their greatest 
amplitude in microbubbles of resonant size (figure 1.1) at low acoustic pressures (Marmottant 
et al 2005, Apfel and Holland 1991, Lauterborn 1976). The PNP influences the radial 
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oscillation amplitude, while the PL defines the cavitation duration. PLs also promote the 
action of primary and secondary acoustic radiation forces (Dayton et al 2002, 1997), as 
described in chapter 1 (eq. (1.6)). Long pulses push the microbubbles to a greater distance, 
because the primary radiation force is applied over a longer duration (Palanchon et al 2005). 
The developed velocities are on the order of m s-1 (figures 1.15, 1.16 and 1.17). For non-
resonant microbubbles, long pulses favour microbubble cluster formation (Chen et al 2016, 
Kotopoulis and Postema 2010) at rates that depend on the acoustic pressure (figures 1.13 and 
1.14). Modifying the pulse shape characteristics can yield a wide range of cavitation 
behaviours, from low-amplitude non-inertial cavitation, to stable inertial cavitation and 
eventually high-amplitude inertial cavitation. In the latter case, microbubbles expand and 
violently collapse due to the inertia of the surrounding fluid, leading to their destruction 
(Stride and Saffari 2003, Chomas et al 2001).  
Pulse shapes trigger cavitation events on a time scale of microseconds or milliseconds 
and therefore interact with a specific population of microbubbles within the focus. In 
therapeutic ultrasound, a large percentage of the sonicated cavitation nuclei are destroyed or 
considerably modified by the end of a single pulse. Thus, an off-time is required to allow for 
full replenishment of the target volume with fresh microbubbles. Therapeutic pulse sequences 
consist of a PRF typically on the order of Hz (Hynynen et al 2001, Goertz et al 2010). 
Finally, the number of pulses determines the amount of cavitation events the target is treated 
by and the total duration of the treatment. 
Depending on the pulse shape and the properties of the fluid and the environment 
surrounding the cavitation nuclei, ultrasound exposure can cause the microbubbles to radially 
oscillate in either linear or non-linear cavitation modes, known as stable non-inertial, stable 
inertial, or transient inertial cavitation (Church and Carstensen 2001, Flynn 1982). Cavitation 
modes can be characterised by analysing the acoustic emissions radiated by the sonicated 
microbubbles. High magnitude non-inertial and low magnitude inertial cavitation events emit 
sound at the driving frequency and its integer multiples, known as harmonics (Apfel 1997). In 
contrast, high magnitude inertial cavitation, which is created by the unstable expansion and 
subsequent violent microbubble fragmentation (Chomas et al 2001) produces broadband 
acoustic emissions. Frequency analysis of the acoustic emissions can provide information 
about the cavitation modes arising within a bubble population (Rozenberg 1971). 
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ii. Microbubble-mediated bioeffects 
Inertial and non-inertial cavitation activity has been shown to produce bioeffects by 
exerting mechanical forces on biological interfaces, such as cell membranes and vessel walls. 
Microbubble-vessel interactions have been characterized according to the mechanical stress 
exerted on the vascular wall. Theoretical (Hosseinkhah et al 2013, Hosseinkhah and Hynynen 
2012, Qin and Ferrara 2006) and experimental (Chen et al 2012, 2011, Caskey et al 2007) 
approaches have correlated the yielded stresses to vascular damage. Violent inertial cavitation 
and subsequent bubble collapse may exert up to four times higher stress than mild and stable 
bubble expansion and contraction (Hosseinkhah et al 2013). Optical evidence suggests that 
stresses caused by stable cavitation originate from the fluid acceleration caused by oscillating 
microbubbles close to the endothelial cells of small vessels (Caskey et al 2007, Chen et al 
2011).  
Although the exact mechanisms are not fully understood, microbubble-mediated 
agitation of the microvasculature has been shown to increase capillary permeability in organs 
such as brain (Hynynen et al 2001), kidney (Li et al 2013), prostate (Liu et al 2013), and liver 
(Wang et al 2013). Capillary opening approaches can noninvasively and locally increase the 
amount of delivered drugs to a target tissue. Enhanced drug delivery can be achieved at 
different length scales. On a cellular level, drugs can permeate into the cell either through 
transient pores formed on the cell membrane (van Wamel et al 2006) or due to increased 
uptake via endocytosis or upregulation of carrier proteins (Meijering et al 2009). On a tissue 
level, local drug concentration may be increased by widening the junctions between adjacent 
cells that form the vascular walls of the targeted tissue (Sheikov et al 2008). Regardless of 
the mechanism, localised drug delivery allows enhancement of the therapeutic window by 
reducing the required systemic doses and thus minimising unwanted side-effects. Drug 
delivery in the brain is considerably hindered by the blood-brain barrier, which tightly 
isolates the brain interstitial space from the vascular system (Zlokovic 2008). 
Neurodegenerative diseases such as Alzheimer’s, Parkinson disease and multiple sclerosis are 
difficult to treat largely because of the impermeability of the blood-brain barrier to large 
therapeutic molecules such as antibodies or peptides (Konofagou 2012). Many studies have 
focused on the disruption of blood-brain barrier using the combined action of focused 
ultrasound and circulating microbubbles (Mead et al 2016, Sun et al 2015, Wang et al 2014, 
Nhan et al 2013, Tung et al 2010, Choi et al 2010). Traditional pulse shapes and sequences 
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are limited by a trade-off between efficacy and safety. Higher pressures increase the dose of 
the drugs delivered (Baseri et al 2010), but they may also cause cell necrosis or bleeding 
(Daffertshofer et al 2005, Hynynen et al 2001). 
Conventional ultrasound therapies are able to control the type and magnitude of 
cavitation, but not the distribution of cavitation in physiologically-relevant systems (Choi and 
Coussios 2012). In capillary opening applications, drug delivery enhancement is usually 
produced in a spot-like pattern, resulting in an non-uniform distribution of model drugs (Choi 
et al 2007b, Stieger et al 2007). This inhomogeneity in treatment may be due to cavitation 
activity being poorly distributed within the microvasculature or due to cluster formation and 
coalescence events occurring in larger vessels (chapter 1). Long PLs (> 10 ms) are likely to 
immobilize microbubbles flowing into the sonicated capillaries due to primary radiation 
forces (Dayton et al 2002), thus limiting their activity to a confined region (Choi and 
Coussios 2012).  
Conventional therapeutic pulses in blood-brain barrier applications have durations 
within the range of 10 to 100 ms and PRFs on the order of Hz. However, most of cavitation 
events occur within the first few milliseconds. Long PLs lead to heterogeneous drug 
distributions in vivo, with molecules accumulating in the vicinity of large vessels, such as 
arterioles and venules (Choi et al 2010). On the other hand, short PLs emitted at repetition 
periods on the order of microseconds have enhanced the delivered doses without 
compromising safety (O’Reilly et al 2011, Choi et al 2011b). Another limitation of long 
pulses is that the pressure threshold for microbubble destruction decreases with the PL (Chen 
et al 2003a, Gruber et al 2014, Radhakrishnan et al 2015, 2013) and thus long PLs lead to 
faster microbubble fragmentation or dissolution, at the same pressure. Furthermore, high 
acoustic pressures and fast microbubble destruction generate a large spatial bias on the 
cavitation distribution in vitro (Choi and Coussios 2012). Moving towards clinical 
applications, conventional ultrasonic pulses are likely to produce over-treated and under-
treated areas within the target volume, thus resulting in either unsafe or non-efficient 
therapies, respectively. 
In this chapter, we sought to incorporate the presence of flow into the design of 
therapeutic ultrasonic pulse sequences in order to improve the spatiotemporal distribution of 
acoustic cavitation and minimise unwanted cavitation activity. We have done so by 
employing μs-long pulses packed within a ms-long ultrasonic burst. Such burst sequences 
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were empirically shown to improve drug delivery distributions in vivo (Choi et al 2011b, 
2011a). However, there has been no evidence of the physical origin of the observed 
improvement. Here, we use passive cavitation detection (PCD) to compare long against 
rapid-short-pulse sonication, in terms of the temporal uniformity of the generated acoustic 
cavitation activity. Whereas conventional pulse shapes and sequences can control the 
cavitation type, magnitude and duration, our rapid short-pulse sequence is expected to have 
the additional control of cavitation distribution. 
2. Materials and methods 
i.   Experimental setup 
In-house manufactured lipid-shelled microbubbles were prepared as described before 
(chapter 1, Materials and methods) and characterized prior to every experiment. The average 
microbubble radius was 0.81 ± 0.43 μm while excluding bubbles with radii below 0.25 μm. 
The suspension was diluted in PBS to approximately 5 × 107 microbubbles ml-1. This 
concentration is equal to 25 times the clinical dose for imaging applications which is 0.02 ml 
kg-1 (Unger et al 2004) or 2 × 106 microbubbles ml-1. This calculation was performed for an 
average male mass of 70 kg with a total blood volume of 5 L. We selected this dose to ensure 
clinical relevance, but also to have an acceptable signal-to-noise ratio (SNR) in our 
measurements. 
We sonicated flowing microbubbles in an in vitro system (figure 2.1). A 300-μm inner 
diameter silicon elastomer tube (inner diameter: 0.3 mm, outer diameter: 0.6 mm; Saint-
Gobain Performance Plastics, Paris, France) was submerged and fixed in a water tank. The 
water was earlier deionised and degassed. Microbubbles were infused into the tube using a 
programmable syringe pump (Instech, Plymouth Meeting, PA, USA) which maintained a 
constant flow rate of 43.6 μl min-1, translating into a fluid velocity of 10 mm s-1. Blood 
velocity in an arteriole similar to our tube model is on the same order of magnitude  
(Tangelder et al 1986).  
A 0.5 MHz spherical-segment, single-element focused ultrasound transducer (part 
number: H107, active diameter: 64 mm, FWHM: 5.85 mm, focal distance: 62.6 mm; Sonic 
Concepts Inc., Bothell, WA, USA) was used to sonicate the flowing cavitation nuclei. We 
placed the tube approximately 6 cm away from the transducer’s surface, within its focal 
volume. The focal area was determined earlier using a 0.2 mm PVDF needle hydrophone 
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(Precision Acoustics Ltd, Dorchester, UK). Ultrasound emission and detection was controlled 
with Matlab (The Mathworks, Natick, MA, USA). Two function generators (33500B Series, 
Agilent technologies, Santa Clara, CA, USA) were employed for the generation of the 
different pulse shapes and sequences (figure 2.1(a)). The first was used to define the pulse 
sequence and the second was used to define the pulse shape. The electric signals were 
amplified with a 50 dB power amplifier (Precision Acoustics Ltd, Dorchester, UK) and then 
applied to the 0.5 MHz focused ultrasound transducer via a matching box (Sonic Concepts 
Inc., WA, USA). 
 
Figure 2. 1: In vitro experimental setup for PCD measurements. (a) Two function generators produced 
defined pulse shapes and sequences, which were then emitted by a 0.5 MHz focused ultrasound transducer. The 
time-domain PCD signal was fed through a 5 MHz high-pass filter, recorded with an 8-bit oscilloscope and 
saved to a PC for off-line processing. (b) Microbubbles flowed at a constant rate within the 300-μm diameter 
tube due to controlled infusion using a syringe pump. 
 
Microbubble acoustic emissions were passively captured with a 7.5 MHz transducer 
(part number: U8423589, diameter: 12.7 mm, focal length: 60 mm; Olympus Industrial, 
Essex, UK), inserted into and coaxially aligned with the 0.5 MHz transducer (figure 2.1). The 
foci of the two transducers overlapped. The detected signal was filtered with a 5-MHz high-
pass filter (part number: MH-500P-C-P; Allen Avionics, Mineola, NY, USA) in order to 
cancel the contribution of the fundamental frequency and the lower harmonics. The 28 dB 
 Controlling microbubble dynamics in ultrasound therapy 
 
 
74 
 
preamplifier (Stanford Research Systems, Sunnyvale, CA, USA) amplified the signal 
captured with PCD before being recorded by an oscilloscope (8-bit, sampling rate 50 MSa/s; 
Tektronix, Bracknell, UK). The time-domain trace was finally saved to a PC for off-line 
processing. 
ii.    Ultrasound parameters  
Our design of pulse sequencing was oriented towards enhancing the lifetime and the 
mobility of the microbubble population. Based on previously published in vivo studies (Choi 
et al 2011a, 2011b), we tested a multitude of rapid short-pulse sequences (Table 2.I). Rapid 
short-pulse sequences are different from conventional pulse sequences in terms of the 
timescale. Although conventional pulse repetition periods are on the order of seconds, here 
the time interval between the pulses was on the order of microseconds or milliseconds (figure 
2.2). Additionally, typical therapeutic pulse lengths are on the order of 10 to 100 ms. Thus, a 
100ms-long pulse was used as a control, compared against our 100ms-long bursts.  
 
Figure 2. 2: Rapid short-pulse sequence schematic. Short-pulses were separated with μs-long intervals and 
were packed within 100-ms long ultrasound bursts. Bursts were emitted every 4 s. Explanation of each 
abbreviation and corresponding values can be found in table 2.I. 
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Table 2. I: Ultrasound parameters for PCD measurements. 
Abbreviation Parameter Values / Units 
PNP Peak-negative pressure 40 – 366 kPa 
PL Pulse length 5 cycles 25 cycles 
PRF Pulse repetition frequency 
0.62, 1.25, 
2.5, 5 kHz 
1.25. 2.5, 5, 
10 kHz 
BL Burst length 100 ms 
BRF Burst repetition frequency 0.25 Hz 
- Number of bursts 10 
 
We maintained a constant burst length (i.e., 100 ms) for all the experiments, because 
we intended to compare the energy emission temporal distribution in various pulse sequences 
within a defined period of ultrasound-on time. The burst repetition frequency (BRF) was 0.25 
Hz, i.e. bursts were emitted every 4 seconds, to allow for full focal volume replenishment 
between each sonication. We tested pulse lengths of 5 and 25 cycles, i.e. 10 and 50μs-long 
pulses respectively. A total number of 10 bursts were emitted for each experimental 
parameter.  
iii.   Data analysis 
a.   Energy analysis 
We analysed the acoustic energy produced by the sonicated microbubbles to assess the 
cavitation magnitude, duration and temporal distribution. We defined cavitation magnitude as 
the total energy emitted due to acoustic cavitation activity during a single ultrasound burst. 
Cavitation duration was the total time over which acoustic energy was emitted and temporal 
distribution referred to the rate in which energy was emitted over time. Energy was calculated 
by integrating the time-domain trace with respect to time, i.e. by integrating the squared 
voltage vs. time. The voltage values over time were acquired from the PCD circuit and were 
proportional to the pressure emitted by the microbubbles at each time point. Furthermore, we 
corrected the energy values for the electrical noise contribution. The mean noise energy was 
computed in a signal segment where no acoustic cavitation was detected. We then subtracted 
the noise energy from the energy value of each point throughout the 100-ms pulse or burst.  
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 2 2
0
T
total measured noise
t
E V V t

                    (2.1) 
where measuredV  was the voltage level measured at each time point, noiseV  was the mean 
noise level, t  was the sampling period and T  was either the pulse or the burst duration. We 
plotted cumulative energy plots to characterise the temporal distribution of the acoustic 
cavitation emissions. Two time constants were calculated, namely t50 and t80, which 
represented the time at which energy emissions reached 50% and 80% of the maximum 
value, respectively. Although it is difficult to measure the lifetime of a microbubble 
population, in this study we chose to compare the microbubble persistence across the 
parametric sets by assessing the rise time of the acoustic energy. Increased time constants 
implied increased microbubble lifetime and longer microbubble travel distance. Short pulses 
were expected to avoid immediate microbubble destruction (Chen et al 2003a), while the 
short off-times would allow the same microbubble population to move and be sonicated at 
multiple locations due to the presence of flow.  
Except for increased cavitation persistence, the pulse sequences should ideally produce 
a desired cavitation magnitude or total emitted energy due to acoustic cavitation activity, 
which is correlated to distinct bioeffects such as drug delivery increase (Choi et al 2014, 
Graham et al 2014), tissue heating (Jensen et al 2012) or haemolysis efficacy (Chen et al 
2003b). In order to compare the cavitation activity produced by different parametric sets, we 
defined the acoustic cavitation output parameter O . This parameter was calculated as: 
80totalO E t                      (2.2) 
where totalE  was the total energy detected during a single ultrasound burst. Large values 
of this parameter would suggest that the tested pulse sequence yields cavitation of both high 
magnitude and increased persistence. Cavitation output was used as an indirect metric to 
assess the potential bioeffect of each pulse sequence, by combining its in vitro cavitation 
“dose” and spatiotemporal distribution. 
 b.   Spectral analysis 
Microbubble emissions were analysed in the frequency domain to discriminate the 
cavitation regime and determine its duration. Analysis was performed both throughout the 
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entire 100ms-long burst and across each distinct pulse of a single burst. For the second 
approach, each of the pulses was windowed and analysed separately.  
In order to quantify the observed spectral features, we calculated a metric called 
Harmonic to Broadband (HtB) ratio. High HtB values would indicate dominance of harmonic 
frequencies, while HtB values close to 1 would indicate dominance of broadband emissions 
in the microbubble emission spectra. We separated the frequency domain into two regimes: a) 
the harmonic component, i.e. the spectral regions surrounding the harmonic peaks                   
(
, 0.1H nf MHz , [10,20]n ), and b) the non-harmonic or broadband component, i.e. the 
region between the harmonic peaks (
, , 10.1 , 0.1H n H nf MHz f MHz  ). Harmonic frequencies 
are integer multiples of the fundamental frequency, i.e. 
, 0H nf nf  where 0 0.5f MHz . We 
summed the spectral energy in the harmonic and non-harmonic regions and calculated the 
HtB ratio by dividing the harmonic by the non-harmonic energy value. To account for the 
different bandwidths of the two regions (0.2 MHz for the harmonic against 0.3 MHz for the 
broadband region), the harmonic energy was multiplied by a factor of 3/2. Using this 
weighting factor, equal spectral magnitudes for the two regimes should return HtB ratios of 1. 
3. Results 
i.   Energy analysis 
Using eq. (2.1) we calculated the acoustic cavitation energy emitted during each 
ultrasonic burst. The average cavitation energy per burst increased with the PNP (figure 2.3). 
We did not detect any microbubble activity below 100 kPapk-neg due to low SNR. Cavitation 
energy generated by rapid short-pulse sonication increased linearly with pressure, in contrast 
to the 100ms-long pulse which reached a plateau after 250 kPapk-neg, in agreement with 
previous studies (Choi and Coussios 2012). We did not observe noticeable trends for the PRF 
dependence. For the 5-cycle PL there was no difference between the different PRFs (figure 
2.3(a)). This was not expected, taking into account the different duty cycles of each sequence. 
For the 25-cycle PL, lower PRFs of 0.62 kHz and 1.25 kHz led to lower burst energies (figure 
2.3(b)), due to the lower number of pulses emitted during the 100ms burst. Surprisingly, for 
pressures above 200 kPapk-neg, the 2.5 kHz pulse sequence generated more intense energy 
emissions compared to the other PRFs at PL of 25 cycles (figure 2.3(b)). Although this result 
may seem paradoxical, similar observations have been previously reported for pulsed 
sonication (Flynn and Church 1984, Ciaravino et al 1981).  
 Controlling microbubble dynamics in ultrasound therapy 
 
 
78 
 
 
Figure 2. 3: Emitted acoustic energy across the acoustic pressures. Total burst energy for (a) 5-cycle and (b) 
25-cycle short-pulse sequences. 
We characterised the spatiotemporal distribution of acoustic cavitation activity by 
analysing the cumulative energy over time (figure 2.4). During a 100ms-long burst, the 
cumulative cavitation energy increased rapidly in the first few milliseconds and then reached 
a plateau. The control sequence generated acoustic energy up to 4 times higher than the short-
pulse sequences (figure 2.4(a)). In most of the evaluated sequences, there was no detectable 
energy emission after the first 40 ms. Thus, the pulse-on time beyond this point did not 
trigger any cavitation activity. The step-wise increase measured during short-pulse sonication 
illustrated the pulse-on and pulse-off times (figure 2.4(a)). The width of each step matched 
the PL, i.e. the duration of a single pulse. To focus on the temporal evolution rather than the 
absolute value of the generated energy, we normalised the cumulative energy to its maximum 
for each sequence (figure 2.4(b)). Our main assumption was that the slope of the cumulative 
energy is correlated with the spatial distribution of cavitation activity due to the presence of 
flow. We calculated the t50 and t80 constants, which were indicators of the lifetime of the 
microbubble population, based on the cumulative energy plots (figure 2.4(b)).  
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Figure 2. 4: Temporal evolution of acoustic energy emission. Cumulative energy plot over time in (a) 
absolute and (b) normalised values. PNP: 147 kPa, PL: 25 cycles. 
Microbubble lifetime was higher in the low-pressure sonication regime (PNP < 150 
kPa) at all tested PRFs (figures 2.5). Comparing the 5-cycle (figures 2.5(a) and 2.5(c)) against 
25-cycle sonication (figures 2.5(b) and 3.3(d)), we measured higher t50 and t80 values for the 
shorter tested PL, up to 35 ms. Sonicating with 5-cycle pulses increased and stabilised the t50 
and t80 values for pressures higher than 200 kPapk-neg.  Lower PRFs or longer pulse repetition 
periods increased the time constants for both PLs. This was expected because a lower number 
of acoustic cycles were emitted within a single ultrasonic burst, thus fast microbubble 
destruction was less likely to occur. An exception to this trend was the PRF of 0.62 kHz 
which yielded lower time constants than 1.25 kHz at pressures below 175 kPapk-neg and a PL 
of 25 cycles (figures 2.5(b) and 2.5(d)). This may stem from the low SNR in the time-domain 
 Controlling microbubble dynamics in ultrasound therapy 
 
 
80 
 
signal and from variations of the microbubble concentration across the experimental repeats. 
We excluded values below 100 kPa due to low SNR. 
 
Figure 2. 5: Microbubble lifetime across the pulse sequences. Lifetimes for PLs of 5 (a and c) and 25 (b and 
d) cycles, expressed by the t50 (a and b) and t80 (b and d) time constants. 
Effective ultrasound therapies should produce a controllable magnitude of uniformly 
distributed acoustic cavitation activity. We combined the magnitude of the acoustic energy 
emissions with the temporal persistence in order to calculate the cavitation output parameter 
(eq. (2.2)). Output was higher for low PRFs at 5-cycle sonication but we found no visible 
trend across the PNPs (figure 2.6(a)). In 25-cycle sonication, cavitation output acquired its 
maximum value within the PNP range of 100 - 200 kPa (figure 2.6(b)). Thus, PNPs around 
150 kPa are suitable candidates for the “optimal” 25-cycle pulse sequence (figure 3.4(b)), 
producing a fine balance between microbubble activity and longevity. Cavitation output was 
larger at higher pressures (around 225 kPapk-neg) in the 100-ms pulse. 5-cycle pulses resulted 
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in higher output values than 25-cycle pulses, which was due to the increased t80 values of the 
5-cycle sequences (figures 2.5(c) and 2.5(d)). 
 
Figure 2. 6: Acoustic cavitation output. Output values at (a) 5-cycles and (b) 25-cycle sonication. 
 
ii.  Spectral analysis 
We identified the cavitation mode through frequency analysis of the microbubble 
acoustic emissions. Fast Fourier transforms of the time-domain PCD signal, which was 
captured during the entire burst, consisted of multiple harmonics to the driving frequency 
(figure 2.7(a) for PNP: 147 kPa, PL: 25 cycles). The harmonic width was greater for the rapid 
short-pulse sequences than for the 100ms pulse due to the shorter PL (i.e., 5 and 25 cycles). 
Furthermore, the harmonic magnitude varied with the PRF due to the different number of 
acoustic cycles within the burst. The highest HtB ratio was observed within a pressure range 
of 100 – 200 kPapk-neg (figure 2.7(b)), indicating increased dominance of the harmonic traits. 
In other words, stable cavitation dominated over transient and inertial cavitation at these 
acoustic pressures. Qualitative analysis of the spectra above 200 kPapk-neg confirmed that HtB 
ratios decrease due to the increase of the broadband signal levels, i.e. due to the increased 
number of transient inertial cavitation events. 
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Figure 2. 7: Spectral analysis of the time-domain PCD signal captured during an entire ultrasonic burst. 
(a) Magnitude of fast Fourier transforms for the tested PRFs (PNP: 147 kPa, PL: 25 cycles). (b) HtB ratio across 
the pulse sequences and acoustic pressures. 
Next, we performed pulse-by-pulse analysis of the rapid short-pulse sequences to 
investigate the cavitation mode in a time-resolved manner (figure 2.8). At low pressures 
spectrograms showed no detectable microbubble activity (figure 2.8(a)). High-pressure 
sonication triggered short-lived transient cavitation (figure 2.8(c)). In contrast, at moderate 
pressures cavitation activity was maintained for longer compared to high pressures (figure 
3.6(b)). The increased persistence of harmonics and limited presence of broadband signal 
indicated mainly stable microbubble oscillations. Broadband emissions in the beginning of 
sonication may be due to destruction of resonant bubbles (figure 2.8(b)).  
Finally, we quantified the time-resolved HtB radio of the 25-cycle pulse sequences 
(figure 2.9). Its maximum values were obtained in the pressure region of 100-200 kPapk-neg, as 
before. The dominance of harmonic over the broadband traits persisted for approximately 40 
pulses (figures 2.9(b)-(d)). 5-cycle pulse sequences produced inherently broadened 
harmonics; hence, we did not quantify the HtB ratio for the PL of 5 cycles. Also, bubble 
destruction was not evaluated in the frequency domain due to the short pulse length. 
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Figure 2. 8: Time-resolved frequency analysis. Spectrograms for rapid short-pulse sonications at PNP of (a) 
75 kPa, (b) 147 kPa, and (c) 294 kPa. PRF: 2.5 kHz, PL: 25 cycles. Reproduced with permission from IOP. 
 
 
Figure 2. 9: Time-resolved HtB ratio. Interpolated contour plots of pulse-by-pulse HtB ratio for PRF of  (a) 
1.25 kHz, (b) 2.5 kHz, and (c) 10 kHz. PL: 25 cycles. 
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4. Discussion  
i.   Acoustic cavitation distribution 
In this chapter, we have demonstrated that the lifetime of flowing microbubbles can be 
adjusted by modifying specific features of an ultrasonic pulse shape and sequence. 
Microbubble-mediated therapeutic approaches typically use high acoustic pressures and 
trigger transient cavitation events to produce the desired bioeffect, e.g. vascular permeability 
increase for targeted drug delivery (Nhan et al 2013, Choi et al 2011a, O’Reilly and Hynynen 
2012, Choi et al 2010, 2007a). Here, we showed that moderate pressures and stable 
microbubble activity facilitates longer and more uniform acoustic cavitation distribution 
(figures 2.5 and 2.8). The trade-off between cavitation magnitude and distribution was shown 
to balance in a pressure range of 100 – 200 kPapk-neg (figures 2.7 and 2.9), which is below the 
high-magnitude inertial cavitation threshold (figure 2.8). Pressures above the threshold of 
transient inertial cavitation lead to rapid microbubble collapse (figure 2.5) and high energy 
output (figure 2.3), i.e. increased induced stresses within the vasculature (Chen et al 2011, 
2012, Caskey et al 2007). In this regime, the exerted forces are higher but not uniformly 
distributed across the vasculature (Choi et al 2007b, Stieger et al 2007). Fast elimination of 
cavitation nuclei occurs in less than 1 ms at high acoustic pressures (figures 2.5), rendering 
long pulses (> 1 ms) superfluous. Furthermore, long pulse repetition periods (0.1 to 2 
seconds) are required to allow full microbubble replenishment in the focal volume (Choi et al 
2011a). The pressure threshold of transient inertial cavitation has been shown to be in the 
pressure area above 250 – 300 kPapk-neg, both in high (Radhakrishnan et al 2013) and low 
(Gruber et al 2014) sonication frequencies.  
We hypothesized that temporal uniformity can be improved by sonicating multiple 
times the same microbubble population with moderate acoustic pressures (< 200 kPapk-neg). 5-
cycle sonication sustained cavitation for longer than the 25-cycle sonication (figure 2.5). 
Shorter PLs improve the lifetime of the flowing microbubbles by reducing their destruction 
rate (Chen et al 2003a), leading to a more uniform distribution of bioeffects within the 
vasculature. This beneficial effect of short-PL sonication has been shown empirically by 
qualitatively assessing the blood-brain barrier disruption distribution in vivo (Choi et al 
2011b, 2011a). In this chapter, we have confirmed that the reported improvement may be 
correlated with the longevity of microbubble-seeded acoustic cavitation activity (figures 2.5 
and 2.8). 
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Microbubble activity persisted for approximately 40 pulses at moderate pressures for 
25-cycle sonication (figures 2.8 and 2.9), implying that the microbubble lifetime at a given 
pressure depends on the number of the experienced acoustic cycles. In the stable cavitation 
regime, i.e. below 200 kPa (figure 2.8), microbubbles diminish in size during each acoustic 
cycle due to dissolution of the encapsulated gas (Borden and Longo 2002) and gradually lose 
their echogenicity (Radhakrishnan et al 2013). By modifying the number of the emitted 
ultrasound cycles, one can control the longevity of ultrasound-microbubble interactions and 
thus control the spatiotemporal distribution of acoustic cavitation activity.   
Our main assumption in assessing the cavitation distribution was that microbubbles are 
free to follow the flow during the off-time of the short-pulse sequence. However, direct 
measurements were lacking and we relied on indirect acoustic measurements using PCD. 
Cavitation distribution was thus assessed by the temporal constants t50 and t80. The highest t80 
values were ~ 30 - 35 ms (figure 2.5). Assuming that the microbubble velocity during the off-
time was approximately equal to 10 mm s-1, an off-time of 0.75 ms and 40-pulse microbubble 
persistence (figure 2.9) would result in a single microbubble moving ~ 0.3 mm along the 
lateral direction. In the case of the 100ms-long pulse, microbubbles were not expected to 
move laterally due to primary radiation force effects (Dayton et al 2002) and fast destruction. 
The pulse interval (~ 0.1 - 1 ms) allowed inter-pulse microbubble movement of several 
micrometres (1 - 10 μm). Increased t80 values were expected to result in a more uniform 
cavitation distribution due to the increased mobility of the cavitation nuclei.  
In our experimental setup, the volume of the microbubble solution within the focal 
volume was ~ 0.35 mm3. At the clinical dose (2 × 106 microbubbles ml-1) and assuming 
uniform microbubble distribution across the 5 mm lateral FWHM, approximately 700 
microbubbles were present across 5 mm or one microbubble every 7 μm. If each microbubble 
moved more than 7 μm during the off-time between two subsequent pulses, then we could 
effectively use the same microbubble population to produce cavitation at multiple sites 
throughout the focus. In this way, the spatial distribution of cavitation and its associated 
bioeffects could be improved at the micrometre-scale. Regarding in vivo applications, the 
concept of moving bubbles may change the inhomogeneous pattern of drug delivery (Nhan et 
al 2013, Stieger et al 2007) into a more uniform pattern (Choi et al 2011b, 2011a).  
These calculations are valid only if rapid microbubble destruction is avoided, i.e. for 
recurrent stable cavitation. Stable cavitation was the dominant cavitation mode below 200 
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kPa (figures 2.7, 2.8, 2.9). Acoustic pressures between 100 and 200 kPapk-neg had equal or 
higher values of acoustic cavitation output (figure 2.6). Short-pulse sonication at these 
moderate pressures is therefore equally or more efficient than long-pulse sonication, in terms 
of both magnitude and uniformity of the spatiotemporal acoustic cavitation. 
ii.   Limitations of the PCD study 
The results presented in this chapter were based on the data captured using a single-
element PCD, which is an efficient and inexpensive tool to assess cavitation activity. 
Although PCD can been used as a therapy monitoring tool (Sun et al 2015, O’Reilly and 
Hynynen 2012, Graham et al 2014), it is not able to provide spatial information out of the 
“listening” focal volume or to localise sources of cavitation activity within the focal volume. 
There are also limits regarding the sensitivity of the PCD method due to electronic noise. The 
temporal constants found here (figure 2.5) are prone to underestimation, because a signal 
below the noise floor could not be detected. Another limitation of the PCD method is that 
when frequency analysis is required, short PLs return an increased mixture of frequency 
content and thus harmonics are inherently broadened.  
 More importantly, despite the improved distribution in our simple in vitro model, the 
bioeffect of such pulse shapes and sequences were expected to differ in vivo. Our simplistic 
physiologically-relevant model provided useful insight about the effect of the short-pulse 
sonication on the dynamics of the flowing cavitation nuclei. However, the real vasculature 
cannot be adequately approximated in vitro. A diverse range of physiological parameters, 
such as vessel diameters, angles, flow rates and acoustic pressure inhomogeneity are expected 
to influence the spatiotemporal evolution of cavitation dynamics. Vessel size for example 
affects the microbubble activity, especially in small-size vessels where the wall directly 
influences the volumetric oscillation boundary conditions (Garbin et al 2007, Caskey et al 
2007, 2006). Additionally, PBS is not the ideal blood-mimicking material since its viscosity 
differs from blood and different microbubble responses may arise in vivo (Holland and Apfel 
1990, Apfel and Holland 1991).  
Another important source of bias is the microbubble concentration within the focal area 
in each experiment. Despite efforts to avoid concentration variations, it is likely that the 
concentration of the sonicated microbubbles fluctuated. Such fluctuation may have caused the 
unexpected trends in the total emitted energy (figure 2.4) or the time constants of each 
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sequence (figure 2.5). Finally, blood flow rates in vivo span over a wide range, but here only 
one flow rate was tested (i.e., 10 mm s-1).  
iii. Clinical relevance  
Low-pressure and short-PL sonication may find use in a wide range of clinical 
applications such as targeted drug delivery (Ferrara et al 2007), sonothrombolysis (Holland et 
al 2002), and sonoporation (Yu and Xu 2014). Short PLs with sufficiently low amplitude 
have the advantage of reduced standing-wave formation, limited interference and negligible 
thermal effects. Particularly for brain therapies, the formation of standing waves within the 
skull is expected to be significantly suppressed using μs-long pulses. Standing-wave 
formation in 25ms-long sonication has recently produced periodic increase and decrease of 
the drug concentration along the ultrasound propagation direction in human patients 
(Carpentier et al 2016). Treatment using shorter pulses could eliminate this shortfall 
(O’Reilly et al 2010). Additionally, the focal area can be defined more accurately because 
skull-derived aberrations and sidelobe amplitude are negligible for short-PL sonication (Jones 
et al 2013, O’Reilly et al 2014).  
We have shown that cavitation output for 5-cycle pulses was comparable to longer 25-
cycle pulses (figure 2.6). It is likely that a shorter pulse will have a similar bioeffect, as 
shown before in blood-brain barrier disruption studies (Choi et al 2011b, 2011a). 
Furthermore, single-cycle sonication at pulse repetition periods on the order of μs can 
successfully produce blood-brain barrier disruption (O’Reilly et al 2011). Additionally, the  
distribution of the delivered drugs within the targeted brain parenchyma was more uniform 
for sonication with short-PL and PRF on the order of kHz (Choi et al 2011b). In this chapter 
we proposed that the mechanistic reason for these observations is that microbubbles can 
move during the off-time of the ultrasonic pulse sequence. 
5. Conclusions 
In conclusion, we incorporated the presence of flow in the design of therapy pulse 
shapes and sequences, comprised of μs-pulses repeated at PRFs on the order of kHz and 
packed within 100ms-long ultrasonic bursts. In doing so, we sought to control the 
spatiotemporal evolution of acoustic cavitation activity within the focal volume. Stable 
cavitation with sufficiently high cavitation output and prolonged persistence was observed at 
pressures between 100 and 200 kPapk-neg and for lower PRFs. Short PLs permitted longer 
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acoustic cavitation activity and microbubble mobility. Low-pressure, rapid short-pulse 
sequences can uniformly distribute microbubble-seeded acoustic cavitation and may lead to 
safe, efficient and homogenous treatment of a range of pathologies.  
These conclusions are valid under the fundamental assumption of microbubble flowing 
during the off-time of the sequence. To corroborate our assumption regarding microbubble 
mobility, we will present the direct observations made using passive acoustic mapping and 
high-speed microscopy in the next chapter. In the last chapter of the present thesis, we will 
evaluate the efficacy of rapid short-pulse sonication in blood-brain barrier opening, and will 
compare it against its long-pulse counterpart. 
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CHAPTER 3 
RAPID SHORT-PULSE SEQUENCES – DIRECT EVALUATION 
 
1. Introduction 
 
In the previous chapter, we assessed sonication with rapid short-pulse sequences using 
single-element passive cavitation detection (PCD). PCD provided useful information about 
the cavitation dynamics within the focal volume, such as the cavitation magnitude (figure 
2.3), persistence (figure 2.5) and mode (figures 2.7, 2.8 and 2.9). These traits have been 
employed to drive and control cavitation activity during ultrasound therapy in vivo (Sun et al 
2015, Arvanitis et al 2012, O’Reilly and Hynynen 2012, Hockham et al 2010). However, 
PCD is able to monitor cavitation activity occurring within the entire focal volume, without 
discriminating the spatial location of microbubble emissions.  
Time exposure acoustics (TEA) is one of the available approaches to localise acoustic 
sources (Norton and Won 2000). Using this method, seismic-wave sources were passively 
imaged by assuming spatially-incoherent ambient noise which could be eliminated. The same 
algorithm was applied in the field of biomedical ultrasound by Gyöngy et al. (2008) and, 
using a similar method but in the frequency domain, by Salgaonkar et al. (2009). These 
approaches were named passive acoustic mapping (PAM) (Gyöngy et al 2008) and passive 
cavitation imaging (PCI) (Salgaonkar et al 2009), respectively. PAM can approximate the 
acoustic cavitation source strength at specified locations within a field of view, using an array 
of transducers in receive-only mode (Gyöngy and Coussios 2010a, Gyöngy and Coviello 
2011, Gyöngy and Coussios 2010b).  
PAM has been previously used to evaluate the evolution of spatiotemporal cavitation 
dynamics in vitro, revealing the upstream bias produced by ms-long sonications (Choi and 
Coussios 2012). Ex vivo high-intensity focused ultrasound treatment can also be monitored 
using PAM (Jensen et al 2012, 2013). For in vivo applications, PAM is able to monitor 
microbubble-mediated drug delivery in a real-time and passive manner, correlating 
microbubble activity with the delivered drug concentration (Choi et al 2014). PAM is thus a 
powerful therapy-monitoring tool, despite its poor axial resolution which is on the mm-range 
for typical linear arrays (Gyöngy and Coussios 2010a). A number of improvements in the 
conventional PAM method such as robust Capon beamforming (RCB) (Coviello et al 2015) 
or the sum-of-harmonics method (Lyka et al 2016) have been proposed. 
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In this chapter, we use RCB-PAM and high-speed microscopy to directly assess the 
spatiotemporal distribution of acoustic cavitation activity triggered by rapid short-pulse 
sequence sonication. In the previous chapter, we indirectly inferred cavitation distributions by 
assuming that microbubbles follow the fluid flow when not sonicated. Under this assumption, 
the prolonged lifetime of the microbubble population (figure 2.5) suggested more uniform 
spatial distributions of the cavitation activity. A uniform distribution is achieved when similar 
amounts of acoustic cavitation activity are detected throughout the focal volume. 
Heterogeneous cavitation activity within the focus (Choi and Coussios 2012) can be 
correlated with heterogeneous bioeffects during treatment (Stieger et al 2007, Choi et al 
2007, 2011b, 2011a, 2014). Uniform cavitation activity could instead enable uniform 
therapeutic effects within the focal area. Here, we directly test the assumption of improved 
uniformity of cavitation activity during rapid short-pulse sonication, both acoustically and 
optically. 
 
2. Materials and methods 
 
i. Experimental setup 
 
a. Flow system for passive acoustic mapping 
Flow experiments were conducted in an in vitro setup similar to the one shown in 
chapter 2 (figure 2.1). Instead of having a coaxially aligned PCD sensor, we used an ATL L7-
4 linear array to passively capture microbubble acoustic emissions (figure 3.1). Also, the 300 
μm tube was replaced with a 0.8 mm in diameter silicon elastomer tube (Saint-Gobain 
Performance Plastics, Paris, France), which was fixed horizontally in a tank containing 
degassed and deionized water. In-house manufactured microbubbles were prepared as 
described previously (chapter 1, Materials and methods). The average microbubble diameter 
was 1.53 ± 1.11 μm, excluding diameters below or above the 0.5 - 10 μm range. The 
microbubble solution was diluted using PBS to a concentration of approximately 2 × 107 
microbubbles ml-1, approximately 10× the recommended clinical dose of Definity contrast 
agents in ultrasound imaging applications (Unger et al 2004) and moderately lower than the 
concentration used in chapter 2. The diluted microbubble solution was continuously stirred 
within a beaker using a magnetic stirrer (Jencons-VWR, East Grinstead, UK) and was 
withdrawn for the majority of the experiments at a constant velocity of 10 mm s-1 using a 
syringe pump (Instech, Plymouth Meeting, PA, USA). This velocity matched the velocity 
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used in chapter 2 to allow for comparison. Other flow rates were also tested (table 3.I), to 
evaluate the effect of the reperfusion rate on the produced acoustic distributions. 
 
 
Figure 3. 1: In vitro experimental setup for PAM measurements. The emission circuit was identical with the 
one described in chapter 2. A linear array was placed orthogonally to the ultrasound beam and passively 
captured the microbubble acoustic emissions, which were saved to a PC through the Verasonics Vantage 
research platform. 
The emission system used here was identical with the one described in the previous 
chapter (chapter 2, Materials and methods). Instead of using PCD, we passively captured the 
acoustic emissions generated by the sonicated microbubbles using an ATL L7-4 linear array 
(center frequency: 5.2 MHz, number of elements: 128, aperture size: 38.4 mm, element inter-
space: 0.3 mm; Philips Healthcare, Guildford, Surrey, UK). The long axis of the array was 
orthogonal to the ultrasound beam propagation direction and was aligned with the tube 
(figures 3.1). A Verasonics Vantage research platform (128 channels; Verasonics Inc., 
Kirkland, WA, USA) was used to align the setup and record the radiofrequency (RF) acoustic 
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signals. Using a hydrophone and B-mode ultrasound imaging, we placed the array so that the 
focus of the therapeutic transducer was as close as possible to its central elements. 
Acquisition in Verasonics was triggered by function generator 2. Acquisition duration and 
repetition period were 150 μs and 800 μs (figure 3.2), respectively, so that the entire 
cavitation response fitted within a single frame (figure 3.2). A delay of 0.2 ms was added 
between emission and reception, in order to compensate for the time of flight and the 
software-hardware overheads. RF lines were saved to a PC for off-line processing. 
b. Ultrasound parameters 
We chose the tested ultrasound parameters based on the pulse shape and sequence 
design described before (chapter 2, Materials and methods), which has previously enhanced 
the induced bioeffect in vivo (Choi et al 2011b). As discussed, we replaced a 100ms-long 
ultrasonic pulse, which is used in therapeutic ultrasound applications (Choi et al 2014), with a 
rapid short-pulse sequence. The sonication duration was again kept equal to 100 ms, 
including short off-time periods on the order of hundreds μs. Our hypothesis was that the 
introduced off-times would facilitate inter-pulse microbubble movement and extend the 
microbubble lifetime. The difference in microbubble dissolution would be negligible at this 
timescale. 
 
Figure 3. 2: Emission and PAM acquisition synchronisation. The pulse repetition period was 800 μs and the 
acquisition duration 150 μs. Acquisition was synced to emission to ensure capturing of the entire cavitation 
signal. 
The PRF, PL and flow rates were on the order of kHz, tens of μs and mm s-1, 
respectively (figure 3.2 and table 3.I). We used the same number of pulses for each 
parametric dataset (i.e., 125 pulses for a PRF of 1.25 kHz). The total input energy was lower 
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for the shorter PLs, thus lower output energy was expected. The acoustic pressures tested 
here were higher than the pressures tested in chapter 2, because linear arrays have lower 
sensitivity than PCD. At a fluid velocity of 10 mm s-1 and with a pulse repetition period of 
800 μs, individual microbubbles would cover an inter-pulse distance of 8 μm or 1 mm during 
an entire 100ms-long burst. For a microbubble population uniformly distributed across the 
therapeutic beam, sonication with rapid short-pulse sequences could allow for treatment of 
the entire focal area. To determine the spatiotemporal acoustic cavitation outcome of each 
pulse sequence, we generated maps of acoustic cavitation activity within the focus using the 
RCB-PAM algorithm. We will illustrate the trends with a single data set, with a PRF of 1.25 
kHz and PNP of 460 kPa. 
Table 3. I: Ultrasound and physiological parameters for PAM measurements. 
Experimental 
set 
Peak-Negative 
Pressure (kPa) 
Pulse repetition 
frequency (kHz) 
Pulse length 
( cycles) 
Flow rate 
(mm s-1) 
Burst length 
(ms) 
A 
160, 310, 460 
1.25 5, 25, 50 10 
100 
B 1.25 50 
1.67, 3.3, 
6.6, 10, 20, 
40 
C 
0.3125, 0.625, 
1.25, 2.5 
25 10 
 
ii. Passive acoustic mapping 
 
a. Reconstruction algorithm 
 
Microbubble-generated acoustic cavitation activity within the focal volume was 
mapped using a script to perform PAM in Matlab. Time-domain RF data was captured with 
the ATL L7-4 array at a frame rate which matched the PRF of the tested rapid short-pulse 
sequence (i.e., 1.25 kHz). Each frame consisted of 150μs-long data sets acquired at a 
sampling frequency of 20.8 MHz. Each short pulse fitted within one acquisition frame. 
 The reconstruction algorithm was based on the TEA method (Norton and Won 2000). 
An acoustic event that occurs at location r  and has acoustic strength of (r, )q t , generates 
pressure at location r΄  and at time t  equal to:  
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 
 r΄ r /
r ,΄
4 r΄ r
q t c
P t

 


                  (3.1) 
 where c  is the speed of sound in water, equal to 1497 m s-1. Eq. (3.1) accounts for the 
attenuation of the acoustic wave due to spherical propagation and the time of arrival to the 
observer. An estimation of the acoustic source strength can be given by inverting eq. (3.1) 
and accounting for the acoustic pressures  ir ,P t  detected at each sensor, i.e. each channel of 
the array, located at position ir . The approximated acoustic strength  r,q t  can be calculated 
by applying delays to the acoustic signal of the i -th channel and averaging across all the N  
channels (Gyöngy and Coussios 2010a): 
   i
1
1
r, 4 r r r , r r /i i
N
i
i
q t w P t c
N


                     (3.2) 
where iw  is the weight applied to the i -th channel. In TEA, each channel has equal 
contribution to the average acoustic strength and all weights are equal to 1 (Gyöngy and 
Coussios 2010a, Gyöngy and Coviello 2011). The acoustic energy radiated by this single 
acoustic event can be estimated as: 
   2
0
1
r r,
4
T
l
E q t dt
c
                    (3.3) 
where l  is the water density equal to 1000 kg m
-3 and T  is the duration of the acoustic 
signal.  
TEA-PAM has lateral and elevational resolutions of 0.28 mm and 2.35 mm in our 
setup, respectively (Gyöngy and Coussios 2010a). These values were calculated using the 
centre frequency and aperture size of the ATL L7-4 imaging probe, which were 5.208 MHz 
and 32.8 mm, respectively. The aforementioned resolutions correspond to an imaging depth 
of 41.5 mm, which was the elevational distance between the linear array and the tube (figure 
3.1). The poor axial resolution of TEA-PAM is exacerbated by an artefact known as the “tail 
effect”. In conventional passive acoustic maps, apparent acoustic activity appears out of the 
focal volume, both towards and away from the array. This activity which does not correspond 
to real acoustic emissions (Gyöngy and Coussios 2010b, 2010a, Choi and Coussios 2012) has 
been attributed to diffraction patterns arising on the array (Haworth et al 2012) and to 
interference from multiple bubbles within the region of interest (Coviello et al 2015). 
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Robust Capon beamforming (RCB) was used here to suppress the tail effect (Li et al 
2003, Stoica et al 2003, Coviello et al 2015). Briefly, Capon beamformer calculated the 
weights iw  appearing in eq. (3.2) to minimize the measured power while maintaining unity 
gain in the direction of the focal area (Capon 1969, Åsen et al 2014). This process suppresses 
signals originating from non-focal directions and improves the axial and lateral resolution of 
the beamformed map (Taki et al 2012). The passive acoustic maps presented in this chapter 
are 81 × 21 pixel maps generated with the RCB-PAM algorithm, with lateral and elevational 
pixel size of 0.25 mm × 1 mm (figure 3.3). Following multiple iterations, the RCB epsilon 
value was defined to be 0.01 for all the data sets. Using this epsilon value, we generated maps 
with the lowest percentage of acoustic energy out of the focus.  
 
b. Symmetry estimation 
Rapid short-pulse sequences were designed to produce uniform and symmetrical 
acoustic cavitation activity distributions. A symmetry index was thus defined in order to 
assess the uniformity of the flowing microbubble activity. We separated the focal area into 2 
different lateral regions, i.e. upstream and downstream (figure 3.3). The lateral uniformity 
index ( LU ) was calculated using the energy values measured within the tube in these 
semicircles: 
downstream upstream
downstream upstream
E E
LU
E E



                   (3.4) 
where E  was the energy measured per frame in each lateral compartment using 
equation (3.3).  LU  values varied between -1 and 1, with -1 denoting 100% of the energy 
located upstream, and 1 denoting 100% of the energy located downstream. A value of 0 
would indicate absolute symmetry between the upstream and downstream parts of the flow. 
We have also calculated the spatiotemporal uniformity index SUI , to compare the different 
parametric sets:  
1
1
frN
fr i
i
SUI LU
N 
                     (3.5) 
where 
frN  was the total number of frames. SUI varied between 0 and 1, for uniformity 
and asymmetry, respectively.  
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Figure 3. 3: Example of a passive acoustic map separated into the upstream and downstream regions. 
 
c. Acoustic cavitation analysis 
Except for the magnitude of the detected cavitation activity, we were also interested in 
identifying the cavitation mode during rapid short-pulse sonication. We thus extracted the 
time trace (i.e., RF line) at three different spatial locations within the focal volume (green 
circles in figure 3.3). These points corresponded to the upstream, central, and downstream 
regions of the acoustic focus. We spectrally analysed these traces by performing fast Fourier 
transforms (FFTs) on the beamformed RF lines of each pixel of interest. FFTs were 
calculated over the entire 150μs-long acquisition for every pixel to identify the distinct 
cavitation mode instigated by each pulse. Time-resolved spectral information was assessed to 
determine the cavitation regime over space and time. 
iii. High-speed microscopy 
Although PAM is able to provide a map of acoustic activity within the focus, it lacks 
information about the mobility of individual cavitation nuclei. To confirm that microbubbles 
sonicated with rapid short-pulse sequences are able to flow during the short off-times, we 
conducted high-speed microscopy experiments. We used the optical setup described 
previously (figure 1.3) and a round glass capillary of 0.6 mm inner diameter. The high-speed 
camera was connected to an upright microscope and recorded videos with a 250 × 237 μm2 
field of view at 10 kfps. The field size was selected to allow depiction of as many 
microbubbles as possible. Our purpose was to qualitatively analyse the microbubble 
movement, thus no further quantification of translational dynamics was performed.   
A.N. Pouliopoulos  Doctoral dissertation 
 
 
101 
 
3. Results 
 
i. Passive acoustic mapping 
 
a. Temporal evolution of cavitation energy 
 
In this chapter, we evaluated the cavitation distribution by assessing the longevity of 
the acoustic cavitation emissions (figure 2.5). We conducted a similar analysis here, using the 
PAM data and summing the estimated energies for all the pixels within the focal area (figure 
3.3). Acoustic energies within the focal area were monitored over time for the different rapid 
short-pulse sequences (figure 3.4). The acoustic output generated by long-pulse sonication 
was expected to be higher than by rapid short-pulse sonication. The total focal energy was 
indeed higher in the beginning of sonication for the 100-ms pulse, but rapidly decreased over 
time (figure 3.4(a)). For this particular example (PNP: 460 kPa, PRF: 1.25 kHz) the energy 
detected at the beginning of sonication was decreased by 3, 15, and 150 times for PLs of 50, 
25, and 5 cycles, respectively. However, shorter pulses maintained cavitation activity for 
longer time. The reduction rate increased with pulse length (figure 3.4(b)). 5-cycle sonication 
maintained similar levels of acoustic cavitation activity throughout the 125-pulse burst 
(figure 3.4(a)). The time in which energy decreased to the 20% of its maximum value was 
equal to 82.4 ms, 34.4 ms, 20 ms, and 6 ms for PLs of 5, 25, 50, and 50,000 cycles, 
respectively.  
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Figure 3. 4: Focal energy over time. (a) Absolute values in logarithmic scale. (b) Normalised values. Rapid 
short-pulse sonication maintained acoustic cavitation activity of lower magnitude but for longer time than the 
100ms-long control pulse. PNP: 460 kPa, PRF: 1.25 kHz. 
We calculated the cumulative energy over time to directly compare the values 
measured with PAM (figure 3.4) with the PCD measurements (figure 2.4). The total emitted 
energies were similar as measured before, i.e. on the order of 10-8 V2s (figure 3.5). Short-
pulse sonication generally generated lower acoustic emissions, as expected (figure 3.5(a)). 
Interestingly, the measured energy during 50-cycle sonication was approximately 2 times 
larger than the 100ms-long pulse. An ideal pulse sequence should instigate similar acoustic 
cavitation outcome per pulse. This is illustrated as a “line of equal emissions per pulse” or 
identity line in the normalised cumulative energy plot (dotted line in figure 3.5(b)). 5-cycle 
sonication approached the identity line, producing similar amount of acoustic energy per 
pulse during the entire 100-ms burst (figure 3.5(b)). Instead, cavitation energy was 
“concentrated” in the first 10 ms of the long pulse.  Generally, we observed that shorter PLs 
produced more uniform acoustic emissions over time. By reducing the PL, the cumulative 
energy plot approached the identity line (figure 3.5(b)). The t80 constants for this example 
were 72 ms, 30.4 ms, 16.8 ms, and 4.8 ms for 5, 25, 50, and 50,000-cycle sonication. These 
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values are higher than the ones measured by PCD (figure 2.5). This may be due to the high 
electronic noise in PCD measurements, which led to t80 underestimation (see chapter 2, 
Discussion). 
 
 
Figure 3. 5: Temporal evolution of focal energy. Cumulative energy over time in (a) absolute and (b) 
normalised values. The line of identity (dotted line) indicated a pulse sequence with equal magnitude of 
cavitation energy emissions per pulse. 
b. Spatiotemporal distribution of acoustic cavitation activity 
The aim of this chapter was to directly assess the spatiotemporal distribution of 
cavitation activity produced by rapid short-pulse sonication. Our hypothesis was that the 
enhanced temporal persistence shown in the energy analysis could be translated to improved 
spatial distributions within the focus. We have confirmed this hypothesis using passive 
acoustic mapping (figure 3.6). For the example of sonication at PNP of 460 kPa, the first 
pulse generally produced a uniform distribution within the focal volume for all pulse lengths 
(figure 3.6, top). During exposure with a 100ms-long pulse, the energy of the acoustic 
emissions diminished rapidly due to microbubble destruction (figure 3.6, centre). By 50 ms, 
the distribution remained uniform for the PL of 5 cycles, but was progressively less uniform 
for longer PLs (figure 3.6, centre). By the end of the 100-ms burst, only the PL of 5 cycles 
 Controlling microbubble dynamics in ultrasound therapy 
 
 
104 
 
sustained a uniform distribution within the focus (figure 3.6, bottom). Increasing the PL led 
to faster transitions from uniformity to upstream bias in the acoustic cavitation activity 
distributions. Similar trends were observed at all sonication pressures (data not shown). 
Qualitatively, decreasing the acoustic pressures moved the transition point later in time for all 
PLs. Loss of uniformity occurred slower at lower pressures due to the limited destruction of 
the cavitation nuclei. 
 
Figure 3. 6: Spatiotemporal evolution of acoustic cavitation activity. Passive acoustic maps during 
sonication for PLs of 5, 25, 50 and 50,000 cycles at (top) t = 0 ms, (centre) t = 50 ms and (bottom) t = 100 ms. 
Microbubbles flowed from left to right. All energy values were normalised to the maximum energy of the first 
frame acquired during 100-ms-long exposure. PNP: 460 kPa. 
Bioeffects have been correlated with the acoustic cavitation activity type and 
distribution during microbubble-mediated ultrasound therapy (Choi et al 2014). We were 
interested in the cumulative distribution of cavitation activity over the entire 100-ms bursts. 
Cumulative energy plots revealed a strong upstream bias produced by long-pulse sonication 
(figure 3.7). Microbubbles entering the focus were readily destroyed throughout the long 
pulse, thus accumulating the acoustic energy emission at the entry point of the focal volume. 
In contrast, sonication with the rapid short-pulse sequences greatly reduced the observed bias, 
resulting in uniform acoustic cavitation distributions within the focus (figure 3.7). In this 
particular example, the maximum energy generated during 50-cycle sonication was higher 
than the long pulse control. Generally, we observed a trade-off between uniformity and 
magnitude of the acoustic emissions within the focus.   
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Figure 3. 7: Cumulative energy maps for 5, 25, 50, and 50,000-cycle sonication. The strong upstream bias 
observed in long pulses was greatly reduced in short pulses. PNP: 460 kPa. 
 
c. Cavitation mode 
In order to confirm the cause of the observed biases in the cavitation distribution 
(figures 3.6 and 3.7), we spectrally analyzed the time traces to determine the type of 
cavitation occurring at each of the three different locations within the focus (figure 3.8). The 
first observation was that broadband emissions were evident for all pulse lengths at acoustic 
pressure of 460 kPapk-neg. This suggested that high-magnitude inertial cavitation was 
dominant and caused transient events such as microbubble fragmentation. Broadband 
emissions were more intense and persisted for longer at the upstream and central locations of 
the focal volume. This indicated that microbubbles flowing into the focal volume were 
readily being destroyed (figure 3.8, top and centre), as confirmed by the energy maps (figure 
3.6).  
Both the magnitude and the duration of the broadband emissions varied with pulse 
length. Larger pulse length produced increased broadband emissions which were generally 
shorter in duration. Strong and recurrent harmonic and broadband emissions were observed at 
the upstream point of the focus (figure 3.8, top), due to the continuous replenishment of the 
focal volume with cavitation nuclei.  
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Figure 3. 8: Spatiotemporally-resolved frequency analysis. Spectrograms of the (top) upstream, (centre) 
central, and (bottom) downstream locations within the focus for 5, 25, 50, and 50,000-cycle sonication. PNP: 
460 kPa. 
 
d. Symmetry indices to assess spatiotemporal uniformity 
 
Using eq. (3.3), we calculated the lateral uniformity index. All tested pulse sequences 
produced uniform distributions of acoustic cavitation activity in the beginning of sonication, 
thus returning values of LU  close to 0 (figure 3.9). The LU  values during long-pulse 
sonication progressively shifted towards -1, yielding strong upstream biases. In contrast, 5-
cycle sonication consistently yielded uniform distributions (i.e., 0LU  ) throughout the 100-
ms burst. By increasing the pulse length, the lateral uniformity index increasingly deviated 
from 0. 
To compare the distributions produced from all the parametric sets tested (table 3.I), we 
calculated the spatiotemporal uniformity index using eq. (3.4) (figure 3.10). The experimental 
sets were chosen to evaluate the effect of PL (figure 3.10(a)), flow velocity (figure 3.10(b)), 
and PRF (figure 3.10(c)), across the acoustic pressures. Larger pulse lengths led to more 
asymmetric distributions at PNP of 460 kPa (figure 3.10(a)). However, at lower acoustic 
pressures there was no observable trend. Faster flow rates increased SUI  and produced 
stronger spatial biases (figure 3.10(b)). This was a result of a larger number of bubbles 
entering the focal volume per unit time, and thus stronger asymmetry in the emitted energy 
patterns. Larger SUI  values were observed at higher acoustic pressures, possibly due to the 
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faster microbubble destruction rates. Finally, the PRF did not considerably affect the average 
uniformity (figure 3.10(c)). Unexpectedly, higher pressures triggered more uniform 
distributions in the experimental set C. 
 
Figure 3. 9: Lateral uniformity index. PNP: 460 kPa. 
 
 
Figure 3. 10: Spatiotemporal uniformity index. SUI was calculated for all tested (a) PLs, (b) flow velocities, 
and (c) pulse repetition frequencies. 
 Controlling microbubble dynamics in ultrasound therapy 
 
 
108 
 
ii. High-speed microscopy 
 
Our optical observations showed that the microbubble translational dynamics at low 
acoustic pressures (PNP: 150 kPa) were predominantly affected by secondary radiation forces 
during the ultrasound on-time. At high-duty-cycle sonication secondary acoustic radiation 
resulted in fast cluster formation (figure 3.11). Primary radiation forces forced microbubble 
clusters to move away from the transducer. In contrast, at low-duty-cycle sonication, 
microbubbles experienced attractive forces only during the short on-time. Instead, they 
moved freely due to the drag force rising from the fluid flow during the off-time of the 
sequence (figure 3.11). Thus, we confirmed our hypothesis of enhanced microbubble 
mobility during low-duty-cycle sonication. At higher acoustic pressures (PNP > 200 kPa) 
microbubbles either were destroyed or disappeared from the field-of-view due to strong 
primary radiation forces.  
 
 
Figure 3. 11: High-speed observations of microbubble translational dynamics during rapid short-pulse 
and low-power sonication. Pulses were emitted at (a) 0.62 kHz and (b) 5 kHz. PNP: 150 kPa, PL: 25 cycles. 
Adapted from (Pouliopoulos et al 2016), with the permission of the Acoustical Society of America. 
 
4. Discussion 
 
In this chapter, we directly evaluated the effect of rapid short-pulse sonication using 
RCB-PAM and high-speed microscopy. We have shown that the non-uniform acoustic 
cavitation distribution produced by long-pulse sonication (Choi and Coussios 2012) can be 
improved by introducing short off-time intervals on the order of μs. Rapid short-pulse 
sequences eliminated the upstream bias observed in conventional therapies and produced 
uniform cavitation distribution throughout the focal volume (figures 3.6, 3.7 and 3.9). 
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Our rationale in the design of this pulse sequence was based on the observation that the 
inertial cavitation dose and the produced bioeffect (e.g., haemolysis) depend on the pulse 
length (Chen et al 2003). At the same acoustic pressure, smaller pulses are less likely to 
trigger transient cavitation events than longer pulses. Thus, the slower destruction rate was 
expected to change the energy patterns produced by flowing cavitation nuclei (Choi and 
Coussios 2012). We have confirmed here that 5-cycle sonication can sustain similar levels of 
cavitation activity within the focus throughout a 100ms-long burst (figure 3.6). In contrast, 
sonication with 50,000 cycles reduced the emitted energy over time by a factor of 103, 
accumulating most of the acoustic activity at the beginning of the focal volume, upstream to 
the flow (figure 3.7). Although our experiments were conducted in a simple in vitro model, 
some of our conclusions, such as the upstream bias reduction using short-pulse sonication, 
may be extendable to more complex in vivo environments. 
Short-pulse sonication has enhanced the drug concentration in blood-brain barrier 
opening studies (Choi et al., 2011a, 2011b). Short pulses of 2.3 μs emitted at pulse repetition 
periods on the order of μs produced the therapeutic bioeffect, i.e. vascular permeability 
enhancement, without irreversible tissue damage or signs of haemorrhage (Choi et al 2011b). 
In stark contrast, long-pulse sonication accumulated the model drugs in the vicinity of large 
vessels and produced heterogeneous drug distributions in the targeted hippocampi (Choi et al 
2010, 2007, 2011a). We propose here that the basis of this difference is the acoustic 
cavitation activity distribution within a treatment volume. We have demonstrated that the 
improved distribution triggered by short pulses may lead to favourable cavitation dynamics 
that reduce over-treated areas. 
Rapid short-pulse sonication can be adopted in ultrasound therapies such as reversible 
blood-brain barrier disruption (Hynynen et al 2001, Konofagou 2012), intracellular drug 
delivery (Zhou et al 2008, Hu et al 2013, Shamout et al 2015), and sonothrombolysis 
(Holland et al 2002, Bader et al 2015). Cancer treatment is expected to benefit from our 
approach, because a uniform drug distribution within a tumour’s core and periphery is 
substantial for successful therapy. The combined use of focused ultrasound and circulating 
microbubbles has enhanced the intratumoral concentration of a variety of drugs such as 
adenoviruses, liposomes, antibodies and genes (Liao et al 2015, Carlisle et al 2013, Graham 
et al 2014, Choi et al 2014, Nomikou and McHale 2012). Transient inertial cavitation 
followed by microbubble fragmentation increased the delivered doses even at large distances 
away from the vasculature.  
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Despite this increase, limited control of cavitation dynamics in the focal volume 
resulted in a non-uniform drug distribution within the tumour stroma (Graham et al 2014, 
Liao et al 2015). In vivo PAM data suggested that a higher magnitude of acoustic cavitation 
activity appeared at the distal to the skin part of the targeted tumour, on the far end of the 
targeted volume (Choi et al 2014). We hypothesise that this observation can be explained by 
the  rapid destruction of microbubbles flowing into the focal volume through the tortuous 
tumour microvasculature (Kim et al 2012). As shown in our in vitro setup, this 
inhomogeneity in the acoustic activity distribution (figures 3.6, 3.7 and 3.9) results in 
accumulation of acoustic activity or induced stresses upstream to the flow. The acoustic 
activity within the tumour was concentrated in the first 10 ms of the 100ms-long pulse (Choi 
et al 2014), as shown here.  
Although we improved the distribution of cavitation activity in the focus, the acoustic 
emissions magnitude produced in short-pulse sonication was lower than the long-pulse 
sonication (figure 3.4). Ultrasound therapies often require high magnitudes of acoustic 
activity to occur, employing transient inertial cavitation to produce the desired bioeffect  
(Graham et al 2014, Choi et al 2014). Such cavitation mode produces high stresses within the 
microvasculature (Hosseinkhah et al 2013), but is also associated here with inhomogeneous 
effects and strong spatial biases (figures 3.6, 3.7, 3.8). Our target was to trigger the right 
magnitude of microbubble-seeded cavitation activity at the proper location. Rapid short-pulse 
sonication can produce higher magnitude of acoustic activity by increasing the acoustic 
pressure (figure 2.3), without a considerable penalty in terms of uniformity (figure 3.10). To 
evaluate the in vivo effects produced by rapid short-pulse sonication, we will evaluate its 
efficacy in blood-brain barrier opening (chapter 6).  
The lateral uniformity and spatiotemporal uniformity indices defined in this chapter 
(eq. (3.4) and (3.5)) can be used in feedback-loop therapies based on RCB-PAM. Such PCD-
based feedback-driven systems have been employed in real-time therapy monitoring to adjust 
the sonication pressure (Sun et al 2015, O’Reilly and Hynynen 2012, Hockham et al 2010). 
We anticipate that RCB-PAM-based drug delivery systems can calculate these symmetry 
metrics (figure 3.9 and 3.10) in real-time and accordingly modify the emitted acoustic 
pressure, pulse length, and pulse repetition frequency (figure 3.10). The pulse shape and 
sequence could be modified in order to minimize the uniformity indices while maintaining a 
high magnitude of acoustic emissions over time (figure 3.4 and 3.5). Spatiotemporal 
uniformity index was not sensitive to temporal changes (figure 3.10) as it was calculated by 
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averaging a highly unstable set of values over time (figure 3.9). Thus, time-resolved lateral 
uniformity can be complemented with an elevational uniformity metric to achieve uniform 
2D therapies in vivo.  
Microbubble mobility was enhanced during low-duty-cycle sonication (figure 3.11). 
Long ultrasound on-times promote the action of primary and secondary radiation forces 
(Dayton et al 2002). At low-pressure continuous sonication, secondary interactions lead to 
the formation of microbubble clusters (Chen et al 2016, Fan et al 2014) within a few ms 
(figures 1.7, 1.12, 1.13, and 1.14). In contrast, short-pulse exposures facilitated movement of 
microbubbles during the entire ultrasound burst, allowing them to follow the fluid flow 
without aggregating (figure 3.11). As discussed in chapter 1, the formation of microbubble 
clusters may be either desirable or harmful in vivo. Short-pulse sonication can reduce the 
formation of these aggregates to avoid unwanted bioeffects such as capillary blockage.  
Our in vitro setup modelled the microbubble flow within a big vessel. Despite the 
useful insight on the evolution of cavitation activity in the focus, this simple model cannot 
capture the overwhelming complexity and diversity of real vascular networks. Similar 
uniformity patterns are expected if we assume continuous flow of cavitation nuclei into a 
capillary bed. This may be true in healthy vasculature but it does not apply to unhealthy 
vasculature. For example, blood flow is irregular and heterogeneous in the tumour 
microvasculature (Kim et al 2012, Zhu et al 2013) and a different acoustic cavitation 
distribution may arise within the tumour. 
 
5. Conclusions 
In this chapter we have shown that ultrasound exposure with rapid short-pulse 
sonication reduces or eliminates the non-uniform acoustic cavitation activity distributions and 
the spatial biases produced by long-pulse sonication. Short pulses separated by μs off-times 
sustained uniform acoustic emissions and reduced primary and secondary radiation force 
effects over time. We spread the microbubble-seeded cavitation activity in space and time by 
enhancing the microbubble lifetime and mobility. A trade-off between the total energy of 
cavitation activity and its spatiotemporal uniformity was evident during sonication with short 
pulses. RCB-PAM-monitored rapid short-pulse sonication assessing the symmetry indices 
presented here can be used to control microbubble dynamics in ultrasound therapy 
applications. 
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PART C 
 
 
MONITORING ULTRASOUND THERAPY 
 
 
 
 
“EVERYTHING WE DO IS SOMEHOW CONNECTED TO VELOCITY.” 
HANS-ULRICH OBRIST 
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CHAPTER 4 
SUPERHARMONIC MICROBUBBLE DOPPLER EFFECT 
 
1. Introduction 
 
i. Therapy monitoring techniques 
In the previous two chapters, we assessed the effect of short-pulse sequences on 
cavitation dynamics using existing therapy monitoring techniques. The magnitude, type and 
duration of acoustic cavitation activity using single-element passive cavitation detection 
(PCD) can be assessed both in vitro (Gruber et al 2014, Shamout et al 2015, Radhakrishnan 
et al 2015) and in vivo (Sun et al 2015, Graham et al 2014, Wu et al 2014). As described in 
chapter 3, one can also localise the position of the generated acoustic emissions using passive 
cavitation mapping (Gyöngy and Coussios 2010, Salgaonkar et al 2009) both in vitro (Choi 
and Coussios 2012) and in vivo (Choi et al 2014, Jones et al 2013). The aforementioned 
techniques can thus quantify the location, type, duration, and magnitude of microbubble 
acoustic cavitation activity within the focus. However, as described before (chapter 1), 
microbubbles move during sonication due to acoustic radiation forces (Bjerknes 1906, 
Dayton et al 2002). Currently none of these techniques is able to monitor microbubble 
velocities based on their acoustic emissions. Microbubble velocity may be an important 
parameter in applications that require microbubbles to move towards a treatment site, such as 
in sonothrombolysis (Acconcia et al 2013, 2014, Bader et al 2015). In this chapter, we 
introduce our approach to quantifying the microbubble velocities passively and in real-time 
manner: the superharmonic microbubble Doppler effect.  
 
ii. Microbubble Doppler effect in ultrasound imaging 
Christian Doppler noticed in 1842 that a frequency shift occurs when an acoustic source 
is moving with respect to an observer. The Doppler effect has been used in a multitude of 
applications even since, such as radar technology, astronomy, and medicine. In biomedical 
imaging, active Doppler ultrasound is used for quantifying the blood flow, based on the 
spectral broadening, i.e. the detected phase shifts, in the scattered ultrasound waves (Evans 
and McDicken 2000). Blood velocity and direction in large vessels can be estimated using 
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conventional Doppler imaging. To perform perfusion studies for example in the heart (Bruce 
et al 2004), ultrasound contrast agents, i.e. microbubbles, are necessary, in order to enhance 
the acoustic signal originating from the vasculature (Stride and Saffari 2003, Cosgrove 2006). 
Active Doppler imaging, such as colour Doppler, is based on the detected phase shifts 
between the echoes of imaging pulses (Evans et al 2011). The use of microbubbles poses 
challenges to Doppler imaging, because of the non-linear scattering and loss of phase 
coherence occurring because of the bubble cloud.  
As discussed earlier (chapter 1), sonicated microbubbles experience primary and 
secondary Bjerknes forces (Bjerknes 1906). Primary acoustic radiation forces arise due to 
interaction of the microbubbles with the acoustic field produced by an external source, such 
as an ultrasound transducer. Momentum transfer yields a non-zero force in the direction of 
propagation for a free travelling wave (Dayton et al 1997, Palanchon et al 2005). This force 
depends on the acoustic field local gradient and the microbubble volume (eq. (1.5) and (1.6)). 
Secondary acoustic radiation forces arise due to bubble-bubble interactions (eq. (1.4)) and 
can be attractive or repulsive, depending on the phase difference in the volumetric 
oscillations of the interacting microbubbles (Doinikov 2005, Apfel 1988). Sonication with 
short pulses at high PRFs, i.e. with parameters used in medical imaging, revealed that 
radiation forces accelerate individual microbubbles to velocities up to 0.5 m s-1 (Dayton et al 
2002). 
Tortoli and his collaborators were the first to show that a frequency shift emerges in the 
microbubble emission spectrum when microbubbles are moving (Tortoli et al 1999a, 1999b). 
Using typical ultrasound imaging sequences (fc: 4 MHz, PL: 1.3 μs) they measured a negative 
frequency shift of the fundamental peak on the order of 1 kHz. This experimental observation 
was corroborated by numerical simulations of microbubbles moving due to primary acoustic 
radiation and drag forces (Tortoli et al 1999b). The asymmetric spectral broadening depended 
on the characteristics of the employed pulse sequence, i.e. the pulse length, the pulse 
repetition frequency and the acoustic pressure (Tortoli et al 1999a). Regardless of the pulse 
sequence used, the frequency shifts were consistently negative with respect to the primary 
harmonic peak. These negative frequency shifts persisted even under laminar flow of the 
surrounding fluid, indicating that their origin is the microbubble movement away from the 
transducer (Tortoli et al 2000). Sonication at acoustic pressures that were above the 
microbubble fragmentation threshold (> 500 kPapk-neg) resulted in a symmetric increase of the 
broadband emissions. The shape of the frequency shift was not affected by the broadband 
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emissions, suggesting that the asymmetric broadening was indeed due to acoustic radiation 
forces (Tortoli et al 2005). Acoustic streaming was proposed as a possible explanation for the 
frequency shifts (Nyborg 1958), yet its contribution was not found relevant at the μs 
timescale (Tortoli et al 2001).  
 
iii. Imaging vs. therapy 
The studies by Tortoli et al. used imaging pulse shapes and sequences in active pulse-
echo mode. The center frequencies were in the range of 2.5 – 8 MHz, the imaging pulse 
lengths were up to 10cycle-long (or a few μs) and the PRFs on the order of kHz. Thus, it was 
argued that the detected shifts were due to the microbubble inter-pulse movement and not due 
to continuous microbubble motion. Microbubbles moved at instantaneous m s-1 velocities 
only during the short on-time of the imaging sequence, thus the frequency shifts were 
attributed to the different microbubble locations between ultrasound pulses (Tortoli et al 
2009).  
Unlike imaging applications, ultrasound therapies are typically performed using 
relatively low centre frequencies (< 2 MHz) and long pulses (> 1,000 cycles) (Coussios and 
Roy 2008, Ferrara et al 2007). Low frequency ultrasound penetrates deeper into the body and 
can generally converge to a large treatment volume. Long pulse lengths are thought to 
increase the induced therapeutic effect, such as blood-brain barrier opening (Hynynen et al 
2001, Konofagou 2012) and sonothrombolysis (de Saint Victor et al 2014), although they are 
correlated with poor distributions (chapters 2 and 3). The natural frequency of an isolated, 
coated, and average-sized microbubble is typically higher than therapeutic centre frequencies 
(van der Meer et al 2007). However, the effective resonance frequency of a population of 
microbubbles can be lower, down to 0.5 to 1 MHz, depending on the concentration (Yasui et 
al 2009).  
Long therapeutic pulses can continuously displace individual microbubbles (Palanchon 
et al 2005). At low-pressure sonication, microbubble acoustic activity can be sustained over 
long periods (Hitchcock et al 2011), while at high-pressure sonication microbubbles undergo 
high-magnitude inertial cavitation and may dissolute or get fragmented (Chen et al 2003, 
Pouliopoulos et al 2014). Microbubbles sonicated with ms-long pulses were shown to 
develop speeds on the order of 1 m s-1 (Koruk et al 2015). Microbubbles moved at this 
velocity until they reached the distal wall or forced out of the focal area. At high microbubble 
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concentrations, microbubbles were trapped into vortices and were continuously redistributed 
within the focal area  (Koruk et al 2015). 
In this chapter, we measure the microbubble Doppler shift appearing in ultrasound 
therapy. Our hypothesis was that the asymmetric spectral broadening observed in imaging 
sequences also occurs in therapeutic sequences. We focused on microbubble acoustic 
emissions above the 10th harmonic, in the spectral region of superharmonics. Our simple 
approach is intended to add an extra dimension in the existing therapy monitoring techniques: 
microbubble velocity monitoring. The purpose of measuring velocity is to know whether 
primary acoustic radiation forces are present during therapy in applications that require 
microbubbles being pushed to regions of interest. 
 
2. Materials and methods 
 
i. Experimental setup 
Microbubbles were prepared in-house as described previously (chapter 1, Materials and 
methods). The average radius for this set of experiments was 0.6 ± 0.4 μm and the range was 
0.25 to 4.45 μm. The activated microbubble solution was diluted in PBS to an estimated 
concentration of 5 × 107 microbubbles ml-1. The majority of our measurements were 
conducted with this nominal concentration. Initial solutions were also diluted to 5 × 106, 5 × 
105, and 5 × 104 microbubbles ml-1, to investigate the effect of microbubble concentration on 
the resulting Doppler shifts. 
The cavitation nuclei were infused in a 4-mm tube (Saint-Gobain Performance Plastics, 
Paris, France) which was placed in a tank containing degassed and deionised water (figure 
4.1). Our experiments were conducted in static conditions, to reduce the spectral shifts due to 
the fluid flow and focus on the effects of radiation forces. A plastic tube was preferred over a 
plexiglas tube, because stiff materials may produce Doppler artefacts due to shear and 
longitudinal waves (Tortoli et al 1997). A function generator (33500B Series, Agilent 
technologies, Santa Clara, CA, USA) was used to produce the therapeutic pulses (fc: 0.5 
MHz, PL: 100 ms or 50,000 cycles). The pulses were amplified with a 50 dB amplifier 
(Precision Acoustics Ltd, Dorchester, UK) and were applied to the transducer through an 
impedance matching box (Sonic Concepts Inc., Bothell, WA, USA). Focused ultrasound was 
emitted using a single-element, spherically-focused 0.5 MHz ultrasound transducer (part 
number: H107, lateral FWHM: 5.85 mm, axial FWHM: 29.78 mm; Sonic Concepts Inc., 
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Bothell, WA, USA), whose focus coincided with the tube, along the axial and elevational 
directions. The acoustic pressures (PNP: 75, 147, 217, 294, and 366 kPa) were selected based 
on previous studies (Pouliopoulos et al 2014) to instigate cavitation modes ranging from non-
inertial to inertial cavitation. 
 
Figure 4. 1: In vitro experimental setup for PCD measurement of microbubble Doppler shifts. The setup 
was  comprised of an emission (white) and detection (grey) circuit. Reproduced from (Pouliopoulos and Choi 
2016) under the terms of the Creative Commons Attribution 3.0 license. 
A co-aligned inserted 7.5 MHz passive cavitation detector (part number: U8423589, 
diameter: 12.7 mm, focal length: 60 mm; Olympus Industrial, Essex, UK) was used to 
capture the microbubble acoustic emissions. The foci of the two transducers were aligned and 
overlapped. There were no waveform distortions caused by nonlinear propagation at the 
focus at the tested acoustic pressures. We filtered out the fundamental frequency and the 
lower harmonics using an analogue 5 MHz high-pass filter (part number: MH-500 P-C-P; 
Allen Avionics, Mineola, NY, USA). The filtered signal was fed through a 28 dB pre-
amplifier (Stanford Research Systems, Sunnyvale, CA, USA) and was then captured with an 
8-bit digital oscilloscope (Tektronix, Bracknell, UK) at a sampling rate of 25 MSa s-1. Both 
emission and detection were controlled with Matlab (The Mathworks, Natick, MA, USA). 
We saved the raw RF data to a PC for processing off-line.  
 
ii. Signal processing 
A simple signal processing routine was developed in Matlab (figure 4.2). First, we 
performed a fast Fourier transform (figure 4.2(b)) of the captured time-domain signal (figure 
4.2(a)). The spectral analysis was performed for both the entire 100-ms sonication and within 
1ms-long time windows. Unlike previous studies on the microbubble Doppler shift in 
ultrasound imaging (Tortoli et al 1999a, 1999b, 2000, 2001), our approach had several traits 
specific to ultrasound therapy. First, therapeutic pulses are typically longer and are emitted at 
low centre frequencies. Longer sonication duration (> 1 ms) forces microbubbles to move due 
to continuous primary acoustic radiation forces, thus increasing microbubble velocities. Low 
centre frequencies (< 2 MHz) are thought to trigger larger microbubble population responses 
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(Yasui et al 2009). Second, our approach differs in the method used to capture the acoustic 
emissions. In imaging, a single transducer was typically used in pulse-echo mode. In therapy, 
due to the long pulse lengths, acoustic emissions need to be captured while the therapeutic 
pulse is being emitted. Thus, PCD needs to be used to capture the reradiated microbubble 
acoustic waves. Finally, we chose a different spectral region to conduct our spectral analysis. 
In imaging, first or second harmonics were analysed while here we chose to analyse the 
superharmonic region (> 10th harmonic) to avoid reflections at lower harmonics, non-linear 
propagation effects and signal saturation. Additionally, Doppler shifts increase with 
frequency, thus we expected that superharmonic analysis would enable easier velocity 
characterisation and quantification.  
 
Figure 4. 2: Signal processing routine to analyse superharmonic Doppler shifts. Microbubble acoustic 
emissions were captured in the (a) time-domain and were then analysed in the (b) frequency domain, for either 
the whole 100-ms sonication or for 1-ms time segments. (c) Superharmonics were isolated and then (d) 
smoothed using a 3-kHz moving average filter. The peak shown in (c) and (d) is the 10th harmonic from (b). 
Adapted from (Pouliopoulos and Choi 2016) under the terms of the Creative Commons Attribution 3.0 license. 
 
Following the Fourier analysis (figure 4.2(b)), we isolated each of the superharmonics. 
We segmented the spectrum up to 0.1 MHz on either side of the expected peak position 
(figure 4.2(c)). Working on the superharmonic region, we did not subtract the baseline 
spectrum because reflections were negligible in this domain. The final step was to apply a 
moving average filter in order to smooth the noisy spectra (figure 4.2(d)). Following 
iterations with different frequency spans, we chose a span of 3 kHz. Such span resulted in 
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clear peaks without considerable modification of the peak’s fine structure (figure 4.2(d)). To 
analyse microbubble Doppler shifts in a time-resolved manner, we conducted spectral 
analysis with 1ms-long Hanning windows and 0.5 ms overlap between neighboring segments. 
Microbubble velocities were derived using the modified Doppler equation. 
Microbubbles are both ultrasound receivers and emitters at the same time, thus a factor of 2 
was included (Tortoli et al 2000): 
2
eff
SH
c
v f
f
                                                                           (4.1) 
where f  was the detected frequency shift, SHf   was the frequency of the expected 
superharmonic peak, 
effv  was the effective microbubble velocity and c  was the speed of 
sound. We repeated every measurement multiple times using similar experimental conditions. 
Thus, all spectra presented in this chapter were averaged across the repeats in the frequency 
domain and were presented as mean ± standard deviation. 
 
3. Results 
 
i. Evaluation of the microbubble superharmonic Doppler effect 
We sought to detect and quantify the superharmonic microbubble Doppler effect in 
low-frequency and long-pulse ultrasound therapy. Microbubble acoustic emissions were 
passively recorded and superharmonic regions (10th to 15th harmonic) were isolated and 
analyzed (figure 4.3). All spectra were averaged in the frequency domain across repeats and 
shaded areas show one standard deviation. At low-pressure sonication (PNP: 75 kPa) we did 
not detect any signal due to the low signal-to-noise ratio at the superharmonic region. At PNP 
of 147 kPa, we observed a subtle peak broadening, negatively shifted with respect to the 
expected superharmonic peak position (figure 4.3(a)). At peak-negative pressures above 200 
kPa, we observed a clear secondary peak emerging next to the primary superharmonic peak 
(figure 4.3(b)). Higher-order superharmonics had lower amplitude, yet the shape of the 
spectral broadening was consistent for different frequencies. This asymmetric negative 
broadening of the superharmonic peak was attributed to the axial microbubble movement 
away from the PCD transducer. We will thus hereafter refer to the emerged peak as the 
“Doppler peak”. At peak-negative pressures higher than 217 kPa, Doppler peaks generally 
increased in width and decreased in amplitude (figure 4.3(c)-(d) and figure 4.5). 
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Figure 4. 3: Doppler shifts across the superharmonics (10th to 15th). Sonication at PNP of (a) 147kPa, (b) 
217kPa, (c) 294kPa and (d) 366kPa. Lines and shaded areas stand for average spectra and one standard 
deviation, respectively (n=5). Microbubble concentration: 5 × 107 ml-1. Reproduced from (Pouliopoulos and 
Choi 2016) under the terms of the Creative Commons Attribution 3.0 license. 
 
ii. Doppler peak characterisation 
To illustrate our method, we characterised the superharmonic microbubble Doppler 
effect at PNP of 217 kPa as an example (figure 4.4). The amplitude of the harmonic and 
Doppler peaks decreased with frequency. This was due to the combination of lower emitted 
amplitude and higher attenuation at higher harmonics. In this particular example, the Doppler 
peak amplitude was higher than the primary peak amplitude (figure 4.4(a)). At higher 
acoustic pressures the Doppler peak was generally lower than the primary peak (figure 4.3). 
Frequency shifts (figure 4.4(b)) were converted into “effective” microbubble velocities 
(figure 4.4(c)) using eq. (4.1). Effective velocities provided an overview of the complex 
movement of the polydisperse microbubble population. They were calculated as a 
comparative measurement and did not necessarily correspond to the average microbubble 
velocity during sonication. Our data showed that the linear increase in the detected shifts 
(figure 4.4(b)) returned estimated velocities on the same range for all superharmonics (figure 
4.4(c)). This provides evidence that the secondary peaks correspond to Doppler peaks, 
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because, based on the Doppler equation, Doppler shifts increase linearly with frequency for a 
given velocity. At PNP of 147 kPa, the average effective microbubble velocity was 2.26 ± 
0.03 m s-1 (n=6). Primary harmonic peaks had an apparent shift of up to -4 kHz (figure 
4.4(b)). This was possibly due to non-linear sound propagation or the application of the 
moving average filter which had an averaging span of 3 kHz.  
 
Figure 4. 4: Quantification of Doppler shift across the superharmonics (PNP: 217kPa, microbubble 
concentration: 5×107 ml-1). (a) Harmonic and Doppler peak amplitudes. (b) Detected frequency shifts of the 
harmonic and Doppler peaks. (c) Effective velocities across the superharmonics. All measurements are 
presented as mean ± S.D (n=5). Reproduced from (Pouliopoulos and Choi 2016) under the terms of the Creative 
Commons Attribution 3.0 license. 
 
Qualitatively, the emergent Doppler peaks changed in shape for different insonation 
pressures (figure 4.5). Higher acoustic pressures resulted in larger Doppler shifts. The 
Doppler peak width increased with pressure, up until 300 kPapk-neg. The Doppler peak 
amplitude decreased with pressure for PNP higher than 217 kPa. The broadband floor 
increased with pressure, except for the highest pressure tested (PNP: 366 kPa) where it 
decreased. 
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Figure 4. 5: Microbubble superharmonic Doppler shifts across the acoustic pressures (10th harmonic, 
microbubble concentration: 5×107 ml-1). Lines and shaded areas stand for average spectra and one standard 
deviation, respectively (n=5). Reproduced from (Pouliopoulos and Choi 2016) under the terms of the Creative 
Commons Attribution 3.0 license. 
 
We quantified these qualitative observations by fitting the two peaks with Lorentzian 
functions (figure 4.6(a)). Lorentzian functions were chosen over Gaussian function due to 
better fitting accuracy (R2 > 0.9). Lorentzian response curves are characteristic of damped 
harmonic oscillators such as sonicated microbubbles. Negative Doppler shifts increased 
linearly with pressure, from -5 kHz at PNP of 147 kPa to -30 kHz at PNP of 366 kPa (figure 
4.6(b)). A few superharmonics at the highest tested pressure did not follow this trend. This 
was possibly due to poor fitting and large standard deviations (figure 4.3(d)). These 
frequency shifts were converted into effective velocities using eq. (4.1) (figure 4.6(c)). An 
effective velocity of 1 m s-1 was measured at PNP of 147 kPa, even though the Doppler peak 
was not distinguishable from the primary superharmonic at this pressure (figure 4.5). At 
higher acoustic pressures microbubbles moved faster, with effective velocities up to 3.1 m s-1 
at 294 kPapk-neg.  
The width of the Doppler peaks, as expressed by the FWHM, generally increased with 
pressure (figure 4.6(d)). In contrast, the width of primary superharmonic peaks was 
effectively constant across the acoustic pressures. The deviation from the trend was also 
observed for the Doppler peak FWHM at the highest pressure. Standard deviations were on 
the order of 1 kHz but were discarded from figures 4.6(b) and 4.6(d) to avoid clutter. 
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Figure 4. 6: Doppler shift quantification across the acoustic pressures. (a) Dual-peak Lorentzian fits gave 
the best fitting accuracy (10th harmonic, PNP: 217 kPa). (b) Frequency shifts of the Doppler peak over the 
acoustic pressure across the superharmonics. (c) Estimated effective velocities of the sonicated microbubbles at 
different acoustic pressures. Averaging was conducted across the harmonics (n=6). (d) FWHM for the Doppler 
and the harmonic peaks. Reproduced from (Pouliopoulos and Choi 2016) under the terms of the Creative 
Commons Attribution 3.0 license. 
 
Frequency shifts were expected to change over time, thus we performed a time-resolved 
frequency analysis of the time-domain signal (figure 4.7). At low-pressure sonication 
Doppler and primary peaks were entangled and indistinguishable (figure 4.7(a)). A zoomed 
view revealed that the negative shift appearing as an asymmetric broadening of the 
superharmonic peak was present throughout sonication (figure 4.7(a)). At higher sonication 
pressures, the Doppler peak was consistently distinguishable during the entire pulse (figure 
4.7(b)-(c)). Sonication at 366 kPapk-neg increased the detected broadband signal in the first 10 
ms of the therapeutic pulse. The amplitude of the Doppler shift was thereafter lower for the 
remainder of the pulse (figure 4.7(d)). 
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Figure 4. 7: Time-resolved analysis of frequency shifts. Sonication at PNPs of (a) 147kPa, (b) 217kPa, (c) 
294kPa, and (d) 366kPa (10th harmonic, microbubble concentration: 5×107 ml-1). Reproduced from 
(Pouliopoulos and Choi 2016) under the terms of the Creative Commons Attribution 3.0 license. 
 
iii. Effect  of microbubble concentration 
The microbubble concentration used in the experiments shown so far was 5 × 107 
microbubbles ml-1. In this concentration, secondary radiation forces and coupling effects 
were expected to be significant (Stride and Saffari 2005). To study the influence of 
microbubble concentration on the generated Doppler shifts, we tested different concentrations 
(i.e., 5 × 106, 5 × 105, 5 × 104 microbubbles ml-1) and repeated the experiments at an acoustic 
pressure of 217 kPapk-neg (n=3). By lowering the microbubble concentration, the acquired 
spectrum had progressively lower amplitude (figure 4.8). With the exception of the lowest 
concentration tested (5 × 104 microbubbles ml-1), all diluted microbubble solutions produced 
superharmonic spectra with high signal-to-noise ratio. Doppler shifts decreased for lower 
concentrations (Table 4.I), suggesting that microbubbles in the dilute samples were 
accelerated to lower velocities than the more concentrated samples. Despite the large 
standard deviations at the low concentrations (figure 4.8), the Doppler peak widths generally 
decreased for lower concentrations (Table 4.I). Lorentzian peak widths are proportional to the 
damping coefficient of single damped forced oscillators, so we expected wider peaks for 
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highly concentrated microbubble populations. However, the collective behaviour of the 
sonicated microbubble population may also influence the shape of the Doppler peaks. 
 
Figure 4. 8: Doppler shifts across the microbubble concentrations (10th harmonic, PRP: 217kPa). Lines and 
shaded areas stand for average spectra and one standard deviation, respectively (n=3). Reproduced from 
(Pouliopoulos and Choi 2016) under the terms of the Creative Commons Attribution 3.0 license. 
 
We performed time-resolved Fourier analysis to shed light on the observed Doppler 
shifts across the microbubble concentrations. As shown before (figure 4.7(b)-4.7(d)), Doppler 
shifts persisted over time in the dense microbubble solution (figure 4.9(a)). In contrast, for 
lower concentrations spectrograms showed that the Doppler shifts were limited within the 
first part of the 100ms-long pulse (figure 4.9(b)-4.9(d)). At concentrations of 5 × 106 and 5 × 
105 microbubbles ml-1, the tens-of-kHz shift persisted approximately for 25 ms and 10 ms, 
respectively. Following this time period, the microbubble signal decreased considerably 
either due to microbubble destruction or movement out of the PCD focal volume. 
 
Table 4. I: Superharmonic microbubble Doppler effect across the concentrations (10th harmonic, PNP: 
217 kPa). 
Concentration 
(microbubbles ml-1) 
Doppler peak shift 
(MHz) 
Doppler peak 
FWHM (MHz) 
Effective velocity  
(m s-1) 
5 × 107 -0.017 0.027 2.55 
5 × 106 -0.014 0.026 2.1 
5 × 105 -0.013 0.021 1.95 
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Figure 4. 9: Time-resolved frequency analysis across the microbubble concentrations. (a). 5×107, (b) 
5×106, (c) 5×105, and (d) 5×104 microbubbles ml-1 (10th harmonic, PRP: 217kPa). Reproduced from 
(Pouliopoulos and Choi 2016) under the terms of the Creative Commons Attribution 3.0 license. 
 
iv. Optoacoustical comparison 
The Doppler shifts observed here were produced by microbubble movement with 
respect to the PCD transducer. To compare the microbubble dynamics shown in the first 
chapter with the acoustic data shown in the current chapter, we performed an initial 
optoacoustical comparison for sonication at similar acoustic pressures and experimental 
conditions (PNP: ~ 200 kPa, PL: 100 ms; figure 4.10). Using the optical flow method 
(chapter 1, Materials and methods) we calculated microbubble velocities in the direction of 
ultrasound propagation as captured in the high-frame-rate videos. The velocities captured for 
every frame were summed in velocity bins and then transformed into frequency shifts (figure 
4.10, red bars). This “optical spectrum” (i.e., the counts of the velocity or frequency bins) had 
a structure similar to the acoustic spectrum (figure 4.10, blue line). Optical shifts were 
centered closer to the expected harmonic position compared to the fitted Doppler peak (figure 
4.10, green line). Nevertheless, both spectra presented peaks on the same order of frequency 
shift magnitude, showing that optics can be matched with acoustics in future experiments.    
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Figure 4. 10: Optoacoustical comparison. Optically measured velocities during sonication were converted into 
frequency shift bins (red columns) and compared against acoustically-derived Doppler shifts (Doppler peak fit 
in green, raw spectrum in blue). PNP ≈ 200 kPa, 10th harmonic. 
 
4. Discussion 
 
i. Origin of superharmonic Doppler effect in ultrasound therapy 
In this chapter, we have shown that microbubbles sonicated with a therapeutic 
ultrasonic pulse generated asymmetrically broadened superharmonic peaks (figures 4.3 and 
4.5). Doppler peaks negatively shifted up to -30 kHz emerged next to the primary 
superharmonic peaks (figures 4.3, 4.5, 4.8), suggesting microbubble velocities on the order of 
m s-1 (figure 4.4(c) and 4.6(c)). Imaging and therapeutic regimes were shown to differ in the 
scale of the resulting Doppler shifts. In previous studies concerning the frequency shift in 
ultrasound imaging, Doppler shifts were on the order of few hundreds of Hz (Tortoli et al 
1999b, 1999a, 2000, 2005). Instead, we measured here that the relevant shifts in ultrasound 
therapy were on the order of tens of kHz away from the expected superharmonic position. 
Additionally, Doppler shifts were previously expressed as a broadening of the fundamental 
peak (Tortoli et al 2000, 2005), while here we observed the emergence of a separate peak 
adjacent to the primary superharmonic. Previous studies focused on the fundamental 
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frequency and detected shifts that were not generated by continuous translation of the 
acoustic sources. On the contrary, Doppler shifts were due to microbubble movement 
between each pulse (Tortoli et al 2009). Thus, although instantaneous m s-1 velocities should 
translate into frequency shifts of tens of kHz, the observed broadening was limited to few 
hundreds Hz (Tortoli et al 2005, 2009). 
 
ii. On the temporal persistence of microbubble Doppler shifts 
Time-resolved frequency analysis revealed different translational dynamics during 
sonication (figures 4.7 and 4.9). Dense microbubble populations produced negative frequency 
shift throughout sonication (figure 4.7), suggesting that microbubble movement cannot be 
unidirectional. At a velocity on the order of m s-1 (figures 4.4(c), 4.6(c) and table 4.I), 
microbubbles could move from the proximal to the distal wall of the 4-mm tube within a few 
ms. Yet, the continuous Doppler requires another mechanism that is capable of setting 
microbubbles into continuous motion during therapeutic sonication. We hypothesize that 
acoustic streaming in the direction of ultrasound propagation can be a plausible mechanism 
(Nyborg 1958). We based our hypothesis on recent experimental observations (Koruk et al 
2015, Cho et al 2015). In our work, we have shown that highly concentrated microbubble 
populations can deform elastic interfaces for tens of milliseconds (Koruk et al 2015). High-
speed optical measurements revealed microbubbles trapped within vortices in the focal 
volume.  
In our experiments, such vortices may continuously redistribute the sonicated 
microbubbles and contribute to the persistence of the detected Doppler shifts. The focal 
volume of the 7.5 MHz PCD transducer was smaller than and embedded within that of the 0.5 
MHz therapeutic transducer. Captured acoustic signals may stem from microbubbles moving 
away from the PCD transducer, while spinning in these vortices and re-entering the listening 
volume. Another possibility is that large microbubble clusters spin around their centre-of-
mass due to strong cohesive forces and produced asymmetric shift. However, such movement 
should introduce a symmetrical positive shift of the harmonic peaks, due to the microbubble 
movement towards the transducer. At low concentrations, microbubbles moved along the 
ultrasound propagation direction in m s-1 velocities before being forced out of the focus 
(Koruk et al 2015). Our measurements at low concentrations (table 4.I and figure 4.9) are in 
agreement with this observation, because Doppler shifts persist only for few ms (figure 
4.9(b)-4.9(d)). Vortex creation was less likely to occur at low concentrations since fluid 
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would not be displaced at a high extent. Also, sparse microbubbles are less likely to form 
clusters (Chen et al 2016) or coalescence into larger bubbles (Bader et al 2015, Fan et al 
2014), which may be the origin of the majority of the detected signal.  
Microbubbles sonicated at 1 - 2.25 MHz centre frequencies triggered streaming 
velocities on the order of cm s-1 and produced symmetric vortices at the outskirts of the focus 
(Cho et al 2015). Fluid streaming originated from microbubble clustering (Koda et al 2011) 
or coalescence (Postema et al 2004) and the collective translation of the microbubble 
population (Koruk et al 2015). Fast microbubble dynamics may emerge in low frequency 
sonication due to microbubble population resonance effects (Yasui et al 2009). Microbubble 
coalescence may significantly influence the captured acoustic emissions (Postema et al 
2004). As shown in chapter 1, long-pulse therapeutic sonication lead to fast microbubble 
coalescence (Bader et al 2015, Fan et al 2014), especially at highly concentrated populations 
and high acoustic pressures (figures 1.15 and 1.17). Microbubbles with sizes close to the 
resonance size at 0.5 MHz may produce a large portion of the detected shifts, because 
proximity to resonance leads to large volumetric oscillations (i.e., generated acoustic 
emissions, eq. (1.3)) and primary acoustic radiation forces (eq. (1.6)). Resonant bubbles thus 
emit more ultrasound and move faster (figure 1.16). Lastly, the collective oscillations of the 
sonicated microbubble population may produce resonant behaviors due to the complex many-
body coupled interactions (Zeravcic et al 2011), thus increasing velocities to the m s-1 scale 
(figure 4.10 and 1.7). 
Although microbubble translation is a manifestation of complex dynamics (Doinikov 
and Bouakaz 2015, Doinikov 2005), our simple strategy provided an estimate of the 
microbubble velocity during sonication. Doppler shifts increased linearly with frequency, 
allowing high accuracy in the measured effective velocities (figures 4.4(c) and 4.6(c)).  
Doppler peak width and shift increased with pressure (figures 4.3, 4.5, and 4.6), suggesting 
that microbubbles moved faster at higher sonication pressures (figure 4.6(c)). At the highest 
tested pressure (PNP: 366 kPa), resonant microbubbles were readily destroyed (figure 4.7(d)), 
thus the effective velocities decreased (figure 4.6(c)). At acoustic pressures higher than the 
inertial cavitation threshold (Choi and Coussios 2012) the noise floor rose (figure 4.7(c)-
4.7(d)). High-magnitude inertial cavitation and fast microbubble destruction were inferred 
from the broadband signal level at the beginning of 366-kPapk-neg sonication (figure 4.7(d)).  
Similar frequency shifts were also observed in the ultraharmonics (i.e., odd multiples of 
half the fundamental frequency). Ultraharmonics are produced only by microbubbles 
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undergoing nonlinear volumetric oscillations (Lauterborn 1976, Apfel 1997), thus the 
asymmetric frequency shifts could be attributed only to translating microbubble activity. 
Non-linear propagation and reflections were rejected as causes of the detected shift, because 
such phenomena are negligible in the superharmonic range. Furthermore, there is no evidence 
that phenomena such as chaotic microbubble behaviour, fragmentation, or lipid shedding, 
would result in such asymmetric frequency shifts which increase linearly with frequency 
(figure 4.4(b)).  
 
iii. Clinical relevance 
The superharmonic microbubble Doppler effect provides the capability of estimating 
microbubble velocities in ultrasound therapy in real-time and in a passive manner. Real-time 
estimation of microbubble velocities (figure 4.4(c) and 4.6(c)) would increase our control of 
the induced bioeffect, complementing existing monitoring techniques such as PCD or PAM. 
Microbubble movement towards surfaces is required in applications such as 
sonothrombolysis (Bader et al 2015, Acconcia et al 2015, 2014, 2013), sonoporation (Fan et 
al 2014, Shamout et al 2015), acoustic particle palpation (Koruk et al 2015), and molecular 
therapy or imaging (Dayton et al 1999). Passive monitoring of the microbubble velocities 
using the Doppler effect can be performed by simple signal processing routines implemented 
in standard PCD systems.  
This technique provides a cheap, accessible, and simple tool for the estimation of 
microbubble movement near the vessel wall or other targeted surfaces. Microbubble-
mediated therapies can be currently assessed passively in vivo using PCD (Sun et al 2015, 
Hockham et al 2010, Graham et al 2014) and PAM (Choi et al 2014). However neither of 
these techniques can provide estimates about the microbubble translation due to acoustic 
radiation forces. In this chapter, we introduced the dimension of acoustic cavitation 
translation within the focal volume. Understanding microbubble translational dynamics 
during ultrasound therapy could increase our control over the induced bioeffects and result in 
safe and efficient focused ultrasound therapies. Finally, the superharmonic microbubble 
Doppler effect may also find use in other applications where moving bubbles are required, 
such as surface cleaning, non-destructive testing etc. 
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iv. Limitations 
We have demonstrated that the shifts emerging in the acoustic emissions of translating 
microbubbles can provide estimates about the microbubble population movement during 
ultrasound therapy. This effect was demonstrated in a 4-mm elastomer tube (figure 4.1), 
because it was expected to be prominent in large vessels. Large vessel volumes offer the 
advantage of having a large number of sonicated bubbles within the focus and the space 
availability for microbubbles to move. In real vasculature, large vessels have blood flowing at 
high flow velocities. However, in our experiments we decided to investigate the microbubble 
dynamics without fluid flow, in order to study microbubble movement only due to primary 
and secondary acoustic radiation forces. The detected Doppler and superharmonic peaks are 
expected to be negatively or positively shifted in vivo, according to the direction of the blood 
flow (Tortoli et al 2000). Additionally, as mentioned in previous chapters, microbubbles were 
not diluted in blood, but in PBS. This would change the microbubble translational dynamics 
in vivo, since the hydrodynamic properties of blood, such as viscosity, differ from water. 
Thus, the acoustic cavitation mode may change in vivo (Apfel and Holland 1991). Finally, the 
calculated effective velocities are derived from the frequency shift of the Doppler peak and 
are thus estimates of the average microbubble velocity. 
 
5. Conclusions 
In this chapter, we have captured and quantified the microbubble Doppler effect under 
low-frequency and long-pulse therapeutic sonication. A secondary peak negatively was 
shown to emerge adjacent to the superharmonic emissions, shifted tens of kHz away from the 
expected harmonic position. The shift, amplitude, and FWHM of the Doppler peak depended 
on the sonication pressure and the concentration of the microbubble solution. Using a simple 
signal processing routine, we estimated the effective microbubble velocities during 
sonication, which were on the order of m s-1. Analysis of the superharmonic Doppler effect 
can monitor microbubble velocities in real-time during focused ultrasound treatment. In the 
next chapter, we will extend this technique from 1D to 2D, in order to produce microbubble 
velocity maps.   
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 CHAPTER 5 
DOPPLER PASSIVE ACOUSTIC MAPPING 
 
1. Introduction 
 
Microbubble-mediated focused ultrasound therapies such as clot dissolution (Acconcia 
et al 2013, Bader et al 2015) and intracellular drug delivery (Fan et al 2014, Shamout et al 
2015) require that microbubbles move towards the treatment site. In these examples, 
microbubbles located at the centre of a blood vessel must travel several micrometres or 
millimetres to the diseased site so that they can produce their therapeutic effect. Despite the 
importance of these dynamics, existing therapy monitoring techniques, such as passive 
cavitation detection (PCD) or passive acoustic mapping (PAM), are unable to detect or 
visualise the translational dynamics of sonicated cavitation nuclei.  
In the previous chapter, we described a method to deduce microbubble velocities by 
evaluating the superharmonic microbubble Doppler effect. We have shown that frequency 
analysis of the acoustic emissions captured by PCD can estimate the effective microbubble 
velocities during sonication. Although effective, single-element PCD measurements do not 
allow us to determine where the cavitation is being produced within a large focal volume. 
The effective velocities were thus indicative of the 1D microbubble movement throughout the 
“listening” volume. However, microbubble translational dynamics evolve in sub-mm scales 
(chapter 1), thus further localization of effective velocities within the focus would allow for 
more accurate monitoring.  PAM can localise acoustic events within a region of interest 
(chapter 3), thereby allowing for visualisation of events within the focal volume. This 
technique applies beamforming algorithms on passively captured acoustic emissions recorded 
from many receiving elements (Gyöngy and Coussios 2010a, 2010b).  
In this chapter, we develop a method that can passively visualise microbubble velocities 
in 2D, by combining PAM algorithms with our superharmonic microbubble Doppler effect 
analysis. Our technique, called Doppler passive acoustic mapping or simply Doppler PAM, 
was tested in a tissue-mimicking phantom, in order to localise acoustic emissions and 
effective velocities within the focal volume. Our aim was to passively produce maps of 
microbubble velocities in 2D. 
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2. Materials and methods 
 
i. Experimental setup 
We demonstrated the Doppler PAM technique in an in vitro setup (figure 5.1). A 1 
MHz focused ultrasound transducer with a rectangular cut-out (part no.: H-198, S/N: 001, 
active diameter: 90 mm, focal depth: 60.5 mm from exit plane of transducer, lateral FWHM: 
2 mm, elevational FWHM: 1 mm, axial FWHM: 20 mm, rectangular opening: 30 mm × 70 
mm; Sonic Concepts, Bothell, WA, USA) was mounted onto a 3D motorised positioning 
system. An ATL L7-4 linear array (centre frequency: 5.2 MHz, number of elements: 128, 
aperture size: 38.4 mm, element spacing: 0.3 mm; Philips Healthcare, Guildford, Surrey, UK) 
was inserted through the rectangular cut-out and fixed 75 mm away from the focal point of 
the therapeutic transducer.  
In-house manufactured microbubbles were prepared as described previously (chapter 1) 
and diluted to a desired concentration. Since the superharmonic Doppler effect depends on 
the microbubble concentration (figures 4.8 and 4.9), we evaluated Doppler PAM using 
different concentrations. Our reference dose was 2 × 106 microbubbles ml-1, which is an 
approximation to the recommended clinical dose for imaging applications of Definity (Unger 
et al 2004). The microbubble solution was diluted to 1×, 10×, and 100× the clinical dose, i.e. 
to 2 × 106, 2 × 107, and 2 × 108 microbubbles ml-1, respectively. The diluted microbubble 
solution was infused into a 5-mm wall-less vessel embedded within a tissue-mimicking 
phantom (gelatine 5% w/v). Using B-mode imaging, we positioned the transducer-array 
system so that the acoustic focus was located at the centre of the vessel, both axially and 
elevationally.   
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Figure 5. 1: In vitro experimental setup for Doppler PAM measurements. 
 
Ultrasound emission and reception processes were controlled with Matlab (The 
Mathworks, Natick, MA, USA). The focused ultrasound transducer was driven at 1 MHz 
with a function generator (33500B Series, Agilent technologies, Santa Clara, CA, USA) 
through a 50 dB amplifier (Precision Acoustics Ltd, Dorchester, UK) and a matching box 
(Sonic Concepts, Bothell, WA, USA). Free-field acoustic pressures were measured using a 
0.2 mm PVDF hydrophone (Precision Acoustics Ltd, Dorchester, UK) within the focal 
volume. A Verasonics® research platform was used to record the acoustic signals captured 
passively by the linear array. Verasonics® acquisition was triggered by the function generator. 
We adjusted the trigger delay and the recording duration to include the entire acoustic 
cavitation signal within a single acquisition frame. RF lines from each element were sampled 
at 20.8 MSa s-1 and were saved to a PC for off-line processing. 
 
ii. Ultrasound parameters 
Although Doppler PAM can track velocities of moving sounds sources in other 
applications, our interest is in its use as an ultrasound therapy monitoring technique. 
Consequently, we chose ultrasound parameters relevant to therapeutic applications (table 5.I). 
Typically, therapeutic pulses are 10 - 100ms-long, comprised of thousands of acoustic cycles 
(Choi et al 2014, Liao et al 2015, Hynynen et al 2001, Bader et al 2015). We thus sonicated 
the microbubbles with a 50ms-long pulse. Acoustic pressures were chosen to excite different 
acoustic cavitation modes. We used peak-negative pressures within the range 200 – 600 kPa, 
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in order to have an acceptable signal-to-noise ratio and considerable movement of the 
cavitation nuclei. 
Table 5. I: Experimental parameters for Doppler PAM experiments. 
Parameter Values / Units 
Centre frequency 1 MHz 
Peak-negative pressure 200, 300, 400, 500, 600kPa 
Pulse length 50 ms 
Acquisition length 55 ms 
Sampling frequency 20.8 MSa s-1 
Microbubble concentration 2 × 106, 2 × 107, 2 × 108 microbubbles ml-1 
Repetitions per condition 3 
 
iii. Signal processing 
We combined the PAM (chapter 3) and microbubble Doppler effect (chapter 4) 
algorithms, in order to passively generate microbubble velocity maps (figure 5.2). Acquired 
RF lines were first processed using the PAM algorithm (Gyöngy and Coussios 2010a), which 
has been described in chapter 3 (eq. (3.1) and (3.2)). Capon beamforming (Li et al 2003) was 
implemented to reduce the “tail effect”, which refers to the erroneously detected acoustic 
activity out of the focal region (Coviello et al 2015). Capon-PAM beamforming provided RF 
lines indicative of the acoustic activity for every pixel within the region of interest. RF lines 
were separated into 55 equal segments in the time domain, each with a length of 1 ms.  
The beamformed RF lines for each spatial location were then spectrally analyzed 
(figure 5.3(a)). We followed the frequency analysis described in chapter 4, in order to 
estimate microbubble velocities based on the Doppler shift of the microbubble acoustic 
emissions (Pouliopoulos and Choi 2016). Each of the higher harmonics (>4th harmonic or 4 
MHz) was isolated and analyzed independently. The analysis was performed for each of the 
1ms-long windows in the time-domain signal. Our aim was to determine whether there was a 
Doppler shift in the acoustic emissions for every pixel and time window. Localised Doppler 
shifts were expected to give an estimate of the velocity at which acoustic sources are moving 
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at every location within the focal volume. 
For each spatial location r , we subtracted the baseline offset and then calculated the 
spectral energy at either side of the harmonic region (figure 5.3(b)). We calculated the 
negative and positive Doppler shift energy D , respectively:  
   
2
0.1
r . .{ r, }
f H
i H
f f
f f MHz
D F T q t f


                     (5.1) 
where Hf  was the higher harmonic frequency, . .{}F T   was the magnitude of the 
Fourier transform of the acoustic signal q  detected at position r , and f was the frequency 
bin width. D  and D were indicators of the extent of microbubble movement away and 
towards the linear array, respectively.  
 
Figure 5. 2: Block diagram of the Doppler PAM algorithm. 
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We determined the Doppler shift f  at every pixel and for each time window. Because 
of the variable structure of the Doppler shift distribution, we approximated the shift centre as 
the equivalent of the “center-of-mass” in the frequency domain (grey circle in figure 5.3): 
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  where if  were the frequency shifts of each point in the frequency domain with 
respect to the expected harmonic position. A frequency shift of zero would indicate either 
symmetric harmonics or low signal-to-noise ratio. To further suppress erroneously detected 
shifts out of the focal area, we weighted the calculated shifts with the total acoustic power 
measured at each pixel.  
Finally, we estimated the effective velocity 
effv  of the microbubble population within 
the region of interest, both away and towards the detector. This was achieved by assessing the 
Doppler shifts emerging on either side of the harmonic (chapter 4), and using the Doppler 
equation to determine the relative velocities (Tortoli et al 2000):  
   r r
2
eff
H
c
v f
f
                     (5.3) 
where f  and f  were the weighted negative or positive frequency shifts of the 
asymmetric harmonic peaks found via eq. (5.2) (figure 5.3(b)). Effective velocity was 
calculated based on the centre of the frequency shifts. These velocities did not necessarily 
correspond to the average microbubble velocity, but were calculated as a metric to provide an 
overview of the movement of the microbubble population. To compensate for the velocity 
underestimation due to weighting factor applied before, we rescaled the velocity maps to the 
maximum velocity measured before the weighting process. effv

 and effv

 were indicators of 
the microbubble velocities away and towards the receiver array, respectively. To compare 
velocity maps across the experimental conditions, we calculated the maximum and average 
velocities during sonication for the tested acoustic pressures and microbubble concentrations. 
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Figure 5. 3: Frequency analysis for Doppler PAM. (a) A fast Fourier transform was performed for each pixel 
within the region of interest (FFT length: 50ms). (b) The harmonics were isolated and separated into negative 
(red) and positive (green) shifts. The centre-of-shift (grey circle) was calculated to deduce the effective 
velocities at each spatial location. 
 
3. Results 
 
i. Doppler shift energy  
To evaluate the movement of microbubbles within the focus, we generated maps of the 
Doppler shift magnitude. This was displayed as a map of negative (figure 5.4) and positive 
(figure 5.5) Doppler shift energies, calculated in the frequency domain using eq. (5.1) and 
used as a comparative measure of microbubble movement across the acoustic pressures. We 
assumed that negatively shifted energy was emitted by microbubbles moving away from the 
transducer, while positively shifted energy was emitted by microbubbles moving towards the 
transducer. Higher acoustic pressures generated higher shift energies during the first ms of 
sonication, as expected (figures 5.4 and 5.5). Maximum acoustic energies were on the same 
order of magnitude for both negative and positive Doppler shifts at the same pressure.  
Qualitative comparison of the energy maps at different time points suggested an inverse 
relationship between negative and positive shift energies. Spatial locations that had high 
energy values in the negative shift maps had low energy values in the positive map, and vice 
versa. This indicated that movement away or towards the transducer dominates in each pixel 
and there is an asymmetric broadening of the harmonic emissions. Furthermore, this supports 
the hypothesis that the detected shifts are Doppler-related and do not stem from destruction-
related broadband emissions. Although negative shift energies had comparable values 
throughout the focal volume (figure 5.4), we observed instances of bias in specific axial 
dimensions in the positive shift energy maps, especially at high acoustic pressures (figure 
5.5).  
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We calculated the total shift energy as the sum of negative and positive shift energies 
per frame. Generally, total shift energy decreased over time during the 50ms-long therapeutic 
pulse (figure 5.6). The rate of decrease depended on the applied acoustic pressure and the 
microbubble concentration. Higher acoustic pressures produced higher shift energies, with 
the exception of 500-kPapk-neg sonication at concentration of 2×10
7 microbubbles ml-1 (figure 
5.6(b)). Although the produced shift energies were higher, the rate of energy decrease was 
also higher at higher pressures. Unexpectedly, the shift energy magnitude decreased with 
microbubble concentration. The order of energy magnitude was 1010, 1010, and 108 V2Hz for 
microbubble concentrations of 2×106, 2×107, and 2×108 microbubbles ml-1, respectively. 
Maximum energy shifts per pixel increased with pressure and were on the same order of 
magnitude for concentrations of 2×106 and 2×107 microbubbles ml-1. However, these were 
approximately two orders of magnitude lower for the highest concentration tested, possibly 
due to acoustic shielding (figure 5.7). Also, the negative and positive maximum shifts were 
on the same order of magnitude for a given acoustic pressure and microbubble concentration 
(figure 5.7). 
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Figure 5. 4: Negative shift energy maps at different time points during sonication for peak-negative pressures 
of (a) 200 kPa, (b) 400 kPa, and (c) 600 kPa. 
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Figure 5. 5: Positive shift energy maps at different time points during sonication for peak-negative pressures 
of (a) 200 kPa, (b) 400 kPa, and (c) 600 kPa. 
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Figure 5. 6: Total shift energy over time across the acoustic pressures for microbubble concentrations of (a) 
2×106, (b) 2×107, and (c) 2×108 microbubbles ml-1(n=3). 
 
 
Figure 5. 7: Maximum energy shifts during sonication. (a) Positive and (b) negative maximum shifts were on 
the same order of magnitude (n=3). 
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ii. Doppler passive acoustic maps 
Using eq. (5.2) and (5.3), we generated Doppler passive acoustic maps to estimate the 
location-specific microbubble velocities (figure 5.8). These maps were produced by analysing 
the 4th harmonic, i.e. the harmonic peak at 4 MHz. Estimated microbubble velocities were on 
the order of 1 - 2 m s-1, both away (negative, in red) and towards (positive, in green) the 
transducer. In the majority of our experiments, microbubbles moved away from the 
transducer during the first ms of sonication (figures 5.8(b) and 5.8(c)). We observed instances 
of positive velocities dominance (2 ms, figure 5.8(a)). Generally, a mixture of negative and 
positive velocities (i.e., shifts) was measured within the sonicated area (figure 5.8(c)). The 
lateral velocity profile along the centre of the 5-mm vessel revealed that the majority of the 
movement occurred within the first 10 ms of focused ultrasound exposure (figure 5.9). At the 
highest acoustic pressure tested, microbubble reorganisation persisted for longer (figure 
5.9(c)).  
To characterise the developed velocities in different experimental conditions, we 
measured the maximum positive and negative velocities during sonication (figure 5.10). 
There was no clear trend among the different concentrations. Positive velocities decreased 
with the acoustic pressure for all the tested concentrations (figure 5.10(a)). Instead, the 
maximum negative velocities generally increased with acoustic pressure (figure 5.10(b)). 
This inverse trend was corroborated by the measurement of average microbubble velocity 
throughout sonication (figure 5.11). At low acoustic pressures, the average velocity was 
approximately equal to zero. In other words, velocities away from the transducer had 
approximately equal incidence and magnitude with the velocities towards the transducer 
(figure 5.11). This was evident from the first ms (figure 5.8(a)) and throughout (figure 5.9(a)) 
low-pressure sonication. Increasing the acoustic pressures led to a decrease of average 
velocities, down to -0.2 m s-1. In other words, the microbubble population moved on average 
away from the transducer during the 50ms-long pulse.  
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Figure 5. 8: Doppler passive acoustic maps at different time points during sonication for peak-negative 
pressures of (a) 200 kPa, (b) 400 kPa, and (c) 600 kPa. Concentration: 2×107 microbubbles ml-1. 
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Figure 5. 9: Lateral effective velocity profiles over time for peak-negative pressures of (a) 200 kPa, (b) 400 
kPa, and (c) 600 kPa. Concentration: 2×107 microbubbles ml-1. The profile shown corresponds to the line 
crossing the middle of the 5-mm channel. 
 
 
Figure 5. 10: Maximum microbubble effective velocities (a) towards and (b) away from the transducer across 
the microbubble concentrations (n=3). 
 
Figure 5. 11: Average microbubble effective velocities during sonication across the microbubble 
concentrations (n=3). 
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4. Discussion 
 
i. On the Doppler PAM  
In this chapter, we have extended the 1D velocity estimation shown in chapter 4 into 
2D velocity mapping. We have done so by incorporating the superharmonic microbubble 
Doppler effect method (Pouliopoulos and Choi 2016) into the Capon-beamformed passive 
acoustic mapping routine (figure 5.2) (Gyöngy and Coussios 2010a, Coviello et al 2015). A 
simple frequency analysis (figure 5.3) provided a location-specific Doppler shift across an 
imaging plane. We demonstrated our technique in a phantom made of gelatine (5% w/v), 
which served as a tissue-mimicking material. Microbubbles were embedded within a 5-mm 
wall-less channel located at the centre of the phantom and sonicated with a focused 1 MHz 
ultrasound transducer (figure 5.1). The channel size was comparable to a large vessel and was 
chosen to facilitate easier implementation of the PAM technique, which is limited by poor 
axial resolution (Gyöngy and Coussios 2010a). 
We passively generated maps of frequency shift energies (figures 5.4 and 5.5) and 
effective velocities (figure 5.8) during therapeutic sonication. In contrast to the PCD 
measurements where we measured only negative shifts with respect to the expected harmonic 
position (figure 4.3), here we also observed positive shifts (figure 5.5). These positive shifts 
were translated into effective velocities towards the transducer (figures 5.8 and 5.9). We 
speculate that the reason for microbubbles moving towards the transducer is two-fold. First, 
continuous low-pressure sonication promotes the action of secondary radiation forces 
(chapter 1) which lead to microbubble clustering (figure 1.7). During the clustering process, 
microbubbles may move towards the transducer at m s-1 velocities (figures 1.9 and 1.11), thus 
generating positive frequency shifts in their acoustic emissions (figure 5.5). Second, as 
suggested in chapter 4, microbubble movement due to radiation forces may lead to vortex 
formation within the vessel boundaries (Cho et al 2015, Koruk et al 2015). Microbubbles 
flowing repeatedly within such vortices are expected to produce both negative and positive 
shifts, which were measured here (figures 5.4 and 5.5).  
Microbubble concentration has been shown to affect such dynamics (Koruk et al 2015, 
Chen et al 2016, Kotopoulis and Postema 2010). Although at low concentration the Doppler 
shifts collectively diminished over time (figures 5.6(a) and 5.6(b)), at high concentrations the 
magnitude of the frequency shifts was maintained at similar levels throughout sonication 
(figure 5.6(c)). Similar trends were observed in the time-resolved frequency analysis of PCD 
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time traces, where the Doppler shifts persisted during the entire therapeutic pulse at high 
concentrations (figure 4.7), but were transient at lower concentrations (figure 4.9). Diluted 
microbubble populations were shown to be pushed away from the focus or get destroyed 
when sonicated, in contrast to highly concentrated populations which continuously deformed 
tissue interfaces (Koruk et al 2015).   
The microbubble circulation hypothesis is supported by our Doppler PAM data, which 
showed similar maximum positive and negative shift energies (figure 5.7). Higher acoustic 
pressures increased both positive and negative shift energies in a linear fashion. Circulating 
microbubbles are expected to move in both directions at approximately the same velocity 
(Cho et al 2015), thus shift energies should be on the same order of magnitude. Interestingly, 
the highest microbubble concentration had two orders of magnitude lower shift energy than 
lower concentrations. This observation may be explained by acoustic shielding (Leighton 
1995). Dense microbubble solutions may reflect, refract and attenuate the propagating 
ultrasonic field, thus reducing the acoustic pressure experienced by most microbubbles 
(Zhang et al 2000). This drop in the experienced acoustic field reduces the intensity of 
acoustic cavitation phenomena and the extent of the microbubble movement and reradiated 
acoustic emissions. Furthermore, the acoustic signal emitted by the sonicated microbubbles 
may not reach the detector due to the shielding effects of the surrounding microbubbles.  
The effects of concentration on the shift energies did not reflect on the generated 
effective velocities (figures 5.10 and 5.11). Maximum velocities were on the same order of 
magnitude across the microbubble concentrations (figure 5.10). Maximum velocities towards 
and away from the transducer were within the range of 0.7 - 2.2 m s-1 and 0.7 - 2 m s-1, 
respectively. Velocities towards the transducer generally decreased with acoustic pressure 
(figure 5.10(a)). In contrast, velocities away from the transducer increased with acoustic 
pressure (figure 5.10(b)). This inverse trend is indicative of the balance between acoustic 
radiation forces. The magnitude of primary radiation forces may be lower than secondary 
radiation forces at low pressures. For this reason, clustering occurs before migration towards 
the direction of propagation at low-power sonication (chapter 1). However, increasing the 
acoustic pressure above the inertial cavitation threshold leads to larger volumetric oscillations 
and thus larger primary acoustic radiation forces (Dayton et al 2002).  
Average effective velocities during sonication confirmed that primary radiation forces 
become increasingly dominant with acoustic pressure (figure 5.11). The average velocity at 
PNP of 200 kPa was approximately zero for all tested microbubble concentrations, indicating 
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a balance between positive and negative shifts or velocities towards and away from the 
transducer. Alternatively, it may be due to a low signal-to-noise ratio. Our measurements 
showed that the average velocities progressively decreased with acoustic pressure, i.e. the 
microbubble population progressively moved away from the transducer at a larger extent. 
This trend was violated only by one measurement at acoustic pressure of 600 kPapk-neg and 
concentration of 2×107 microbubbles ml-1.  
The average velocities found here (figure 5.11) were considerably lower than those 
reported in chapter 4 (figure 4.6(c)) and in the literature (Tortoli et al 2009). Interestingly, the 
scale of PCD-derived effective velocities was closer to the scale of the Doppler-PAM-derived 
maximum velocities during sonication (figure 5.10). This underestimation may be due to a 
multitude of reasons. First, the spectra shown in chapter 4 did not reveal any positive shifts in 
the superharmonic regions. All Doppler peaks measured by PCD were negatively shifted with 
respect to the expected harmonic position and the derived velocities were on the order of 1 to 
3 m s-1 for a peak-negative pressure range of 150 to 370 kPa (figure 4.6(c)). These velocities 
coincided with the instantaneous velocities developed during the on-time of ultrasound 
imaging pulses (Tortoli et al 2009). Doppler-PAM-derived shifts were both positive and 
negative (figures 5.4 and 5.5), yielding a mixture of positive and negative velocities in the 
effective velocity maps at every time point (figure 5.8). Averaging across the velocity maps 
during the 50-ms pulse reduced the estimated velocities to under 0.2 m s-1, even at relatively 
high insonation pressures (figure 5.11). Furthermore, averaging was conducted across the 
time points and throughout the passive maps, including areas with zero effective velocities. 
Taking into account that most of microbubble movement occurred during the first ms of 
therapeutic sonication (figure 5.9) and the amount of zero-velocity pixels (figure 5.8), the 
mean velocity values were reasonable.  
Another potential explanation is the difference in the centre frequency of the 
transmitted focused ultrasound wave. Due to the different setups used for the PCD and 
Doppler PAM measurements, we used different transducers to illustrate the two different 
methods, with centre frequencies of 0.5 MHz and 1 MHz, respectively (figures 4.1 and 5.1). 
Although both centre frequencies are well below the eigenfrequency of an isolated, shelled 
microbubble (van der Meer et al 2007), dense microbubble population may resonate in this 
range of frequencies (Yasui et al 2009). Also, we observed faster translational dynamics at 
0.5 MHz rather than 1 MHz sonication in our high-speed microscopy observations (chapter 
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1). This observation may be partially explained by the larger interaction ranges estimated 
using our potential field qualitative method (figure 1.20). 
 
ii. Clinical relevance 
Passively generated microbubble velocity maps (figure 5.8) may find use in any clinical 
application that requires movement of acoustic particles towards a target. A characteristic 
example necessitating microbubble movement is sonothrombolysis (de Saint Victor et al 
2014, Bader et al 2015). Microbubble-mediated thrombolysis driven by focused ultrasound 
exposure has been shown to enhance the thrombolytic effect of agents such as recombinant 
tissue plasminogen (rt-PA) (Datta et al 2008, Hitchcock et al 2011). The mechanisms 
contributing to clot dissolution are acoustic cavitation in the vicinity of the clot (Prokop et al 
2007), thermal effect induced by heat conduction (Stride and Saffari 2004, Yenari et al 1995) 
and collision of translating microbubbles with the clot surface (Bader et al 2015). 
Microbubbles accelerated due to primary Bjerknes forces were shown to hit the clot surface, 
displace it due to their added mass and eventually penetrate deep into the fibrin network 
(Acconcia et al 2013, 2014, 2015). The tunnels formed due to the microbubble penetration 
are thought to facilitate and accelerate the action of the thrombolytic agents. Microbubbles 
moved at m s-1 velocities, but this translational movement was monitored using high-speed 
microscopy in vitro. Using Doppler PAM, one can assess the spatiotemporal variation of 
microbubble velocities treating a thrombus deep inside the body. The velocity patterns are 
expected to affect the stress patterns experienced by the clots and thus the treatment success.  
Another example of a clinical application that may benefit from real-time 2D 
microbubble velocity estimation is sonoporation (Yu and Xu 2014). Intracellular drug 
delivery has been associated with the movement of sonicated microbubbles (van Wamel et al 
2006, Fan et al 2014). The produced sonoporation patterns across cell monolayers are 
generally non-uniform, with instances of cell death or inefficient trans-membrane drug 
delivery (Shamout et al 2015, van Rooij et al 2016). Doppler PAM can correlate the 
microbubble velocities with the damage induced across a plane of cell treatment. Such 
estimates may be used to control the yielded bioeffect both in vitro and in vivo.  
Other applications that require microbubble motion across a 2D plane are acoustic 
particle palpation (Koruk et al 2015) and molecular imaging (Dayton et al 1999). Radiation-
force propelled microbubbles have been used to push against interfaces in order to assess 
tissue elasticity (Koruk et al 2015). Generated shear waves allowed estimation of the tissue 
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stiffness, yet knowledge of the microbubble population velocities would allow estimation of 
the applied stresses onto the interface. Furthermore, molecular imaging requires binding of 
targeted microbubbles onto specific cell types (Kooiman et al 2011, Fan et al 2013). Doppler 
PAM may be used to estimate the translational microbubbles dynamics and predict the 
targeted microbubble binding efficiency in vivo (Villanueva et al 1998).  
Apart from direct clinical applications, Doppler PAM may help in understanding the 
complex translational dynamics of microbubbles exposed to long-pulse and low-frequency 
therapeutic applications. Areas of either high frequency shift energy or effective velocities 
may originate from localised resonances within the microbubble cloud (Zeravcic et al 2011, 
Bremond et al 2006b, 2006a), multiple microbubble coalescence events (figure 1.15 and 
1.17) or resonant microbubbles moving at high velocities (figure 1.16). All the 
aforementioned phenomena involve intense microbubble motion and may contribute to the 
heterogeneous velocity landscape shown in Doppler passive acoustic maps (figure 5.8). Thus, 
our technique can provide quantitative data on these effects and shed light on the conditions 
required for their occurrence. 
 
iii. Limitations 
Doppler PAM was developed as an extension to the superharmonic microbubble 
Doppler effect (chapter 4). However, we have made a set of assumptions to produce these 
initial velocity maps (figure 5.8). Our main assumption was that the frequency shifts 
observed in the beamformed RF line of each pixel are primarily due to the net microbubble 
movement within the region. Capon-enhanced delay-and-sum beamforming is implemented 
in PAM in order to measure the source strength in each spatial location (Coviello et al 2015, 
Gyöngy and Coussios 2010a, 2010b, Gyöngy and Coviello 2011). Although in principle the 
beamforming process should eliminate non-coherent signals from other locations, multi-
bubble interference and diffraction patterns may alter the frequency content of each RF line 
(Haworth et al 2012, Coviello et al 2015). Frequency shifts may have origins other than 
microbubble movement away or towards the receiving array, such as spectral leakage from 
other locations or other non-linear effects arising in dense microbubble populations (Stride 
and Saffari 2005, Sinden et al 2012). Similarly, despite the implementation of Capon 
beamforming (Coviello et al 2015), the poor axial resolution of PAM (Gyöngy and Coussios 
2010a) is evident in Doppler PAM as well. Areas out of the 5-mm channel appear to have 
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either positive or negative frequency shifts (figure 5.4 and 5.5), which translate into apparent 
non-zero effective velocities (figures 5.8).  
Based on this main assumption, our signal processing algorithm (figure 5.2) estimated 
the analogue of the “centre-of-mass” in the frequency domain for each spatial location (figure 
5.3). Another assumption of our technique was that the “centre-of-shift” would give an 
estimate about the net microbubble movement within a specified pixel. In contrast to the PCD 
measurements where the Doppler and superharmonic peaks were fitted using Lorentzian 
functions (figure 4.6(a)), Doppler PAM measurements did not allow for peak fits. The shape 
of the frequency shifts depended on the selected time window. The example spectrum shown 
in figure 5.3(b) corresponded to a 55-ms-long FFT. The estimation of frequency shift centres 
using eq. (5.2) was sensitive to the number of points in which the FFT was performed, i.e. to 
the selected time window duration. To derive maps with temporal resolution of 1 ms (figure 
5.8), we segmented the 55-ms-long acquisition into 55 domains. At a sampling frequency of 
20.8 MSa s-1, only a few tens of frequency bins were used to derive the centre of frequency 
shifts. A bias was thus introduced in the estimation of the effective microbubble velocity for 
every pixel. Signal processing tools such as zero-padding or interpolation are expected to 
enhance the robustness of our algorithm, by enhancing the frequency resolution and allowing 
higher accuracy in the centre-of-shift determination. 
Stemming from the low frequency resolution, we observed a variation in the estimated 
effective velocities across the harmonics. This was not in accordance with the PCD-based 
data, where different superharmonics estimated similar effective velocities within the focal 
volume (figure 4.4). The data shown here were based on the analysis of the 4th harmonic, i.e. 
4 MHz. Analysis of different harmonics often provided different estimates of effective 
velocities per pixel. The variation was generally within 20%, but there were instances of 
estimated velocities in opposite directions for different harmonics. We anticipate that these 
discrepancies are due to the low frequency resolution and signal-to-noise ratio and can be 
eliminated with zero-padding or interpolation of the RF lines. 
Another limitation of our approach was the weighting of the frequency shifts with the 
shift energy measured at every pixel (eq. (5.2)). Weighting was performed to eliminate the 
erroneously detected shifts out of the focal volume. Regions with low energy sporadically 
had harmonic amplitudes that surpassed the arbitrary threshold set to allow for velocity 
estimation (i.e., 5 times higher than the noise, figure 5.2). This resulted in many false positive 
velocity estimations far away from the sonication area. By applying energy weights, all false 
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positive pixels were eliminated but most effective velocities within the focus were suppressed 
to lower values. We thus rescaled the estimated effective velocities to the before-weighting 
range (i.e., m s-1). A more robust method to isolate erroneously detected shifts and effective 
velocities is yet to be determined.  
The Doppler effect is correlated with the axial motion of the acoustic source with 
respect to the detector. Microbubbles moving along the direction of propagation in alignment 
with the central element of the linear array were expected to produce the maximum shift in 
the emissions detected at this element. In principle, the Doppler effect detected at all the other 
elements should be corrected with a cos  factor to account for the angle between the 
element and the movement axes. However, due to the long distance between the focal area 
and the receiving array (75 mm), we estimated the maximum error to be 3% and thus 
neglected this effect from our calculations.    
In terms of our experimental setup limitations, we sonicated microbubbles embedded 
within the 5-mm wall-less vessel in the absence of flow. In vivo blood vessels of this size 
have high flow rates. Blood flow is expected to induce additional shifts in the microbubble 
harmonic emissions (Tortoli et al 2000). A similar limitation to the setups described in 
previous chapters was that our tissue-mimicking phantom served as a crude approximation of 
in vivo vasculature. The vast and diverse vascular structures found in vivo are expected to 
change the velocity patterns observed across a 2D plane.  
Spatially-localised effective velocities provided an estimate of microbubble dynamics 
within the sonicated area. However, these acoustically derived velocities have not been 
simultaneously verified using high-speed microscopy. Future experiments will attempt to 
verify acoustics with optics. 
 
5. Conclusions 
In this chapter, we passively generated maps of effective microbubble velocities in 2D. 
Combining the superharmonic microbubble Doppler analysis with the PAM algorithm, we 
estimated Doppler shift energies and microbubble translational dynamics within the focal 
volume. We measured velocities on the order of m s-1 both away and towards the focused 
ultrasound transducer. The magnitude and direction of these velocities depended on the 
acoustic pressure and the microbubble concentration. 2D microbubble velocity information 
can be used to monitor and control microbubble-mediated therapies such as sonothrombolysis 
and sonoporation. 
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“IN THEORY, THERE IS NO DIFFERENCE BETWEEN THEORY AND PRACTICE. BUT 
IN PRACTICE, THERE IS.” 
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CHAPTER 6 
BLOOD-BRAIN BARRIER OPENING USING RAPID SHORT-PULSE 
SONICATION 
 
1. Introduction 
 
In the previous chapters, we described our contribution to understanding (chapter 1), 
designing (chapters 2 and 3) and monitoring (chapters 4 and 5) microbubble-mediated 
ultrasound therapies. However, our studies have been hitherto limited to in vitro experimental 
setups, such as tissue-mimicking phantoms and vessel-mimicking materials. Such setups are 
simple models of the vasculature and tissue microenvironments that are physically and 
biologically more complex. In the present chapter, we applied the new therapeutic ultrasound 
pulse sequence design in an in vivo animal model, which more closely resembles human 
tissue. The purpose of the work described in this chapter was to use the technologies we 
developed in vitro to improve the efficiency and safety of the drug delivery to the brain in 
vivo.   
Specifically, we used rapid short-pulse sonication to achieve blood-brain barrier 
opening in the mouse brain. We compared the drug delivery produced by implementing our 
therapeutic design against the long-pulse sonication. Acoustic cavitation activity within the 
mouse brain was monitored in real-time using PCD. Our hypothesis was that rapid short-pulse 
sonication produces more uniform drug delivery within the targeted brain region compared to long-
pulse sonication. More uniform drug delivery would mean less over-treated and under-treated areas, 
thus safer therapeutic bioeffects.  
 
i. The blood-brain barrier 
The brain is a vital organ which regulates the central nervous system and complex 
functions in a living organism. Cerebral vessels must provide the brain with a strict molecular 
environment for it to perform these functions. Unlike normal continuous vessels found 
elsewhere in the body (Paaske and Sejrsen 1989), the brain tissue is protected by the blood-
brain barrier, i.e. the system that lies between the vessel lumen and the brain interstitial space. 
The blood-brain barrier consists of endothelial cells surrounded by astrocytes, pericytes, and 
microglia, and maintains the brain homeostasis. It also regulates the molecular interchange 
between the brain and the circulatory system (Obermeier et al 2013, Zlokovic 2008). The 
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presence of the blood-brain barrier significantly reduces the ability of drugs larger than 180 
Da to reach the brain parenchyma (Kroll and Neuwelt 1998) and is one the main barriers to 
the development of treatments for central nervous system pathologies such as Alzheimer’s 
disease, Parkinson’s syndrome and multiple sclerosis. Apart from the microvascular 
ultrastructure (Clough 1991), vascular permeability rates are affected by the size, type, 
charge, and lipid solubility of the drug, and other factors such as inflammatory conditions and 
receptor-mediated delivery (Michel and Curry 1999).  
A number of methods have been proposed to overcome the blood-brain barrier in order 
to facilitate drug extravasation into the brain (Lu et al 2014). These methods include, but are 
not limited to, chemical modification of the therapeutic molecules (Bodor and Buchwald 
1999), receptor-mediated delivery (Kang et al 1994), intra-cerebral implants (Vukelja et al 
2007), and intra-arterial infusions of hyperosmotic agents (Doolittle et al 2000). Most of 
these techniques induce diffuse blood-brain barrier disruption and are unable to limit the 
bioeffect to a targeted region within the brain. High-intensity focused ultrasound was 
proposed as a method to locally disrupt the blood-brain barrier (Vykhodtseva et al 1995), but 
the high focal energies raised safety concerns. 
 
ii. Microbubble-mediated blood-brain barrier opening 
Blood-brain barrier can be transiently opened using relatively low-power focused 
ultrasound and circulating microbubbles. This targeted drug delivery approach was first 
demonstrated in a rabbit model (Hynynen et al 2001). In this study, the targeted brain regions 
were sonicated using 10 or 100ms-long ultrasound pulses and peak-negative pressures of up 
to 5 MPa. The reversible blood-brain barrier opening was correlated with the acoustic 
pressure and was due to the ultrasound-driven microbubble acoustic cavitation activity within 
the brain microvasculature. From this early work, an inverse relationship between efficacy 
and safety was reported, with high-pressure sonication leading to higher drug doses delivered 
but also to haemorrhages and neuron loss. 
The mechanisms contributing to the increase in vascular permeability during 
microbubble-mediated ultrasound therapies are not fully understood. Drugs may extravasate 
due to either widened junctions between endothelial cells (Sheikov et al 2008), enhanced 
trans-cellular transport via endocytosis or upregulation of carrier proteins (Meijering et al 
2009), and transient pore formation in the cell membrane (van Wamel et al 2006). Also, 
increased levels of reactive oxygen species and intracellular calcium have been shown to 
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increase in intra- and inter-cellular permeability of endothelial cells (Juffermans et al 2009, 
Kooiman and Steen 2013).  
A large body of work has focused on microbubble-mediated blood-brain barrier 
opening ever since (Sheikov et al 2004, McDannold et al 2006, Choi et al 2007a, Sheikov et 
al 2008, Choi et al 2010, Tung et al 2010, Choi et al 2011b, 2011a, O’Reilly and Hynynen 
2012, Nhan et al 2013, Wu et al 2014, Sun et al 2015, Fan et al 2016, Kobus et al 2016). The 
majority of these studies investigated the permeability increase characteristics in the brain of 
small-animal models, such as mice, rats, and rabbits. Targeted drug delivery into the brain 
using focused ultrasound has been also demonstrated in non-human primates (Downs et al 
2015b, 2015a) and in phase 1 clinical trials for the treatment of glioblastoma (Carpentier et al 
2016). 
 
iii. Challenges in blood-brain barrier opening applications 
Despite the advantages of non-invasive ultrasound drug delivery, there are certain 
limitations and concerns that are preventing its use in patients with neurological disorders, 
such as Alzheimer’s disease and Parkinson’s syndrome. One limitation of the state-of-the-art 
techniques is related to the poor and heterogeneous drug distribution within the targeted area. 
This non-uniform drug delivery poses safety concerns which hinder the translation of this 
technology into the clinic (Choi et al 2007b, Baseri et al 2010, Stieger et al 2007). 
Although producing the highest magnitude of permeability increase and delivered drug 
doses (Tung et al 2010), high acoustic pressures trigger violent transient microbubble 
behaviours (Chomas et al 2001). High-magnitude inertial cavitation has been associated with 
erythrocyte extravasation, microvacuolation and irreversible neuronal damage (Baseri et al 
2010). These effects are limited to the microbubble locations within the vasculature upon 
ultrasound exposure. Microbubbles undergoing inertial cavitation next to vessel walls 
produce extensive vessel distention and invagination (Chen et al 2011, 2012). The exerted 
stresses are thus localised to the points of interaction and produce a spot-like pattern of 
permeability increase (Stieger et al 2007). On a tissue level, this results in inhomogeneous 
and anisotropic distributions of permeability increase within the target area (Choi et al 2007b, 
Nhan et al 2013).  
In this thesis, we proposed that the reason for the poor distribution of this bioeffect is 
the lack of control of cavitation dynamics within the acoustic focus. In our in vitro studies, 
we have shown that conventional parameter combinations used in ultrasound therapy are 
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unable to produce favourable acoustic cavitation dynamics and thus need to be modified, as 
shown before (Choi and Coussios 2012). In vivo studies have empirically shown that closely-
timed short pulses on the order of μs enhanced the uniformity of the yielded bioeffect 
(Hynynen et al 2003, O’Reilly et al 2011, Choi et al 2011b, 2011a). However, these studies 
have either used pressures higher than 2 MPa (Hynynen et al 2003) or high duty cycles (Choi 
et al 2011b). Furthermore, a direct comparison between short- and long-pulse sonication is 
still lacking. Our approach was to use low-power rapid short-pulse sonication to spread 
cavitation activity in space and time. Our aim was to extend the microbubble lifetime and 
enhance the microbubble mobility in order to produce more uniform drug delivery patterns. 
We have shown that short pulses emitted at PRFs on the order of kHz can generate 
favourable cavitation distributions in vitro, using PCD (chapter 2), PAM, and high-speed 
microscopy (chapter 3). However, the in vivo effect of this ultrasound sequence design has 
yet to be demonstrated.  
Here, we applied rapid short-pulse sonication to enhance the capillary permeability and 
drug delivery distribution in a mouse model. First, we assessed the acoustic pressure 
threshold required to achieve blood-brain barrier opening and delivery of a model drug. 
Second, we compared short-pulse against conventional long-pulse sonication in terms of the 
amount of the delivered drug and the uniformity of the drug delivery within the targeted 
region. Third, we correlated the yielded bioeffect with the generated microbubble acoustic 
emissions, captured using PCD. Finally, we evaluated the safety of the new sequence using 
histological sectioning and analysis.  
 
 
2. Materials and Methods 
 
i. Experimental setup 
We constructed an in vivo capillary opening system for mice (figure 6.1). Focused 
ultrasound was emitted using a 1 MHz transducer with a rectangular cut-out (part no.: H-198, 
S/N: 001, active diameter: 90 mm, focal depth: 60.5 mm from exit plane of transducer, lateral 
FWHM: 2 mm, elevational FWHM: 1 mm, axial FWHM: 20 mm, rectangular opening: 30 
mm × 70 mm; Sonic Concepts, Bothell, WA, USA) which was fixed into a connective case. 
The case was mounted onto an automated and programmable three-dimensional positioning 
system (Velmex Inc., Bloomfield, NY, USA). The 3D system allowed movement along the 
axial, lateral, and elevational dimensions with a step size of 5 μm. Rapid short-pulse 
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sequences were produced using a system of two function generators (33500B Series, Agilent 
technologies, Santa Clara, CA, USA), as shown previously (chapters 2 and 3). The first 
function generator defined the pulse sequence and the second function generator defined the 
pulse shape. The pulses were amplified using a 50 dB power amplifier (Precision Acoustics 
Ltd, Dorchester, UK) before being applied to the 1 MHz focused ultrasound transducer 
through an impedance matching box (Sonic Concepts Inc., WA, USA). The acoustic 
pressures within the focus were measured in free field with a 0.2 mm PVDF needle 
hydrophone (Precision Acoustics Ltd, Dorchester, UK). All the values reported here are thus 
non-derated peak-negative pressures.  
In order to characterise the acoustic cavitation activity produced within the brain, we 
captured the acoustic emissions generated by the microbubbles using a spherically-focused 
7.5 MHz transducer (part number: U8423539, diameter: 12.7 mm, focal length: 76.2 mm; 
Olympus Industrial, Essex, UK). This acted as a PCD transducer and was fixed into a 3D-
printed case. The case was positioned into the rectangular cut-out of the therapeutic 
transducer. The PCD and the therapeutic transducers’ focal volumes were positioned so that 
their foci overlapped. Acoustic emissions captured with PCD were filtered using a 3 - 30 
MHz band-pass filter (part number: ZABP-16+; Mini Circuits, Brooklyn, NY, USA) to reject 
the large contribution at the fundamental frequency and avoid signal saturation. The filtered 
signal was amplified using a 28 dB pre-amplifier (Stanford Research Systems, Sunnyvale, 
CA, USA) and then recorded with an 8-bit PC oscilloscope at a sampling rate of 250 MSa/s 
(Picoscope 3205A; Pico Technology, Cambridgeshire, UK).  
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Figure 6. 1: Capillary opening system. Targeting of the mouse hippocampus was performed using a 
pulser/receiver and the 1 MHz focused ultrasound transducer. Sonication with different pulse shapes and 
sequences was conducted using two function generators. The acoustic signal was amplified and the therapeutic 
transducer via a matching box. The microbubble acoustic emissions from within the mouse brain were passively 
captured using a 7.5 MHz PCD, filtered with a 3 - 30 MHz band-pass filter, amplified with a 28 dB pre-
amplifier and then captured with a picoscope. A coupling cone and a bath filled with deionised water, along 
with ultrasound gel applied on top of the mouse skull, ensured ultrasound transmission without significant 
attenuation. 
 
To allow for ultrasound propagation into the mouse skull, a water-filled cone was 
attached to the transducer-PCD case (figure 6.1). The cone was made of transparent plastic to 
enable visual contact with the transducer surface. The cone was filled with deionised water 
and closed with an acoustically transparent plastic paraffin film, which served as an acoustic 
window. The ultrasound system was free to move in a water tank, fixed above the mouse 
head. Ample ultrasound gel was placed between the secondary water tank and the mouse 
skull to match the acoustic impedances and enable ultrasound propagation without significant 
attenuation or distortion. The ultrasound gel was centrifuged to avoid air bubble formation. 
Prior to the initiation of every experiment, the mouse head was fixed at pre-calibrated 
positions within a stereotactic frame (45o ear bars; World Precision Instruments, 
Hertfordshire, UK).   
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A potential clinical application of microbubble-mediated focused ultrasound therapies 
is the treatment of Alzheimer’s disease using antibodies or peptides (Bachurin et al 2017), 
thus we decided to target the hippocampus of the mouse brain. The hippocampus is 
considered to be the memory centre of the brain and is one of the main regions affected 
during Alzheimer’s disease progression (Walsh et al 2002, Murphy et al 2011). To target the 
hippocampus, we followed a grid method described before (Choi et al 2007a). A custom-
made metallic grid was placed within the water bath and above specific anatomical 
landmarks of the mouse skull, i.e. lambda and bregma (Paxinos et al 1985). These 
longitudinal sutures are located at defined distances from the hippocampus region, thus 
served as a guide to locate the targeted area. Following accurate placement of the grid above 
the sutures, we performed a raster scan using a pulser-receiver (DPR300; Insidix, Seyssins, 
France) and the 1 MHz transducer in pulse-echo mode. Based on the amplitude of the 
reflections recorded with the picoscope, we were able to locate the metallic grid and move the 
construct to the desired position before sonication. We targeted the left hippocampus and 
used the non-sonicated right hippocampus as the control area.  
 
ii. Capillary opening software 
The setup used for the capillary opening experiments was controlled in Matlab (The 
Mathworks, Natick, MA, USA). We developed a graphical user interface (GUI) to provide an 
intuitive and user-friendly tool for capillary opening experiments (figure 6.2). The capillary 
opening GUI enabled communication with the two function generators, the PC oscilloscope, 
and the 3D positioning system. The different pulse shapes and sequences could be defined 
and set into the two function generators. The user could also control the PCD acquisition 
characteristics, such as the acquisition length and the trigger delay. Time-domain traces were 
depicted in real-time and were saved for off-line processing.  
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Figure 6. 2: Capillary opening GUI. Communication with the function generators, picoscope, and the 3D 
positioning system was achieved through this user interface. Different sonication schemes and imaging 
modalities could be promptly selected. Following a raster scan (image at the GUI centre), the user could target 
the desired treatment area (red star), using the metallic grid reflections as a guide. 
 
iii. Animals 
All animal procedures were approved by the Home Office regulatory service (PPL 
70/8585) and the Imperial College London committee for animal welfare. The approved 
procedures were performed under the author’s personal license (PIL I166C30D4). A total of 
14 female wild type C57bl/6 mice (Envigo, Bicester, UK) were used in our pilot drug 
delivery study. A minimum 3-day acclimatisation period was allowed after the animal arrival 
into the institutional animal facility before any procedure was performed. Animals were kept 
in standard conditions and followed a normal diet. On the day of the experiment, the mice 
had an average age of 8.6 ± 2.3 weeks and an average weight of 18.3 ± 2.5 g. Every effort 
was made to comply with the 3R principles (replacement, reduction, refinement) and to 
minimise the pain and distress experienced by the animals during experimental procedures.  
 
iv. Experimental protocol 
Animals were moved from the housing unit to our lab prior to every experiment. We 
followed an experimental protocol that was similar to those described in previous studies 
(figure 6.3) (Choi et al 2007a, 2010). The mice were anaesthetised in an induction chamber 
(Harvard Apparatus, Cambridge, UK) using 5% isoflurane / 95% O2 anaesthetic gas. The 
isoflurane gas was provided from a vaporiser (Harvard Apparatus, Cambridge, UK), which 
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was filled with isoflurane liquid before the experiment. Anaesthesia was maintained using 3-
4% isoflurane supplied by a mouse face mask. Waste gas from exhalation was collected with 
a Fluovac scavenger (Harvard Apparatus, Cambridge, UK). While the mouse was sedated, we 
shaved the top part of the skull using an electric trimmer. Any excessive hair was cleared by 
applying depilatory cream on the skull for 1-2 min. The hair clearance allowed clear 
visualisation of the mouse skull landmarks (Paxinos et al 1985). 
Following this initial preparation, mice were moved to the capillary opening setup and 
were fixed into the stereotactic frame. Gas inflow and outflow ports in the stereotactic frame 
allowed for maintaining the anaesthesia and scavenging waste gases throughout the 
experiment. Anaesthesia was maintained generally for < 1 h; breathing rate and other vital 
signs were continuously monitored throughout the experimental procedure. We fixed the 
mouse skull horizontally, at defined positions within the frame, using the ear bars. An 
intravenous 29G catheter was inserted into the mouse tail vein to allow for microbubble and 
drug administration (maximum intravenous injection volume: 10 μl g-1 of mass). Once 
successful intravenous access was confirmed, we fixed the catheter to avoid unwanted 
movement. Ultrasound coupling gel was then applied on top of the skin and skull to allow for 
ultrasound propagation. The water tank was positioned on top of the skull and the coupling 
gel. Using tweezers, we carefully placed the metallic grid in alignment with lambda and 
bregma.  
A raster scan was performed to locate the metallic grid using the 1 MHz focused 
transducer and the pulser-receiver. Typically, the raster scan range was 10 mm × 10 mm at a 
resolution of 0.5 mm × 0.5 mm along the lateral and elevational directions, respectively. The 
trigger delay and the acquisition length were adjusted in order to include reflections from an 
axial distance window that included the expected position of the metallic grid. After the end 
of the acquisition, we integrated the time-domain traces within defined time periods for all 
the raster scan positions. By adjusting the integration beginning and end points, we were able 
to delineate the metallic grid (top view of the grid, figure 6.2). We targeted the left 
hippocampus area (red star in figure 6.2) and moved the therapeutic transducer along the 
lateral and elevational axes in order to sonicate this region. The metallic grid was removed 
before sonication to avoid distortions in the acoustic field. The cross-sectional beam area was 
2 mm × 1 mm and covered the entire dentate gyrus of the brain (figure 6.4). 
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Figure 6. 3: Experimental protocol for blood-brain barrier opening experiments. 
 
We sonicated the target region with either long-pulse or rapid short-pulse sequences 
(table 6.I). The microbubble-drug solution was introduced into the circulatory system via the 
tail vein catheter, right after the start of the ultrasound exposure. SonoVue® microbubbles 
(Bracco, Milan, Italy) were freshly activated according to the manufacturer’s instruction 
before every experiment. Fluorescent 3 kDa Dextran (Texas Red, lysine fixable) was chosen 
as the model drug, in accordance with previous studies (Choi et al 2011b). Drugs with such 
molecular weight are impermeable to the blood-brain barrier (Kroll and Neuwelt 1998), thus 
we expected no drug delivery in the non-sonicated control areas. 100 μl of activated 
microbubbles were mixed with 2 mg of 3 kDa Dextran. The solution was further diluted with 
PBS to reach the maximum injectable volume of ~ 200 μl. For comparison, the clinically 
recommended dose for SonoVue® contrast agents in ultrasound imaging applications is 30 μl 
kg-1 or 2.4 ml for an average adult (Madjar et al 2000). The dose used in this pilot study was 
approximately 10 times higher than the dose in previous studies (Vlachos et al 2011, Choi et 
al 2011b) to ensure a therapeutic effect. Microbubbles were co-injected with Dextran, in 
accordance with previous studies using the same model drug (Choi et al 2011a, 2011b). 80% 
of the circulating SonoVue® microbubbles are cleared from the vasculature within 2 - 4 min, 
so we selected a BRF of 0.5 Hz and sonicated the left hippocampus with 125 bursts (table 
6.I). 
When treatment was completed, we administered 200 μl of pentobarbital via the 
intraperitoneal route to induce terminal anaesthesia. Mice were then transcardially perfused 
with 6 ml of PBS to clear blood out of the vasculature, followed by 6 ml of 4% 
paraformaldehyde (PFA) fixative (Sigma Aldrich, St. Louis, MO, USA). The perfusion rate 
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was controlled with a peristaltic pump and was approximately equal to 0.7 ml min-1. The 
brains were excised and placed into 4% PFA solution for fixation before sectioning. 
Table 6. I: In vivo experiments summary. 
Therapy 
scheme 
Pressure 
(kPapk-neg) 
PL (μs) PRF (kHz) BRF (Hz) 
Number of 
bursts 
Sample 
size 
Long 
pulses 
0.2 
10,000 N/A 
0.5 125 
3 0.4 
0.6 
Short 
pulses 
0.4 5 
1.25 
2 
0.6 50 3 
 
v. Histology 
Brains were kept in the 4% PFA solution for approximately 2 hours after excision. We 
chose to use a cryostat for faster sectioning of the brain samples. PFA was thus replaced by 
cryoprotective sucrose solutions to avoid crystal formation during sectioning. First, the brain 
was submerged in 15% sucrose for 2 - 3 hours and then in 30% sucrose overnight. The brain 
samples were kept at 4oC. As soon as the samples were cryoprotected, we embedded them in 
optimal cutting temperature medium (OCT; Agar Scientific, Stansted, UK) at dry-ice 
temperature. The blocks were then cut in a cryostat (CryoStar NX70; Thermo Fisher, 
Waltham, MA, US) into representative slices of either 10 μm or 30 μm thickness, at intervals 
of 300 - 500 μm. Unstained slices were dehydrated with ethanol (Sigma Aldrich, St. Louis, 
MO, USA) in increasing concentrations. The slices were then prepared either for fluorescence 
microscopy or haematoxylin and eosin (H&E) staining, to assess drug delivery and safety, 
respectively. 
 
vi. Fluorescence microscopy 
The drug delivery magnitude and distribution within the targeted region were evaluated 
using fluorescence microscopy. 30μm-thick slices were imaged with a WF3 - Zeiss Axio 
Observer (Zeiss, Oberkochen, Germany) inverted widefield fluorescent microscope. Texas 
Red molecules were excited at 562/40 nm and their emission was filtered at 624/40 nm. The 
exposure time was set to 2000 ms. We performed tile scans to acquire an overview of 
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fluorescence intensity in the entire brain (figure 6.4) and then zoomed in the left and right 
hippocampi. Each region of interest was cropped in Matlab and processed to calculate the 
normalised optical density (NOD) metric (Choi et al 2011b). NOD was a measure of the 
relative permeability increase in the sonicated area compared to the control area. In effect, 
NOD was found by summing the fluorescence detected in the sonicated area, and then 
subtracting the fluorescence detected in the non-sonicated control area, and then normalising 
the outcome with the fluorescence in the control area, i.e. the baseline. Artefacts such as 
slides folds were manually segmented and were not included in the NOD calculation. The 
two regions of interest had equal areas. The drug delivery uniformity was assessed using the 
coefficient of variation of the fluorescence intensity, which was calculated as /ICV I , 
where I  and I   were the mean and standard deviation of the intensity measured within 
the region of interest, respectively.   
 
 
Figure 6. 4: Example of a tile scan of a brain slice using fluorescence microscopy (PNP: 400 kPa, PL: 5 
cycles, PRF: 1.25 kHz). The sonicated hippocampus (left area) was compared to the non-sonicated hippocampus 
(right area) which was used as a control. Both areas were cropped around the dentate gyrus and analysed 
independently to evaluate drug delivery efficiency and safety. 
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vii. H&E staining 
The safety of each pulse sequence was tested using H&E staining, one of the most 
common histological stains. The slices were successively submerged in solutions containing 
5% Haematoxylin (5 min), tap water (5 min), 1% acetic acid (3 dips), tap water (5 min), 5% 
Eosin (5 min), tap water (3 min), and deionised water (2 min). The slices were then 
dehydrated with increasing concentrations of ethanol, placed in xylene, and mounted with 
DPX, before microscopy evaluation.  
 
viii. Cavitation analysis 
Microbubble acoustic emissions were passively captured using PCD (figure 6.1). We 
measured the energy emitted over time for every acoustic pulse using eq. (2.1). The captured 
time-traces were 11-ms long, i.e. 1 ms longer than the ultrasound burst, to allow for the 
electronic noise energy estimation. Spectral analysis revealed the acoustic cavitation mode 
during sonication. We performed a fast Fourier transform of the captured time-traces during 
the entire 10ms-long burst. The FFTs per pulse were then stacked over time and gathered into 
spectrograms.  
 
ix. Statistical analysis 
A one-way analysis of variance (ANOVA) test was performed to assess statistically 
significant differences for the pressure threshold experiment. A post hoc Bonferroni analysis 
was conducted to estimate significance in a pairwise manner. A two-sided Student’s t-test 
was performed to assess significance in the comparison between the drug delivery achieved 
using long and rapid short pulses. 0.05p   was considered statistically significant. Where 
applicable, measurements are presented as mean ± standard deviation. 
 
3. Results 
 
i. Pressure threshold 
Before evaluating the effectiveness of our new pulse sequence, we conducted an 
experiment to identify the pressure required for delivering drugs to the brain. Using 
conventional therapeutic ultrasound pulses (PL: 10 ms, PRF: 0.5 Hz), we evaluated three 
different peak-negative pressures, i.e. 200, 400, and 600 kPa (table 6.I). Enhanced drug 
delivery was observed with sonication at 400 kPa and 600 kPa but not at 200 kPa (figure 6.5). 
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Sonication at the lowest pressure tested yielded limited increase in the delivered drug dose 
within the targeted area (figure 6.6). On average, there was an increase of the NOD with 
acoustic pressure, indicating higher doses of drug delivery at high sonication pressures 
(figures 6.5 and 6.6). One-way ANOVA results showed that there was a significant difference 
between the three experimental groups, i.e. that the population mean differences were 
statistically significant ( 0.05p  ). Post hoc Bonferroni analysis revealed that there was no 
significant difference between 200- and 400-kPapk-neg pulses and between 400 and 600 kPapk-
neg ( 0.05p  ). However, there was a significant difference between sonication at 200 and 600 
kPapk-neg ( 0.05p  ). 
 
 
Figure 6. 5: Examples of fluorescent images of mouse brains sonicated at different acoustic pressures. 
(a,c,e) Sonicated and (b,d,f) control areas in the mouse brain for peak-negative pressures of (a,b) 200 kPa, (c,d) 
400 kPa, and (e,f) 600 kPa. PL: 10,000 cycles. White arrows indicate slide folds and not drug delivery. 
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Figure 6. 6: NOD at different acoustic pressures. Measurements are presented as mean ± standard deviation 
(n=3). PL: 10,000 cycles. *: p<0.05. 
 
PCD measurements provided information about the acoustic cavitation activity that was 
produced in the brain during ultrasound exposure. One of the most obvious observations was 
that the energy of the acoustic emissions increased significantly with acoustic pressure. The 
total energy roughly increased by a factor of ten for every doubling of acoustic pressure. 
Microbubble activity at a peak-negative pressure of 200 kPa was on average one order of 
magnitude lower than at 400 kPa, and two orders of magnitude lower than 600 kPa (figure 
6.7). Average energy values at low-pressure sonication were consistent and close to zero, 
accounting for the electronic noise contribution, throughout the therapeutic sequence. Instead, 
for higher pressures focal energies generally had a peak when microbubbles entered the field 
of view for the first time (figures 6.7(b) and 6.7(c)). A gradual decrease in the burst energy 
was then observed, due to either microbubble destruction or filtering from the lungs etc.  
PCD analysis also provided more subtle mechanistic information. Examples from 
individual experiments showed that microbubble-generated acoustic emissions decreased 
over time even at low-pressure sonication (figure 6.8(a)). The decrease was more pronounced 
at higher pressures (figures 6.8(b) and 6.8(c)). The rate of microbubble destruction was lower 
at 400-kPapk-neg sonication (figure 6.8(b)) than at 600-kPapk-neg sonication (figure 6.8(c)). 
Following the peak microbubble activity, the signal was maintained above noise levels for 
approximately 50 and 10 bursts during ultrasound exposure at 400 kPa and 600 kPa, 
respectively. We observed that the emitted energy presented consecutive high and low points, 
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which may indicate that the focal volume was not entirely replenished during the pulse off-
time. Frequency analysis revealed that harmonic contents dominated at this acoustic pressure 
regime (figures 6.8(e) and 6.8(f)). At the highest pressure tested, there were a few instances 
of broadband emissions (figure 6.8(f)), which indicated inertial cavitation events.  
 
 
Figure 6. 7: Average in vivo burst energy over time for sonication at peak-negative pressures of (a) 200 kPa, 
(b) 400 kPa, and (c) 600 kPa. Measurements are presented as mean ± standard deviation (n=3). PL: 10,000 
cycles. 
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Figure 6. 8: Example of burst energies (a,b,c) and frequency content (d,e,f) over time for sonication at 
peak-negative pressures of (a,d) 200 kPa, (b,e) 400 kPa, and (c,f) 600 kPa. Spectrograms showed the presence 
and magnitude of harmonic and non-harmonic microbubble acoustic emissions over time. 
 
Interestingly, there were instances where we observed the superharmonic Doppler 
effect in vivo (figure 6.9). In the 55th burst of a long-pulse sequence at 600-kPapk-neg (figure 
6.8(f)), we observed an asymmetric broadening in the harmonic microbubble emissions 6 ms 
after the start of sonication (denoted with white arrows in figure 6.9). A progressive increase 
in the asymmetric broadening towards the negative harmonic side indicated the presence of 
microbubbles moving away from the PCD transducer (chapter 4). To confirm that the shifts 
are due to the microbubble Doppler effect, we zoomed into the 4th and 8th harmonic (figure 
6.10). As shown before in vitro (figure 4.4), higher frequencies yielded larger Doppler shifts 
as expected. The negative shifts for the 4th and 8th harmonic were approximately 20 kHz and 
40 kHz, respectively. Converting these Doppler shifts using eq. 4.1 returned an effective 
velocity of 3.75 m s-1.  We hypothesise that a resonant bubble was accelerated for approximately 
100μs before hitting a vessel wall, covering a distance of approximately 400 μm. 
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Figure 6. 9: In vivo superharmonic microbubble Doppler effect. PNP: 600 kPa, PL: 10,000 cycles. 
 
Figure 6. 10: Zoomed microbubble emissions at the (a) 4th and (b) 8th harmonic. Doppler shifts increased 
linearly with frequency and originated from microbubbles moving at 3.75 m s-1. 
ii. Drug delivery with rapid short-pulse sequences 
To test whether our rapid short-pulse sequences improved the effectiveness and 
uniformity of drug delivery, we performed a pilot study using two representative sequences 
(table 6.I). Initially, we used a pulse length of 50 cycles at peak-negative pressure of 600 
kPapk-neg (BL: 10 ms, n=3), and then reduced the pulse length to 5 cycles and the peak-
negative pressure set to 400 kPapk-neg (BL: 30 ms, n=2). We compared the results with the 
gold standard, 10ms- or 10,000cycles-long pulse at the same acoustic pressures. 
We observed successful drug delivery using both rapid short-pulse sequences (figures 
6.11 and 6.13). At a PL of 50 cycles and PNP of 600 kPa, the blood-brain barrier was opened 
throughout the hippocampus and within the dentate gyrus (figures 6.11(a)). In contrast, the 
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non-sonicated area did not have observable Dextran penetration into the brain parenchyma 
(figure 6.11(b)).  
PCD measurements provided some mechanistic insight into the microbubble dynamics 
produced by the two pulse sequences. The acoustic energy generated for every burst was 
generally lower than the 10,000-cycle sonication, as expected. While the input energy was 
reduced by a factor of 15, the output energy was reduced by approximately 4 times. The 
maximum energy at rapid short-pulse sonication was approximately 0.09 V2s (figure 6.12(a)), 
while the maximum energy at long-pulse sonication was approximately 0.4 V2s (figures 
6.7(c) and 6.8(c)).  
However, the rate of decrease diminished for exposure at short pulses. Energy was 
sustained above the noise level for approximately 70 short-pulse bursts (figure 6.12(a)). In 
contrast, acoustic energy above the noise was maintained for approximately 10 long-pulse 
emissions (figures 6.7(c) and 6.8(c)). Intense harmonic emissions were observed throughout 
the burst sequence (figure 6.12(b)). Superharmonics persisted in the beginning of the 
sonication and progressively diminished over time, with higher order harmonics persisting for 
shorter durations (figure 6.12(b)). The presence of superharmonics is associated with high-
magnitude stable cavitation (chapters 2, 3, 4), thus their temporal persistence can be 
associated with the microbubble lifetime within the vasculature. 
 
 
Figure 6. 11: Dextran delivery at the (a) sonicated and (b) control areas. PNP: 600 kPa, PL: 50 cycles, 
PRF: 1.25 kHz. 
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Figure 6. 12: (a) Burst energy over time, and (b) spectral analysis of microbubble acoustic emissions. 
PNP: 600 kPa, PL: 50 cycles, PRF: 1.25 kHz. 
 
We also tested a short-pulse sequence consisting of 5-cycle pulses. By further 
decreasing the acoustic pressure and the pulse length, we observed blood-brain barrier 
opening and dextran diffusion into the sonicated hippocampus (figure 6.13). The spot-like 
pattern observed previously at the same pressure (figures 6.5(c)) was replaced by a more 
diffuse drug distribution with less saturated or over-treated areas (figure 6.13(a)). The 
produced distribution was exacerbated by accumulation of the fluorescent drug within large 
vessels, producing over-treated areas in their vicinity. PCD data showed that the acoustic 
emissions were lower than the long-pulse controls and the 50-cycle sonication. The measured 
burst energies started from a maximum value of approximately 0.04 V2s (figure 6.14(a)). In 
contrast to previous sequences that produced burst energies with high temporal variability 
(figures 6.7, 6.8, and 6.11), 5-cycle sonication produced more stable acoustic emissions 
which smoothly diminished with time (figure 6.14(a)). We performed the frequency analysis 
over the entire 30-ms burst, so the harmonic or broadband emissions produced by the short 5-cycle 
pulses were not observable in the frequency domain (figure 6.14(b)). 
 
Figure 6. 13: Dextran delivery at the (a) sonicated and (b) control areas. PNP: 400 kPa, PL: 5 cycles, 
PRF: 1.25 kHz. 
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Figure 6. 14: (a) Burst energy over time, and (b) spectral analysis of microbubble acoustic emissions. 
PNP: 400 kPa, PL: 5 cycles, PRF: 1.25 kHz. 
 
Despite the significantly lower acoustic energy using rapid short-pulse sonication, the 
resulting drug delivery was comparable for both sonication regimes. As indicated by the 
measured NOD within the sonicated region, the average increase in the total detected 
fluorescence was on the same order of magnitude (i.e. 107 a.u.) for long and short pulses 
(figure 6.15). On average, exposure with rapid short pulses led to moderately larger delivered 
drug doses. However, the difference was not statistically significant ( 0.05p  ). Sonication at 
600 kPapk-neg produced more variable results than sonication at 400 kPapk-neg, as suggested by 
the last standard deviation in both sequences.  
 
Figure 6. 15: NOD for sonication with long (grey bars) and short (red bars) pulses. 
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The coefficient of variation CV  was calculated to assess uniformity within the 
sonicated area (table 6.II). CV  was calculated as the ratio between the standard deviation and 
the average value of the fluorescent intensity within the focal volume. Low coefficients 
indicate limited dispersion of the pixel intensities around the mean value, i.e. more uniform 
drug distributions. Despite the smaller sample size, the 5-cycle sonication appeared to 
produce the more uniform distributions. In contrast, sonication with 10,000-cycles and PNP 
of 400 kPa resulted in highly variable and non-uniform drug distributions. Generally, short-
pulse sequences produced more uniform drug distributions than long-pulse sequences (table 
6.II). 
Table 6. II: Coefficients of variation across the pulse sequences (n=3). 
Ultrasound parameters Coefficient of variation (mean ± S.D.) 
PNP: 200 kPa, PL: 10,000 cycles 0.63 ± 0.18 
PNP: 400 kPa, PL: 10,000 cycles 0.81 ± 0.06 
PNP: 600 kPa, PL: 10,000 cycles 0.73 ± 0.04 
PNP: 600 kPa, PL: 50 cycles, 
PRF: 1.25 kHz, PL: 10 ms 
0.64 ± 0.04 
PNP: 400 kPa, PL: 5 cycles, PRF: 
1.25 kHz, PL: 30 ms 
  0.52 ± 0.03* 
*n=2. 
Finally, H&E staining did not reveal any extensive damage or haemorrhage in either 
sonication regime (figure 6.16). Both long (figure 6.16(a)) and short (figure 6.16(c)) pulses 
produced a limited amount of microvacuolations and dark neurons, but neither produced red 
blood-cell extravasation. The brain physiology did not present any notable differences 
between the sonicated (figures 6.16(a) and 6.16(c)) and the control (figures 6.16(b) and 
6.16(d)) regions.   
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Figure 6. 16: H&E staining of (a,c) targeted and (b,d) control areas using (a,b) long (PNP: 600  kPa, PL: 
10,000 cycles, BL: 10 ms) and (c,d) rapid short-pulse sequences (PNP: 600 kPa, PL: 50 cycles, PRF: 1.25 kHz, 
BL: 10ms). 
  
4. Discussion 
 
i. Blood-brain barrier opening using low-pressure short-pulse sonication 
In the last chapter of the present thesis, we applied the therapeutic sequences presented 
before (chapters 2 and 3) to effectively open the blood-brain barrier. We have demonstrated 
that despite the reduction of acoustic energy by a factor of up to 50, rapid short-pulse 
sequences produced a NOD increase on the same order of magnitude as long-pulse sequences 
(figure 6.15). Blood-brain barrier opening using closely-timed short pulses has been 
previously demonstrated (Hynynen et al 2003, O’Reilly et al 2011, Choi et al 2011b, 2011a, 
Bing et al 2009). However, in some of the aforementioned studies, extremely high peak-
negative pressures (above 6 MPa) (Hynynen et al 2003) or therapeutically-irrelevant centre 
frequencies (above 5 MHz) (Bing et al 2009) were used to produce the drug delivery effect.   
Here, we demonstrate for the first time that therapeutically-relevant, short-pulse 
sequences (PL: 5 cycles or 5μs, PRF of 1.25 kHz) can efficiently disrupt the blood-brain 
barrier at peak-negative pressure of 400 kPa (figure 6.13). Previous approaches at high 
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acoustic pressures consistently produced tissue and vascular damage (Hynynen et al 2003), 
with incidences of red blood cell extravasation and oedema formation (O’Reilly et al 2011). 
Although there was no microbubble activity characterisation in these studies, we speculate 
that the induced damages stem from the violent inertial cavitation events within the 
vasculature (Chen et al 2003a, Chomas et al 2001, Chen et al 2012, 2011). Sub-MPa acoustic 
pressures used here did not produce any observable damage to the sonicated mouse brain 
region (figure 6.16).  
To measure the acoustic cavitation activity within the brain during sonication, we 
passively monitored microbubble behaviours using PCD (figure 6.1). Previous studies have 
associated the magnitude of microbubble-seeded acoustic cavitation activity with the 
magnitude of the blood-brain barrier opening (McDannold et al 2006, Sun et al 2015). The 
pressure threshold required to open the blood-brain barrier was shown to depend on acoustic 
parameters such as the pulse length. Sonication at larger pulse lengths decreased the pressure 
threshold required to open the blood-brain barrier (McDannold et al 2008). PCD 
measurements during our pressure threshold experiments did not reveal detectable 
microbubble activity at the lowest pressure tested (figures 6.7 and 6.8(a)). The NOD found at 
200 kPapk-neg exposure was lower than twice the standard deviation of the control region, 
which is an arbitrary threshold set to determine successful drug delivery (Choi et al 2011b). 
Thus, the pressure threshold to open the blood-brain barrier using our system and detect 
microbubble activity through the mouse skull was higher than 200 kPapk-neg. Sonication at 
higher acoustic pressures increased the delivered drug concentration and produced higher 
magnitude of acoustic cavitation activity (figures 6.5, 6.6, 6.7, and 6.8). Higher harmonics 
were detected at peak-negative pressure of 600 kPa but not 400 kPa (figure 6.8). Limited 
broadband emissions were observed in the experiments at 600 kPapk-neg.  
 
ii. Superharmonic microbubble Doppler effect in vivo 
Wherever higher harmonics were detectable, we observed instances of the 
superharmonic microbubble Doppler effect during 10-ms-long ultrasound exposure (figure 
6.9). As shown previously (Tortoli et al 1999), microbubbles moving away from the detector 
due to primary acoustic radiation forces introduce frequency shifts in their acoustic emissions 
(chapter 4). We have shown that this effect can be readily characterised in the superharmonic 
region (figures 4.2 and 4.3). In the example shown here, we speculate that a resonant bubble 
entered the focal area and was violently accelerated away from the transducer. The 
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accelerated bubble reached a maximum effective velocity of 3.75 m s-1, before colliding with 
the distant vessel wall. Based on the spectrograms, the frequency shift lasted for 
approximately 100-200 μs (figure 6.10).  As expected, the Doppler shift increased linearly 
with frequency (eq. (4.1)). The asymmetric broadening was -20 and -40 kHz for the 4th and 
8th harmonic, respectively, confirming that the detected shifts are due to microbubble 
movement away from the transducer. Resonant bubbles may be present in the polydisperse 
population or may be created from coalescence of multiple smaller bubbles (Postema et al 
2004), as shown in the first chapter of this thesis (figures 1.15 and 1.18).  
 
iii. On the delivered drug distribution  
Resonant microbubbles colliding with large vessels at m s-1 velocities (figure 1.16) are 
expected to exert high stresses on the vascular wall. Also, large stresses can be exerted by 
microbubbles undergoing violent inertial cavitation (Hosseinkhah et al 2013). In either case, 
the induced stresses may disrupt the blood-brain barrier locally without affecting the 
surrounding areas. As discussed, the consequence is the production of spatially-constrained 
permeability increase (Stieger et al 2007, Nhan et al 2013). This effect was observed also in 
our experiments, where spot-like patterns emerged at long-pulse sonication (figures 6.5(c) 
and 6.5(e)) and 50-cycle sonication (figure 6.11(a)). We observed limited bright spots in the 
5-cycle sonication (figure 6.13(a)). Interestingly, a strong fluorescence signal was detected in 
the large vessels of the sonicated hippocampus, an effect shown in previous studies (Choi et 
al 2010). However, the Dextran distribution was generally more uniform (CV = 0.52 ± 0.03) 
than in the other exposure schemes ( CV = 0.81 ± 0.06; table 6.II). 
Although these initial conclusions are drawn based on a limited sample size, there is 
evidence that the bioeffect distribution is enhanced using rapid short-pulse sequences (figures 
6.5, 6.11, 6.13 and table 6.II). This enhancement was anticipated since rapid short-pulse 
sonication produces uniform acoustic cavitation distributions within the focus, as shown 
earlier (figures 3.6 and 3.7). We have demonstrated that the reason for this improvement is 
two-fold. Microbubble lifetime is enhanced (figure 2.5) because of the increased pressure 
threshold for inertial cavitation at shorter pulse lengths (Chen et al 2003b, 2003a). 
Microbubble mobility is enhanced (figure 3.11) due to the limited action of primary and 
secondary acoustic radiation forces (Dayton et al 1997). Taken together, increased 
microbubble lifetime and mobility instigated uniform treatments within the focal area in vitro 
(figures 3.6 and 3.7).  We showed here that these traits are likely to be maintained in vivo, 
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allowing treatment throughout capillary beds during a single ultrasonic burst and leading to 
more uniform distributions (figure 6.13). Unlike other pulse sequences that presented an 
oscillatory pattern in the emitted acoustic energy over time (figures 6.7, 6.8(a)-(c), and 6.12), 
5-cycle sonication maintained burst energy levels above the noise threshold throughout the 
burst sequence (figure 6.14(a)). This may be due to the limited microbubble destruction 
during a single burst, which leads to increased circulation times of the cavitation nuclei. 
Finally, short pulses do not lead to extensive cluster formation (figures 1.9, 1.11, and 1.13) or 
coalescence events (figures 1.15 and 1.18). These complex dynamics may contribute to the 
heterogeneous effects observed in long-pulse ultrasound therapy (figure 6.5).  
 
iv. Clinical relevance 
Blood-brain barrier opening using rapid short-pulse sonication may be used clinically 
for the treatment of Alzheimer’s disease, Parkinson’s syndrome, multiple sclerosis, and brain 
cancer. To provide an example of the latter case, glioblastoma multiforme (GBM) is one of 
the most aggressive types of brain cancer, with average survival length of 12 to 15 months 
after diagnosis (Bleeker et al 2012). One of the first clinical trials using low-power 
microbubble-mediated ultrasound therapy focused on the treatment of glioblastoma patients 
(Carpentier et al 2016). In this study, an implantable ultrasound transducer was fixed within 
the patient’s skull and delivered repeatedly non-focused 25ms-long ultrasonic pulses to open 
the blood-brain barrier. Drug delivery was achieved at pressures above 0.8 MPa. However, 
the resulting delivery pattern was periodic along the ultrasound propagation direction, 
possibly due to standing waves forming within the skull (O’Reilly et al 2010). Treatment 
with shorter pulses is expected to reduce the formation of standing waves (O’Reilly et al 
2011, Choi et al 2011b) and result in safer blood-brain barrier opening.  
 
v. Limitations 
Although our pilot study provided some insight on the efficacy and safety of rapid 
short-pulse sonication in vivo, it was constrained to a limited number of animals (n=14). We 
selected to test two distinct rapid short-pulse sequences in vivo (table 6.I), as illustrative 
examples from the infinite parametric space. In future studies, a more comprehensive 
parametric set needs to be explored, in order to investigate the influence of each of the 
acoustic parameter on the blood-brain barrier opening (McDannold et al 2008), using larger 
sample sizes. 
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Quantitative comparisons were conducted using the NOD index, in accordance with 
previous studies (Choi et al 2011b). NOD is a metric that sums the total fluorescence detected 
in the focus, normalised to a control area. However, it is sensitive to imaging and sectioning 
artefacts, such as saturated images, slide folding, cracking etc. Also, the location of NOD 
calculation changes the final outcome. Previous studies segmented the hippocampal area 
using automated algorithms (Choi et al 2011b), however here we segmented the sonicated 
and control areas manually. Image artefacts were manually cropped out and their intensity 
values were set to 0, thus biasing downwards the optical density values within the analysed 
region. Furthermore, the coefficient of variation is a crude estimate of drug distribution and is 
also sensitive to image artefacts and region selection.  
All the in vitro experiments presented in this thesis studied the dynamics of in-house 
manufactured microbubbles exposed to therapeutic pulses (chapters 1, 2, 3, 4, 5). However, 
we used clinically approved SonoVue® contrast agents for the in vivo part of our study. 
SonoVue® microbubbles are routinely used in ultrasound imaging applications (Cosgrove and 
Harvey 2009, Cosgrove 2006) and were thus used to enhance the clinical relevance of our 
results. Because of the different shell structure and size distribution, the two microbubble 
types are expected to exhibit different responses to therapeutic ultrasound exposure. 
SonoVue® exposed to short pulses may respond differently from the in-house microbubbles 
in terms of lifetime (figure 2.5), clustering or coalescence rates (figures 1.14 and 1.15), 
spatiotemporal uniformity within the focal area (figure 3.7), and translational dynamics 
(figures 4.5 and 5.8). Although we have not conducted a direct comparison between the two 
microbubble types, there is evidence that similar dynamics are produced in therapeutic 
exposure of SonoVue® microbubbles (Pouliopoulos et al 2016). 
Finally, as with all small-animal studies, our results may not be scalable or translatable 
to ultrasound therapy in the clinic. The mouse skull is much thinner than the human skull, 
thus the ultrasound beam gets less distorted due to skull-induced aberrations. Aberrations 
may alter the focal area and move the focus away from the intended location within a human 
brain. However, CT-based aberration corrections are currently used to circumvent this 
problem (Jones et al 2015, 2013). Furthermore, the blood-brain barrier structure in rodents 
may differ from the one found in primates and humans. Thus, the exerted stresses required to 
open this barrier may differ in humans. Lastly, the human hippocampus is larger in volume 
than the mouse hippocampus and may not be treatable by a spatially-fixed single-element 
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transducer. Larger treatment volumes will require either beam steering using a multi-element 
ultrasonic array or transducer movement during therapy.  
 
5.   Conclusions 
 
In this chapter, we applied rapid short-pulse sequences in order to open the blood-brain 
barrier in an efficient and safe manner. We compared our therapeutic design with ms-long 
pulses and found that the NOD increase was on the same order of magnitude in both regimes, 
while neither produced damage within the sonicated region of the brain. Short-pulse 
sonication resulted in more spatially homogeneous drug delivery distributions, as indicated 
by the improved coefficient of variation of the fluorescence intensity within the target area. 
This may be correlated with an enhancement in the spatiotemporal distribution of acoustic 
cavitation activity, as shown in vitro. PCD measurements showed that stable cavitation 
activity was maintained for longer periods during rapid short-pulse ultrasound therapy.  
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CONTRIBUTIONS 
In the present doctoral dissertation new ultrasound exposure sequences and monitoring 
techniques were developed, in an effort to increase the control over the microbubble 
dynamics emerging in ultrasound therapy. We first studied the interaction arising in a 
microbubble population within a therapeutic ultrasound field. Using our empirical 
observations and evidence from the literature, we designed new ultrasound pulse shapes and 
sequences in order to achieve uniform and homogeneous distribution of cavitation activity 
within the focal volume. The resulting microbubble dynamics were studied using existing 
therapy monitoring techniques. However these techniques were unable to capture the 
microbubble translational dynamics. Thus, we developed a new therapy monitoring tool to 
estimate microbubble velocities by analysing the Doppler effect arising in the microbubble 
acoustic emission. We studied microbubble movement both along the ultrasound propagation 
direction and across a 2D plane. Finally, we applied our therapeutic approach to achieve 
blood-brain barrier opening in a mouse model.  
High-speed microscopy revealed that microbubbles exposed to low-pressure 
therapeutic ultrasound tend to form clusters and coalesce into larger bubbles. Microbubbles 
moved continuously under the influence of secondary acoustic radiation forces and formed 
aggregates of 1 - 3 microbubbles μm-1 at clustering rates of 0.01 - 0.02 microbubbles μm-1 
ms-1. The clustering magnitudes and rates generally increased with the acoustic pressure. We 
showed that a simple time-average model can approximate the microbubble translational 
dynamics during low-power ultrasound exposure. We observed instances of collective 
microbubble coalescence that led to large bubble formation. Resonant bubbles moved in m s-1 
velocities along the ultrasound propagation direction. Secondary radiation potential and force 
fields were created as a tool to characterise secondary Bjerknes interaction range and 
directionality.  
 We introduced a new therapeutic pulse shape and sequence design, which comprised 
of μs-long pulses emitted at repetition frequencies on the kHz range. Rapid short-pulse 
sonication was assessed in vessel-mimicking phantoms using PCD and RCB-PAM. We 
found that short-pulse exposure extends the microbubble population lifetime up to 5 times, 
when compared to long-pulse exposure at the same acoustic pressure. Enhanced lifetime in 
conjunction with enhanced mobility produced more uniform and homogeneous distributions 
of acoustic cavitation activity within the focus. Better distributions were achieved at the 
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expense of lower acoustic energy in the focus. Thus, we observed a trade-off between 
magnitude and uniformity of acoustic cavitation activity.  
Inspired by previous work in the ultrasound imaging regime, we developed a method of 
estimating microbubble velocities using their acoustic emissions during ultrasound therapy. 
We observed that the acoustic signature of moving microbubbles contains information about 
their velocity, expressed as an asymmetric broadening of their harmonic emissions due to the 
Doppler effect.  We characterised the effect in the superharmonic region and used it to 
passively measure microbubble effective velocities during ultrasound therapy. The measured 
velocities were on the order of 1 - 3 m s-1 in accordance with the literature and with our 
optical observations. Higher acoustic pressures increased the effective microbubble 
velocities, prior to the onset of inertial cavitation. We have also extended our method into 2D 
and produced maps of microbubble velocity across a plane. 
Finally, we used rapid short-pulse sonication to safely open the blood-brain barrier in a 
mouse model. Short pulses were shown to disrupt the barrier with the same efficiency 
compared to the long pulse controls. The amount of delivered drugs was similar for the two 
sonication regimes, but the drug delivery uniformity was moderately enhanced using short 
pulses. Microbubble activity in vivo was continuously monitored using PCD and confirmed 
that microbubbles undergo stable cavitation and survive for longer during short-pulse 
exposure.   
In conclusion, this thesis contributed towards better understanding, designing, 
monitoring, and producing microbubble-mediated ultrasound therapies. Our aim was to 
promote favourable microbubble dynamics while suppressing unwanted activities. Adequate 
control of microbubble dynamics in ultrasound therapy would allow for more efficient and 
safe treatments and pave the way towards the clinical implementation of this exciting, non-
invasive, targeted therapeutic system. 
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FUTURE WORK 
This Ph.D. thesis contributed several discrete technological advances that improve the 
ability to control microbubble responses that are useful in ultrasound therapy. This includes a 
new therapeutic ultrasound pulse shape and sequence and a technique that can monitor 
microbubble movement during therapeutic sonication. However, further advances in 
understanding, designing, and monitoring therapy are required in order to produce 
controllable ultrasound therapies that can be translated into the clinic.  
Understanding the dynamics of microbubbles exposed to a therapeutic field is an active 
research area. This study provided quantification of microbubble clustering during low-
pressure sonication and reported several interesting observations regarding microbubble 
behaviour during high-pressure sonication. Future experiments will attempt to systemically 
study microbubble responses during therapeutic sonication, to ensure reproducibility and 
clinical relevance of these results. Furthermore, our experimental study was limited by the 
stiff boundary condition, the low pressures tested and the low frame rate. Future studies 
should include experiments in more clinically-relevant conditions, in order to acquire more 
translatable results. Finally, a more comprehensive time-resolved model is required in order 
to model the microbubble movement at arbitrary pressures and distances in 3D.  
Rapid short-pulse sequences produced more uniform distributions of acoustic cavitation 
activity within the focal area. This was achieved by emitting μs-long pulses at pulse 
repetition frequencies on the order of kHz. This design can be modified in order to enhance 
the control of a polydisperse microbubble population. For example, amplitude-modulated or 
frequency-modulated pulses may be designed and tested. Modulation of the emitted 
ultrasound could activate microbubbles of different sizes, taking advantage of the different 
resonances within a microbubble population.  
RCB-PAM was used here to assess the acoustic cavitation activity uniformity. 
However, its efficiency was limited by the increased computational power needed during 
processing and the poor axial resolution. Optimising the RCB-PAM algorithm and exploiting 
both CPU and GPU processing would allow for the real-time implementation of this 
technique. Additionally, alternative techniques which eliminate the “tail effect” would be 
desirable, in order to further suppress erroneously detected acoustic cavitation activity. 
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The superharmonic microbubble Doppler effect provided an acoustic means of 
assessing microbubble velocities in 1D and 2D during ultrasound therapy. Although previous 
studies have investigated the motion of sonicated microbubbles reporting velocities on the 
order of m s-1, the acoustic measurements presented here were not accompanied by 
simultaneous optical observations. Future work involves the acquisition of high-speed 
microscopy observations to verify the acoustically-determined microbubble velocities. 
Furthermore, theoretical approaches should attempt to explain the produced Doppler shifts 
considering the collective behaviour of the microbubbles moving under therapeutic 
ultrasound exposure. 
Finally, the in vivo part of this thesis was constrained by the limited number of animals 
used. Despite being a short pilot study, it provided some evidence for more uniform drug 
delivery achieved through rapid short-pulse sonication. Future experiments will focus on 
expanding the parametric set tested in order to study the effect of each pulse shape and 
sequence on the produced therapy.  
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APPENDICES 
A. 1-MHz Sonic Concepts transducer calibration 
The beam profile along the lateral (x) and elevational (y) dimension was obtained from 
calibration of the 1-MHz Sonic Concepts transducer used in chapters 5 and 6. The FWHM 
was 2 mm and 1mm, along the lateral and elevational dimensions, respectively.  
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B. Permission documents for republication of copyrighted work 
Copies of the emails providing permission to use published figures from my own work 
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SYMBOL LIST 
Symbol Name 
A  Number of clustered microbubbles 
B  Clustering rate 
  Microbubble compressibility 
  Polytropic gas exponent 
f  Centre of frequency shift 
s  Microbubble shell viscosity 
  Ultrasound wavelength 
  Liquid viscosity 
l  Liquid density 
PFB  Perfluorobutane density 
  Surface tension 
  Microbubble shell elasticity 
  Ultrasound angular frequency 
c  Speed of sound 
D  Doppler shift energy 
d  Microbubble displacement 
totalE  Total acoustic energy 
E  Estimated acoustic energy 
addF  Added mass force 
dragF  Quasi-static drag force 
intF  Secondary Bjerknes force 
radF  Acoustic radiation force 
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secF  Estimated secondary radiation force 
0f  Microbubble resonant frequency 
cf  Ultrasound centre frequency 
Hf  Harmonic frequency 
SHf  Superharmonic frequency 
I  Pixel intensity 
M  Number of microbubbles 
m  Microbubble mass 
N  Number of channels 
frN  Number of frames 
nˆ  Normal vector 
O  Acoustic output 
P  Absolute pressure 
0P  Ambient pressure 
emP  Pressure emitted by microbubbles 
extP  Externally applied pressure 
pk negP   Peak-negative pressure 
p  Microbubble momentum 
q  Acoustic source strength 
q  Estimated acoustic source strength 
R  Microbubble radius 
0R  Resting microbubble radius 
S  Microbubble surface area 
occS  Surface occupied by microbubbles 
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r  Distance 
r  Mean inter-bubble distance 
T  Acoustic signal duration 
t  Time 
frt  Inter-frame time 
50t  Time at 50% of energy emission 
80t  Time at 80% of energy emission 
U  Secondary radiation force potential 
V  Microbubble volume 
0V  Resting microbubble volume 
measuredV  Measured voltage 
noiseV  Electronic noise voltage 
v  Microbubble velocity 
effv  Effective microbubble velocity 
w  Channel weights in RCB 
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ABBREVIATION LIST 
Abbreviation Explanation 
BL Burst length 
BRF Burst repetition frequency 
CV Coefficient of variation 
FFT Fast Fourier transform 
FWHM Full width at half maximum 
H&E Haematoxylin & Eosin 
HtB Harmonics-to-broadband 
LU Lateral uniformity 
NOD Normalised optical density 
PAM Passive acoustic mapping 
PBS Phosphate buffer saline 
PCD Passive cavitation detection 
PCI Passive cavitation imaging 
PL Pulse length 
PNP Peak-negative pressure 
PRF Pulse repetition frequency 
RCB Robust Capon beamforming 
RP Rayleigh-Plesset 
RF Radiofrequency 
SNR Signal-to-noise ratio 
SUI Spatiotemporal uniformity index 
TEA Time exposure acoustics 
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